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Summary
This investigation examines the efficiency and mechanism of neutralization of 
influenza A/PR/8/34 virus by three haemagglutinin (HA)-specific monoclonal IgGs 
(H36, H37 and H9) and their Fabs. The efficiency of neutralization by the Fabs was 
lower than that of their IgGs. This was concentration-dependent: 50% neutralization 
(N50) required 104- to 375-fold more Fab than IgG, and at N$>o required 15- to 208- 
fold more Fab than IgG. Affinities of the IgGs and Fabs were very similar and thus 
did not contribute to the difference in their neutralization efficiencies. The 
mechanism of neutralization of influenza virus by the IgGs was complex. At N90, the 
majority of the loss of infectivity was attributable to inhibition of virus attachment to 
cells, whilst at N50 inhibition of attachment accounted for only a minority of the 
infectivity loss, with the majority attributed to inhibition of fusion. In between N50 
and N90 both mechanisms operate simultaneously. In contrast, inhibition of 
attachment by the H36 and H37 Fabs was the dominant mechanism of neutralization 
throughout the range of concentrations studied. The H9 Fab did not inhibit virus- 
attachment, but inhibited virus-cell fusion. Therefore, it was concluded that the 
difference between the IgGs and their Fabs was the ability of the IgGs to display 
simultaneous neutralization mechanisms.
Post-attachment neutralization (PAN) provides compelling evidence of the 
ability of antibodies to neutralize by mechanisms other than inhibition of attachment. 
H36, H37 and H9 IgGs and their Fabs gave PAN at 4°C and 37°C. Efficiency of 
PAN by the IgGs was lower than the standard neutralization of free virus (STAN). 
The efficiency of PAN and STAN by the Fabs was similar, except for H9 Fab whose 
PAN activity was significantly greater than its STAN activity. The mechanism of 
PAN by both IgGs and their Fabs was inhibition of fusion.
The HA of influenza A/PR/8/34 virus goes through a series of 
conformational intermediates in the fusion process. Examination of the pre-fusion 
intermediate (created by treating at pH 5 and 4°C) using conformation-specific 
MAbs detected changes in the viral HA, but these were less extensive than in virus 
treated at pH 5 and 37°C (post-fusion conformation). The pre-fusion intermediate 
does not cause fusion, but is a fusion-committed state, as it can subsequently undergo 
fusion at high efficiency at pH 7.5 when the temperature is raised to 37°C. IgGs and 
Fabs did not inhibit the haemolysis of CRBCs by the pre-fusion intermediate, nor did 
they inhibit the conformational changes of the HA that trigger the fusion process. It 
was concluded that these antibodies interfere sterically with events that occur prior to 
the formation of the pre-fusion intermediate.
The point at which neutralization becomes irreversible was investigated 
using the three IgGs and a monoclonal IgA. Neutralization of virus in solution was 
shown to be reversible by removing antibody from the virus with ammonium 
hydroxide (pH 11.5) (AmOH). The reversibility of neutralization was also examined 
under conditions designed to mimic the early steps in the virus infectious cycle, (1) 
virus attachment to cells and (2) low pH-induced virus-cell fusion. Neutralization 
could be reversed by removal of antibody with AmOH, after neutralization of (1) 
virus attached to cells and (2) after low pH treatment of virus attached to cells. This 
suggested that these MAbs do not trigger a permanent loss of virus infectivity, but 
are required to be bound to the virus for the duration of the neutralization process.
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1 Influenza virus
1.1 Overview:
Influenza viruses belong to the family Orthomyxoviridae, which are enveloped 
viruses with a segmented negative sense, single stranded RNA genome (Lamb and 
Krug, 1996). The three types of influenza viruses A, B and C can be distinguished 
on the basis of the antigenicity of their nucleocapsid (NP) and matrix (Ml) proteins. 
The influenza A viruses are also assigned to specific subtypes based on the 
antigenicity of their major surface glycoproteins, haemagglutinin (HA) and 
neuraminidase (NA). Currently there are 15 known HA subtypes (HI to H I5) and 9 
NA subtypes (N1 to N9) (WHO Memorandum, 1980; Rohm et al., 1996). The entire 
spectrum of subtypes are found in aquatic birds, considered to be the natural 
reservoir of influenza A. However, a restricted number are capable of infecting 
mammals, including humans, swine, horses and marine mammals (Webster et al., 
1992).
The current nomenclature system of influenza A viruses includes the type of 
virus, the animal from which it was isolated if not human, the place of isolation, the 
strain number, the year and the subtype of HA and NA (WHO Memorandum, 1980). 
For example, A/Puerto Rico/8/34 (H1N1) is a human influenza A virus, isolated in 
Puerto Rico in 1934, is strain number 8, and has HI subtype HA and N1 subtype NA.
1.2 Influenza A virus infection and disease in humans.
1.2.1 Influenza-thedisease:
Influenza viruses are primarily respiratory pathogens, and are transmitted primarily 
via the aerosol route (Moser et al., 1979). The clinical outcome of the infection is 
dependent both on the virus strain and a number of host factors, such as age, 
physiological state and previous immunological exposure (reviewed in Kilbourne, 
1987). As a result of these factors the disease can have a spectrum of clinical 
outcomes ranging from asymptomatic to lethal due to viral pneumonia, but more 
frequently infection causes an acute debilitating febrile illness (Murphy and Webster,
2
1996). The incubation period is variable, ranging from 24 hours to 5 days and ends 
with an abrupt onset of illness that may include cough, myalgia, malaise, headache, 
high fever and nasal and conjunctival discharge (Kilbourne, 1987). In individuals 
with uncomplicated influenza disease symptoms normally resolve after 1 to 2 weeks. 
Influenza is mainly associated with the upper respiratory tract, but there can be 
involvement of the lung, or blood and can occasionally be associated with 
gastrointestinal and neurological symptoms (reviewed in Sweet and Smith, 1980). 
Secondary bacterial infections are common and in the pre-antibiotic era was a major 
contributor to mortality (Bisno et al., 1971). The risk of mortality is increased in the 
elderly (>65 years) and those with chronic diseases, such as diabetes, asthma, and 
diseases of the kidneys and heart (Kilbourne, 1987).
1.2.2 Epidemiology:
Influenza epidemics occur almost yearly during the winter months. Epidemics occur 
simultaneously along the same lines of latitude, for example, October to March north 
of the equator and from April to September south of the equator (Hope-Simpson, 
1981). Influenza disease is perpetuated by two types of antigenic variations, (1) 
antigenic drift and (2) antigenic shift. Both allow escape from the protective 
immunity in the population generated by infection by previous strains. Antigenic 
drift involves minor antigenic changes in the HA and NA and variants cause 
epidemics of disease, whereas world wide pandemics are caused by antigenic shifts, 
involving major antigenic changes of the HA and sometimes NA resulting from 
replacement of gene segments (Murphy and Webster, 1996).
It is generally accepted that influenza disease spreads via direct contact 
between infected individuals and non-immune individuals (Webster, 1998). 
However, this mode of transmission does not explain how an antigenic drift variant 
can cause simultaneous disease outbreaks in two geographically separate locations 
without a discernible connection. A controversial hypothesis to explain this 
phenomenon proposed that acute infection with influenza virus forms a persistent 
non-infectious state in the host. The host is then an asymptomatic carrier for 1 to 2 
years until seasonal changes, such as solar irradiation reactivate the infectious state 
and infect non-immune individuals (Hope-Simpson and Golubev, 1987; Hope-
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Simpson, 1992). At present no direct evidence exists that latent influenza infections 
can occur in humans or other animals, although a number of studies have 
demonstrated persistent infections in cell culture (Robinson et al., 1979; De and 
Nayak, 1980; Frielle etal., 1984). Alternatively, it has recently been appreciated that 
influenza circulates during inter-epidemic periods at a much reduced incidence. 
Therefore, this could also account for separate geographically distinct outbreaks 
during the winter months (Webster et al., 1992).
1.2.3 Antigenic variation o f influenza A virus.
1.2.3.1 Antigenic drift -
Antigenic drift in the HA occurs by the accumulation of point mutations leading to 
amino acid changes which alter the antigenic sites such that they escape immune 
surveillance (Webster et al., 1982). Antigenic variation in the HA occurs rapidly 
with new epidemiologically important drift variants possessing four or more 
antigenic substitutions in two or more antigenic sites. For example, six amino acid 
changes located in sites B, D, and E were found in the HI epidemic strain of 
influenza A/Chile/83 compared to the previous circulating HI strain (Wilson and 
Cox, 1990). In fact amino acid substitutions occur throughout the HA sequence with 
only a few stretches of conserved residues, indicating the plasticity and evolutionary 
potential of the HA (Both et al., 1983). Two hypotheses have been proposed to 
explain the high rate of variation in the HA:
(1) the mutation rate of the HA gene is higher than the other segments. Hence, 
the rate of neutral changes (silent mutations) is higher and results in a 
higher frequency of incorporation of these changes in the virus strain 
(Gojoborie/a/., 1990; Sugita etal., 1991; Cox and Bender, 1995).
(2) the high mutation rate of the HA is driven by the selective pressure of the 
host immune response (Palese and Young, 1982).
The structure of the influenza A evolutionary tree has been determined as cactus-like, 
with only one lineage (trunk) extending to the top, whilst all other lineages 
(branches) are short representing lineages that died out. The viruses that constitute 
the trunk of the evolutionary tree contain a higher frequency of amino acid
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substitutions in its HA than the viruses on the side branches. This supports the 
second hypothesis that the influenza A virus is undergoing positive Darwinian 
evolution due to the strong selective pressure of the immune response and that its 
primary immune evasion strategy is to “outrun” its immune system “pursuers” 
through new mutations (Fitch et al., 1991). Further strong support comes from 
studies of viral isolates from severely immunocompromised patients showing that the 
HA or NP of the viruses had not undergone any changes (Rocha et al, 1991; Klimov 
etal., 1995).
Antigenic drift can be reproduced in the laboratory by growth of influenza A 
with monoclonal antibodies (MAbs) to a single antigenic site. The escape mutants 
usually possess one amino acid change that prevents binding of the selecting MAb. 
These mutants occur at a frequency of approximately 10'5 (Yewdell et al., 1979; 
Webster and Laver, 1980). However, escape mutations do not arise when virus is 
grown in the presence of MAbs to two antigenic sites as the frequency of producing 
double escape mutants is 10'10. Infection with influenza produces a polyclonal 
antibody response with mixtures of antibodies to each antigenic site; hence it is 
difficult to envisage how antigenic drift mutants arise under these selection pressures 
(Wang et al., 1986). Studies of mouse and rabbit antisera to whole inactivated 
influenza have shown that some were able to select escape mutants, indicating that 
the polyclonal response was biased to a single antigenic site (Lambkin and 
Dimmock, 1995; Cleveland etal., 1997). This suggested that infection of previously 
immunologically naive individuals with influenza virus, such as young children, may 
produce a biased antibody response and drive antigenic drift. However, as changes 
in two antigenic sites are required to generate an epidemiologically important virus, 
then selection of variants may be sequential involving different hosts.
1.2.3.2 Antigenic shift:
Since the first human influenza A virus (H1N1) was isolated in 1933, antigenic shifts 
have occurred in 1957 with the emergence of the H2N2 (Asian influenza) virus, in 
1968 when the H3N2 (Hong Kong influenza) appeared and then in 1977 when the 
H1N1 virus re-emerged. However, the 1977 virus was not strictly speaking an 
antigenic shift as the virus had re-emerged, but it will be grouped as an antigenic 
shift, as it caused a pandemic in the younger members of the population that had
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been bom since the initial outbreak. Seroarcheological evidence has suggested that 
influenza viruses of the HI, H2 and H3 subtypes have infected humans since the 
mid-nineteenth century and there has been a cyclical alternation in there appearance 
(Masurel and Marine, 1973; Webster etal., 1992).
One of the questions central to influenza research to date is where the novel 
strains that cause pandemics come from? Phylogenetic evidence has suggested that 
pandemic strains were derived from avian influenza viruses (Fang et al, 1981; Kida 
et al., 1987). As a result three mechanisms for the introduction of new human 
pandemic strains have been proposed:
(1) Pandemic strains are derived from the reassortment of an avian strain with 
a circulating human strain. Molecular studies have provided convincing 
genetic evidence that the 1957 and 1968 strains arose by genetic 
reassortment. The 1957 H2N2 vims HA, NA and PB1 genes were derived 
from an avian origin, whist the remaining five internal genes were 
conserved from the circulating H1N1 strain at that time. Also the 1968 
H3N2 vims contained an avian vims-like H3 HA and PB1 genes, whilst all 
other genes were retained from the circulating H2N2 strain (Scholtissek et 
a l, 1978b; Gething et al., 1980; Fang et al., 1981; Kawaoka et al., 1989; 
Bean etal., 1992). Other studies have provided strong evidence for genetic 
reassortment in vivo, both between human and animal strains and in 
humans (Webster et al., 1971; Nishikawa and Sugiyama, 1983).
(2) Pandemic strains emerge by direct transmission to the human population of 
an avian strain or strain from another mammal that has become infectious 
for humans. Phylogenetic evidence has indicated that this mechanism may 
explain the appearance of the H1N1 1918 “Spanish influenza” (Gorman et 
al., 1991). Until recently it was considered that this mechanism would 
probably work by an avian to swine, swine to human transmission route as 
even though in volunteer experiments limited infection of humans with 
large doses of avian influenza had been achieved, there had been no report 
of natural infection of humans with avian strains (Beare and Webster, 
1991). In contrast, swine to human transmission had been described in Fort 
Dix in America (Rota et al., 1989). However, recently numerous reports 
have demonstrated direct transmission of avian influenza strains to humans. 
For example, influenza genes obtained from a woman with conjunctivitis
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was found to have an extremely high homology (98.2%) with a H7N7 virus 
isolated from turkeys (Banks et al., 1998). Also most strikingly 18 cases of 
human influenza from multiple transmissions of H5N1 viruses from 
infected chickens were reported from Hong Kong (Claas et al., 1998; 
Subbarao et al., 1998). The human H5N1 virus was extremely similar to an 
avian H5N1 virus that had caused an outbreak in chickens in Hong Kong in 
March / May in 1997. Distinguishing features of the human and avian 
H5N1 strains included (a) a multiple polybasic amino acid cleavage site, a 
motif associated with high pathogenicity in avian viruses, (b) binding to 
NeuAcoc2,3-Gal containing receptors, not NeuAcoc2,6-Gal containing 
receptors, (c) a carbohydrate at position 158 on the HA which decreased 
affinity for cell receptors and (d) a 19 amino acid deletion in the stalk of the 
NA which resulted in a decreased ability to release virus from cells 
(Shortridge et al, 1998; Subbarao et al., 1998; Bender et al., 1999; 
Matrosovich et al., 1999). However, as with other direct transmissions of 
avian-like influenza virus, the human H5N1 virus showed no capacity for 
secondary transmissions to humans. Therefore, if the 1918 pandemic virus 
was a direct transmission of an avian-like virus then the feature it possessed 
to allow human to human transmission remains a mystery. A possible 
explanation is that the HI strain spread from avian to human some years 
prior to 1918, and adapted to its new mammal host before causing 
widespread disease (Reid et al., 1999).
(3) Pandemic strains which have caused epidemics previously may hide in an 
unchanged form before re-establishing infection. Evidence for this comes 
from the reappearance in 1977 of a H1N1 virus that was genetically 
identical to a virus that caused a human epidemic in 1950 (Nakajima et a l, 
1978; Scholtissek et a l, 1978a). Possible hiding places for this virus 
included preservation in frozen storage, preservation in an animal reservoir 
or integration into a host. As integration into a host has not been detected 
and virus from an animal reservoir would contain some changes, it is 
generally thought that the 1977 virus escaped from frozen storage, possibly 
from a laboratory (Webster et al, 1992).
As the most recent pandemic influenza strains of 1957 and 1968 have been
shown to be reassortants between human influenza and non-human influenza
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viruses, the question arises as to where this reassortment takes place? The pig 
has been the prime candidate for this role as it can be host for both avian and 
human influenza strains (Scholtissek et al., 1983). Serological and genetic 
studies of influenza virus (H3N2) isolated from children in the Netherlands 
indicated that they were human-avian reassortants and that they were generated 
and still circulating in European swine (Claas et a l, 1994). Also recent 
molecular characterisation of host cell receptor specificity has shown that 
receptors for both human and avian influenza strains were present in the pig 
tracheas and that avian-like swine viruses acquired the ability to recognise the 
human virus receptors after continued replication (Ito et a l, 1998). However, 
the recent outbreak of H5N1 virus in humans implicates man as a possible 
“intermediate”, as the avian-like virus could mix with a currently circulating 
human influenza virus to form a new pandemic strain (Claas and Osterhaus, 
1998). However, conclusive evidence must await the arrival of the next 
pandemic influenza virus.
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2 Structure of influenza A virus
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2.1 Overview
Electron microscopy of influenza A viruses grown in eggs or tissue culture cells 
(laboratory-adapted) showed that they are mainly spherical particles of between 80- 
120nm in diameter (Figure 2.1) (Nermut and Frank, 1971). In contrast, influenza 
viruses isolated from clinical samples are pleomorphic and may be spherical, 
elongated or filamentous (Home et al., 1960).
The lipid envelope of the virus is derived from the host cell plasma membrane 
(Kates et al., 1961) and contains 3 types of viral transmembrane proteins, the HA, 
NA and M2. The HA and NA glycoproteins project radially outward to 
approximately 14 nm from the surface of the virus and there are estimated to be 
between 400 and 1200 spikes on influenza viruses (Tiffany and Blough, 1970; 
Wrigley, 1979; Taylor eta l, 1987). The M2 protein is an ion channel protein and is 
present on the virion surface in only a few copies (Zebedee and Lamb, 1988; Jackson 
et al., 1991; Hughey et al., 1992). Internal to the lipid bilayer is the viral matrix 
protein (Ml), which is 3 to 4nm thick and encloses the ribonucleoprotein (RNP) 
complexes (Reginster and Nermut, 1976; Ruigrok et al, 1989). The RNP complexes 
can be separated into different size classes and contain 4 types of proteins with 8 
different segments of ssRNA (Pons, 1971; Rees and Dimmock, 1981). The proteins 
include the nucleoprotein (NP) and three polymerase (P) proteins (PB1, PB2 and 
PA). Electron microscopic examination has shown that the RNPs are flexible rods 
with terminal loops and helical mid-section (Pons et al., 1969). The RNP comprises 
the RNA-dependent transcriptase complex, and purified cores carry out cap binding, 
endonuclease, RNA synthesis and polyadenylation reactions (Bishop et al., 1971a; 
Bishop et al., 1971b; Bishop et al., 1972; Compans and Caligiuri, 1973; Plotch et al., 
1979; Plotch et al., 1981; Pritlove et al., 1998). The NS2 protein is an integral 
component of the virion associating with the Ml protein and present in 
approximately 130-200 copies (Richardson and Akkina, 1991; Yasuda et al., 1993). 
The genome is composed as 8 negative sense RNA segments, which encode 10 gene 
products (Table 2.1) (Lamb and Choppin, 1983).
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Figure 2.1 A schematic diagram of the structure of the type A influenza virion
(adapted from Lambkin, 1994).
M1 
NP
NA
Lipid 
bilayer
Table 2.1 Influenza A RNA coding assignments for A/PR/8/34 strain (from Lamb 
and Choppin, 1983)
RNA segment Length
(nucleotides)
Predicted 
Polypeptide length 
(amino acids)
Encoded
polypeptide
1 2341 759 PB2
2 2341 757 PB1
3 2233 716 PA
4 1778 566 HA
5 1565 498 NP
6 1413 454 NA
7 1027 252 Ml
97 M2
8 890 230 NS1
121 NS2
1 1
2.2 Influenza genes and the proteins:
2.2.1 RNA segments 1, 2, and 3 encode polymerase proteins PA, PB1 and PB2
The three largest RNA segments, 1, 2 and 3, encode the 3 polymerase proteins PB2, 
PB1 (basic) and PA (acidic) respectively (Mr -  82k to 95k), which are highly 
conserved among different subtypes (Lamb and Choppin, 1976; Horisberger, 1980; 
Murphy and Webster, 1996). In association with the NP and RNA they form the 
RNP complexes (Perales and Ortin, 1997). The PB2 subunit is required for initiation 
of transcription of viral mRNA, as it binds the 5’ cap of cellular mRNAs and its 
endonuclease activity cleaves them 10-13 nucleotides from their 5’ ends. These 
capped RNA fragments then serve as primers for viral mRNA synthesis (Ulmanen et 
al, 1981; Blaas et al., 1982; Braam et al, 1983; Licheng et al., 1995; Shi et al., 
1996; Perales and Ortin, 1997). However, the cap-dependent endonuclease and RNA 
synthesis activities does require all 3 polymerase protein components (Hagen et al., 
1994; Cianci et al., 1995). The PA is a phosphoprotein and is essential for cRNA- 
dependent virion RNA (vRNA) synthesis, but is also thought to regulate the 
synthesis of viral proteins at the level of mRNA expression (Herget and Scholtissek, 
1993; Nakagawa et al, 1996; Perales and Ortin, 1997; Sanz-Ezquerro et al., 1998). 
Expression of PA by transfection induces degradation of co-expressed proteins and 
this function has been mapped to the amino terminal region of the protein. However, 
the biological significance of this activity is not understood (Sanz-Ezquerro et al., 
1995; Sanz-Ezquerro et al., 1996). The PB1 proteins harbours the polymerase 
activity and is involved in elongation of viral mRNA synthesis, template RNA and 
vRNA synthesis (Braam et al., 1983; Ulmanen et al., 1983; Nakagawa et al., 1995; 
Kobayashi et al., 1996; Toyoda etal., 1996). Recently the RNA binding domain has 
been mapped to two sites on PB1 (Li et al., 1998). Characterisation of the RNA 
binding has found that the N-terminus and C-terminus appear to be involved in 
binding to the 5’ and 3’ arm of the panhandle (González and Ortin, 1999). Nuclear 
localisation signals (NLS) have been found in both the PB1 and PA proteins (Nath 
and Nayak, 1990; Nieto et al., 1994). The functional polymerase complexes PB1, 
PB2 and PA are localised to the nucleus of the cell, where all virus RNA synthesis 
occurs (Jones et al., 1986; Shapiro etal., 1987; Mukaigawa and Nayak, 1991).
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2.2.2 RNA segm ent 4 —Haemagglutinin (HA)
The HA is synthesised as a single polypeptide HAO (Mr ~ 76k). The HA spike 
glycoprotein is a homotrimer of non-covalently linked monomers (Wiley et al., 1977; 
Wilson et al., 1981) and is evenly distributed over the virus surface (Murti and 
Webster, 1986). An important determinant of infectivity is the cleavage of the HAO 
into two disulphide-linked chains HA1 (Mr ~47kD) and HA2 (Mr ~29kD) 
(Lazarowitz and Choppin, 1975; Tashiro and Rott, 1996). The HA has four major 
roles-
(1) responsible for virus attachment to target cells via interaction with sialic acid 
bearing host cell receptors (Lazarowitz and Choppin, 1975)
(2) is responsible for virus-cell fusion virus, which causes release of the core of the 
virus into the cytoplasm (White et al., 1982; Wharton et al., 1986)
(3) is a major determinant of virulence (reviewed by Webster and Rott, 1987)
(4) is the major viral antigen to which neutralizing antibodies are directed (Wilson 
and Cox, 1990).
Cleavage of the HA liberates the hydrophobic N-terminus end of HA2 (fusion 
peptide) which is vital for the virus fusion activity. Increased pathogenicity has been 
associated with the structure of the cleavage site as virulent avian H5 and H7 
subtypes possess a multi-basic residue cleavage site, whereas avirulent strains only 
possess a single arginine residue (Kawaoka and Webster, 1987; Vey et al., 1992).
The cleavage of avirulent strains is restricted to a limited number of proteases 
such as tryptase Clara (Kido et al., 1992), but the polybasic cleavage site of the 
virulent strains allows cleavage by proteases ubiquitously distributed among many 
cell types. This allows replication in many different organs, resulting in increased 
pathogenicity (Kawaoka and Webster, 1988; Steineke-Grober et al., 1992; Vey et al., 
1992; Horimoto and Kawaoka, 1994; Steinhauer, 1999). It is interesting that the 
H5N1 virus that recently infected humans in Hong Kong possessed the multi-basic 
cleavage site, but its infection was confined to the respiratory tract (Subbarao et al., 
1998).
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The X-ray crystallographic structure of bromelain-released HA from a H3 
subtype has been determined (Wilson etal., 1981). The trimer protein extends 135A 
from the viral envelope and has two distinct domains. A 76A fibrous stem formed 
from triple-stranded coiled-coil of a-helices derived from HA1 and HA2 residues 
extends from the envelope to a globular head domain, which consists mainly of anti­
parallel /1-sheets. The hydrophobic fusion peptides released by proteolytic cleavage 
of the HAO are buried between the subunit interfaces approximately 100 A from the 
top of the globular head. Recent determination of the X-ray crystallographic 
structure of recombinant vaccinia-expressed mutant HAO (H3N2) indicated that most 
of the structure is superimposable on that of the cleaved HA (Chen et al., 1998). 
However, the cleavage site forms a prominent loop that protrudes away from the 
surface of the trimer allowing accessibility to proteases. The trimer is stabilised by 
the fibrous stem region, with the globular heads forming a loose association. The 
globular head domain contains the HA receptor-binding site surrounded by the five 
major highly variable antigenic sites. The receptor-binding site consists of a pocket 
inaccessible to antibody, formed by residues of tyr98, trpl53, hisl83, glul90 and 
leul94 in most subtypes (Wilson et al., 1981; Wilson and Cox, 1990). Also the type 
of amino acid at residue 226 has been shown to alter receptor specificity for sialic 
acid linked to galactose by either NeuAca-2,6- or NeuAca-2,3- linkages (Rogers et 
al., 1983; Weis et al., 1988). The HA trimer is glycosylated during maturation and 
transportation to plasma membrane of host cell. The function of the carbohydrate 
chains are currently unknown, but it has been suggested that they could have an 
influence on tropism (Shortridge et al., 1998; Bender et al., 1999) and immune 
evasion by masking antigenic sites (Caton et al., 1982; Skehel et al., 1984; Wiley 
and Skehel, 1987).
2.2.2.1 Antigenic sites on the HI HA (influenza A/PR/8/34 H1N1 virus) -
There are four major antigenic sites on the HI HA; Sa, Sb, Ca and Cb (Figure 2.2) 
(Caton et al., 1982). Sites Sa and Sb lie at the top of the globular head near the 
receptor-binding pocket (Figure 2.3). They are in close proximity, separated by a 
polypeptide loop consisting of residues 156-160. The Sa site includes residues 128, 
129, 158, 160, 162 and 167. The Sb site lies to the rear of the Sa site on the globular
14
head and includes residues 156 159, 192, 193, 196, and 198,. The Sa site 
incorporates the “front-facing” residues of the separating polypeptide chain, 158 and 
160, whilst the Sb site utilises the “rear-facing” residues 156 and 159.
The antigenic site, Ca, can be differentiated into two sub-sites, Cal and Ca2. 
These two sub-sites are in close proximity in the trimer, as they span the monomer- 
monomer interface; hence in the trimer they are opposite each other. Site Cal 
contains residues 169, 173, 207 and 240. Site Ca2 consists of two loops containing 
residues 140, 143, 145,224 and 225.
The fourth antigenic site, Cb, includes residues 78 to 83 (excluding residue 80) 
and 122, at the bottom of the globular head of the HA.
2.2.2.2 Comparison o f antigenic sites on the HI and H3 HAs -
It is possible to compare the antigenic sites of the HI and H3 HAs as structurally 
important amino acids are conserved between both subtypes, indicating a similar 
overall 3-dimensional structure (Caton etal., 1982). However, the HA1 units of the 
HI and H3 HAs show a low overall homology of only 35% (Winter et al., 1981).
A comparison of the HI and H3 antigenic sites are shown diagrammatically in 
Figure 2.3 and in Table 2.1 (reviewed by Lambkin, 1994).
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Figure 2.2 Schematic representation of the H3 HA crystal structure. Shaded 
areas show the HI HA antigenic sites superimposed onto the H3 structure 
(adapted from Dimmock, 1993).
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binding site
Site Sa 
Site Ca2
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Globular
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1 6
Figure 2.3 A comparison of the antigenic sites on the HI HA (A/PR/8/34) and 
the H3 HA (A/Hong Kong/1/68) (Caton et a/., 1982; taken from Schofield, 1996).
Table 2.2 A comparison of antigenic sites on HI and H3.
Amino Acids Antigenic Site
H3 HI
133 and 137 and 140-148
140, 143, 145, 224 and 225
A Ca2
128, 129, 158, 160 and 162-167 
(not 164)
CHO-165 Sa
155-160 and 187-196
156, 159, 192, 193, 196 and 198
B Sb
52 and 277 C CHO-271
201 and 217
169, 173, 207, 240
D Cal
(63, 78, 83)
78-83 (not 80) and 122
E/CHO-81 Cb
Bold type - residues involved in antibody binding in H3 structure.
Italic type - residues involved in antibody binding in HI structure (these are given as 
their relative H3 position for ease of comparison)
CHO - glycosylated
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2.2.3 RNA segm ent 5 — Nucleoprotein (NP)
RNA segment 5 codes for the NP, a basic protein (Mr ~ 56k) which is 
phosphorylated in vivo (Privalsky and Penhoet, 1977; Petri and Dimmock, 1981; 
Privalsky and Penhoet, 1981; Arese and Portela, 1996). The NP interacts with itself 
and with the 8 viral RNA segments to form the RNP complexes. The purified virion 
NP protein assembles in vitro into polymeric forms ranging from trimers to 
structures indistinguishable from the RNP, being double helical hairpins indicating 
that the NP-NP interaction is critical for maintaining structure of the RNPs 
(Kingsbury and Webster, 1969; Pons et al., 1969; Ruigrok and Baudin, 1995; 
Prokudinakantorovich and Semenova, 1996). Recently the oligomerization domain 
has been mapped to the C-terminal third of the protein (Elton et al., 1999). The NP 
has RNA-binding activity, which has been mapped to two distinct regions of the N- 
terminal 180 amino acid of the NP protein, with one molecule of NP protein 
interacting with approximately 20 nucleotides of RNA (Compans and Choppin, 
1975; Baudin et ah, 1994; Albo et ah, 1995).
The NP protein accumulates in the nucleus due to the action of two 
independent nuclear localisation signals (NLS) at the C-terminal and N-terminal and 
their ability to interact with importin-a in the nuclear pore (Davey et ah, 1985; 
ONeill et ah, 1995; Wang et ah, 1997; Weber et ah, 1998). It has also been 
suggested that phosphorylation plays a role in nucleocytoplasmic transport of NP 
(Neumann et ah, 1997). Also recently an interaction between NP and actin filaments 
has been shown to cause cytoplasmic accumulation of the NP protein (Digard et ah, 
1999).
The RNP complexes are the functional templates for the replication and 
transcription of the genome and it has been found that NP in the complexes also 
interacts with the PB1 and PB2 proteins (Biswas et ah, 1998). Recently, it has been 
suggested that this NP-polymerase interaction is responsible for making vRNPs 
switch from mRNA to cRNA synthesis (Mena et ah, 1999). It is evident that the NP 
is a multifunctional protein of pivotal importance to influenza replication.
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2.2.4 RNA segm ent 6 — neuraminidase (NA)
The neuraminidase (NA) is a type II membrane glycoprotein with an uncleaved 
hydrophobic amino-terminal signal/membrane anchor domain and a 6 amino acid tail 
(Air and Laver, 1989). The NA represents approximately 20% of the spikes on the 
virus and has been described as mushroom-like in appearance, with a large oblong 
head domain supported by a thin stalk region (Laver and Valentine, 1969; Taylor et 
al., 1987). Analysis of the distribution of spikes on the virus surface by immuno- 
electron microscopy revealed a uniform distribution of the HA, whilst the NA occur 
in discrete patches (Murti and Webster, 1986).
The NA has a number of functions:
(1) It prevents self-aggregation of the virions by removing sialic acids residues from 
infected cells during both entry and release (Palese et al., 1974; Basak et al., 
1985). The neuraminidase enzyme (acylneuraminyl hydrolase) catalyses the 
cleavage of the a-ketosidic linkage between terminal sialic acid and an adjacent 
D-galactose (Gottschalk, 1957; Lamb and Krug, 1996).
(2) It facilitates passage of virus through the protective mucin-covered target cells in 
the respiratory tract, by desialylation of the sialomucoproteins (Colman and 
Ward, 1985; Klenk and Rott, 1988).
(3) It removes sialic acid from newly synthesised HAO polypeptide which allows 
proteolytic cleavage to occur (Schulman and Palese, 1977).
(4) It facilitates virus envelope-cell membrane fusion (Huang et al., 1980; Huang et 
al., 1985). However, the exact role, if any, the NA plays during fusion has not 
been elucidated and it has been shown the HA alone can mediate fusion (White 
et al., 1982).
It has also been suggested that the length of the NA stalk can confer host range 
specificity (Castrucci and Kawaoka, 1993; Luo et al., 1993). It is interesting that the 
avian H5N1 virus that infected humans in Hong-Kong possessed a 19 amino acid 
deletion in its NA stalk (Subbarao et al., 1998).
There are 9 known NA subtypes of influenza viruses and X-ray 
crystallographic structure of pronase released N2 neuraminidase has been determined 
(Assad et al., 1980; Varghese et al., 1983). The NA exists as a tetrameric spike. 
Each of the monomers are held together in the tetramer by disulphide linkages and 
consist of six topologically identical, four stranded, anti-parallel p-sheets, arranged in
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a propeller-like formation. The box-shaped head domain contains four enzyme 
active (catalytic) sites and has a circular 4-fold symmetry stabilised in part by 
calcium ions. The substrate binding site has been located to a large pocket on the 
surface of each subunit ringed by highly conserved charged residues which are 
important in enzymatic activity (Varghese et al., 1983; Lentz et al., 1987; Varghese 
et al., 1995). Specificity for either NeuAca2-3Gal or NeuAca2-6Gal sialic acid 
substrates is determined by the residues 275 and 431 which are located in the 
framework region of the enzymatic site, but not in the site itself (Kobasa et al., 
1999). The authors suggested that amino acid substitutions in these residues altered 
the conformation of the enzymatic site facilitating binding of different species of 
sialic acid. A mutant resistant to the new anti-neuraminidase drug zanamivir 
(4,guanidino-Neu5Ac2en) also had a mutation in framework residue, 119, again 
indicating the importance of the framework residues in the enzymatic activity (von 
Itzstein et al., 1993; Blick et al., 1995; McKimm-Breschkin et al, 1996; 
Sahasrabudhe et al., 1998). Studies with zanamivir-resistant mutants with changes 
only in their HA and with reassortant viruses, have indicated the critical importance 
of a balance between the affinity of the HA for sialic acid receptors and the extent of 
the removal of the sialic acid residues by NA, in the infectivity of influenza viruses 
(Gubareva etal., 1996; Kaverin et a l, 1998).
Neuraminidase activity can be blocked by anti-NA antibody (Jackson and 
Webster, 1982). This inhibition is substrate size-dependent indicating that the 
antibodies act by steric hindrance. Four antigenic sites on the neuraminidase have 
been mapped. They form a continuous circle around the catalytic site of a monomer 
and can inhibit binding of substrates (Colman et a l, 1983; Webster et al, 1984). 
The antibodies to NA are not neutralizing, but can decrease plaque size when added 
to the overlay (Kilbourne et a l, 1968).
The 6 amino acid cytoplasmic tail is highly conserved in all 9 subtypes of NA, 
suggesting that it has an important function. Using reverse genetics techniques, it 
has been suggested that the cytoplasmic tail affects the NA incorporation into 
virions, virion morphology, and virulence in mice (Bilsel et a l, 1993; Mitnaul et a l, 
1996). However, this has been contradicted by other studies suggesting that NA 
mutants lacking the cytoplasmic tail can be incorporated in virions and are infectious 
(Liu e ta l, 1995).
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2.2.5 RNA segm ent 7 :  matrix proteins M l and M2
RNA segment 7 of influenza encodes two proteins, Ml and M2. A co-linear 
transcript yields the mRNA for Ml protein and splicing of the co-linear mRNA gives 
rise to M2 protein (Lamb and Lai, 1982).
2.2.5.1 M l protein
Ml (Mr ~ 28k) is the most abundant protein in the virion (Skehel and Schild, 1971). 
The Ml is type-specific although some antigenic differences have been demonstrated 
between subtypes withMAbs (Schild, 1972; Le Comte and Oxford, 1981).
The Ml forms a shell beneath the lipid envelope and numerous studies have 
found an interaction between Ml and the membranes (Bucher et al., 1980; 
Gregoriades and Frangione, 1981; Ruigrok et al., 1989; Fujiyoshi et al., 1994). 
Investigation using membrane fractionation has also shown that a proportion of Ml 
associates with the plasma membrane in infected cells, and it has been suggested that 
it also interacts with the cytoskeleton (Kretzschmar et al., 1996; Zhang and Lamb, 
1996). An interaction between Ml and RNA has been demonstrated using immune 
electron microscopy, filter binding assays and blotting (Wakefield and Brownlee, 
1989; Ye et al., 1989; Murti et al., 1992). The X-ray crystal structure of the N- 
terminal portion of Ml (residues 2-158) at pH 4 has recently been determined (Sha 
and Luo, 1997). This Ml fragment structure forms dimers and binds single stranded 
RNA non-specifically via 10 positively charged residues (95-105). The authors also 
propose that a conformational change facilitates interaction of the hydrophobic N- 
domain with the membrane. The electrostatic interaction of the Ml with viral RNA 
allows encapsidation of the RNP complexes and also inhibits transcription and 
replication (Zvonarjev and Ghendon, 1980; Ye et al., 1989). Ml is the main 
regulatory of RNP nuclear transport, promoting export, but inhibiting import (Martin 
and Helenius, 1991a; Martin and Helenius, 1991b; Whittaker et al., 1995; Whittaker 
eta l, 1996; Bui et al., 1996).
2.2.5.2 M2 protein
M2 is a 92 amino acid type III integral membrane protein (Mr ~ 15k) (Lamb et al., 
1985; Hull et al., 1988). It is expressed abundantly on the apical surface of polarised 
epithelial cells, but only a small number of M2 molecules are incorporated into
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virion particles (14-68) (Lamb et a l, 1985; Zebedee and Lamb, 1988; Hughey et al., 
1992). M2 exists as a disulphide bond-linked homotrimer on the cell surface and is 
post-translationally modified by phosphorylation and palmitoylation (Lamb et al, 
1985; Sugrue et al., 1990b);Holsingereta/., 1994).
Extensive studies have revealed a role for the M2 protein in the early and late 
stages of virus infection. Using the anti-viral drugs amantadine and rimantadine, it 
has been determined that when the M2 protein is expressed in cells and in planar 
lipid bilayers, it has ion channel activity allowing the transport H+ ions (Duff and 
Ashley, 1992; Pinto et a l, 1992; Wang et a l, 1994). Amantadine inhibits ion 
transport by binding to the transmembrane domain and blocking the ion channel. 
Resistant mutants possess changes that do not allow interaction with the drug (Hay et 
a l, 1985; Duff and Ashley, 1992; Schroeder et al, 1994). From these studies it was 
suggested that the M2 channel allows passage of H+ ions into the interior of the 
virus, and hence acidification of the core during virus uncoating (reviewed by Hay, 
1992). Acidification of the core influences the rate of fusion and be necessary for the 
dissociation of Ml from the RNP (Martin and Helenius, 1991b; Martin and Helenius, 
1991a; Bron e ta l, 1993; Wharton et al, 1994; Bui et a l, 1996).
M2 also plays a critical role in later stages of infection by modulating the pH of 
intracellular compartments. This prevents the newly synthesised HAO being exposed 
to low pH that would trigger a premature conformational change and result in the 
production of non-infectious particles (Sugrue et a l, 1990a; Ruigrok et al, 1991; 
Ciampor et a l, 1992; Grambas and Hay, 1992).
2.2.6 RNA segment 8: non-structural proteins N Sl and NS2
RNA segment 8 encodes two proteins, NSl and NS2. NSl is encoded by a co-linear 
mRNA transcript, whilst NS2 is encoded by a spliced mRNA.
2.2.6.1 NSl protein
NSl is a phosphorylated protein (Mr ~ 26k) and is abundantly expressed in infected 
cells being associated with polysomes, the nucleus and nucleolus (Lazarowitz et al., 
1971; Privalsky and Penhoet, 1981; Krug and Etkind, 1973). The protein is directed
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to the nucleus by two independent nuclear localisation signals (Greenspan et al., 
1988).
NS1 is a multi-functional protein that interacts with a plethora of cellular 
factors. Functions recently identified include - (1) stimulation of the rate of 
translation of viral mRNAs (Enami et al., 1994; de la Luna et a l, 1995), (2) 
regulation of nuclear export of mRNA (Fortes et al., 1994; Qiu and Krug, 1994), (3) 
inhibition of pre-mRNA splicing (Fortes et al., 1994), (4) inhibition of the activation 
of double-stranded RNA-activated protein kinase mechanism (Lu et al., 1995), and
(5) host gene expression shut-off by down-regulation of cellular mRNA maturation 
at the point of polyadenylation site cleavage (Shimizu et al., 1999). Two functional 
domains have been identified in the NS1 protein: an N-terminal RNA-binding 
domain and an effector domain in the carboxy-half (Qian et al., 1994). The 
inhibition of the nuclear export of mRNA is due to the interaction of two host cell 
proteins with the effector domain of NS1. The NS1 interacts with the 30kD sub-unit 
of the host cell cleavage and polyadenylation factor (CPSF) and the poly(A)-binding 
protein II (PAB II) (Chen et al., 1999). This interaction means that 3’ cleavage of 
cellular RNAs, followed by poly(A) polymerase (PAP) catalysed addition of a short 
poly(A) tail is inhibited. This results in the accumulation of cellular pre-mRNAs 
with short poly(A) tails that can be used as primers for viral mRNA synthesis. The 
RNA binding domain has been implicated in the inhibition of pre-mRNA splicing 
(Fortes et al., 1994; Lu et al., 1994). The NS1 interaction with the U6 small nuclear 
ribonucleoprotein (snRNP), a key component of the catalytic core within the 
spliceosome disrupts its function and inhibits splicing (Lu et al., 1994; Qiu et al., 
1995). Recently, it has been suggested that NS1 also interacts with a novel 70Kda 
human protein, designated as NSl-binding protein (NS1-BP) which also seems to 
have a role in inhibition of splicing (Wolff et al., 1998). Collectively, the functions 
of the NS1 protein may allow it to regulate the switch from early to late protein 
synthesis by retaining late viral mRNAs in nucleus until the appropriate time. This 
would require the NS1 protein at some point losing its functions, and this may be 
brought about by inhibition of post-translational modification, such as 
phosphorylation (Lu et al., 1994; Vogle e ta l,  1994).
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2.2.6.2 NS2 protein
NS2 (Mr ~ Ilk) is a structural protein present in the virion, in association with the 
Ml protein, at approximately 130-200 copies, (Richardson and Akkina, 1991; 
Yasuda et al., 1993). The NS2 protein facilitates nuclear export of viral RJSiPs by 
acting as an adapter between the RNPs and the cellular nucleoporins of the nuclear 
transport machinery (O'Neill et al., 1998). It has recently been renamed as the 
nuclear export protein (NEP) based on its function and its newly identified structural 
role.
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3 Infectious cycle of influenza A virus
3.1 Overview
The infectious cycle of influenza A can be divided into the following 8 steps:
(1) Attachment
(2) Entry (internalisation)
(3) Uncoating
(4) Primary transcription of input vRNA
(5) Replication of vRNA and secondary transcription
(6) Translation of mRNA to produce viral proteins
(7) Post-translational modification of viral proteins
(8) Assembly of virus structural components and release of progeny virus
Steps 1 to 3 are shown in Figure 3.1.
3.2 Virus attachment to target cell receptors
Influenza A virus infection is initiated by attachment of the HA to N-terminal 
acetylneuraminic acid residues (sialic acid) present on cell surface glycoproteins or 
glycolipids (Gottschalk, 1957). The sialic acid residues are ubiquitous on a diverse 
number of cell types. This allows influenza virus to attach to a wide range of cells, 
but not all cells are permissive for infection. Influenza viruses differ in their 
recognition of NeuAca-2,3-Gal or NeuAca-2,6-Gal linkages (Rogers and Paulson, 
1983). Human strains generally show a specificity for NeuAca-2,6-Gal linkages, 
whilst avian strains recognise NeuAca-2,3-Gal linkages, but this can be sub-type 
specific (Pritchett et al., 1987). The HA-sialic acid interaction is of low affinity 
2x10'3M, but a high avidity is achieved by multi-valent interactions (Pritchett and 
Paulson, 1989; Sauter et al., 1989; Glick and Knowles, 1991). The binding kinetics 
of influenza virus attachment to MDCK cells has recently been analysed. More 
virions can bind at lower temperature (4°C) compared to physiological temperatures, 
but there is a higher affinity binding at 37°C (Nunes-Correia et al., 1999).
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Figure 3.1 The influenza A virus infectious cycle. Steps 1 to 3 (taken from Outlaw 
and Dimmock, 1993).
Step 1. Attachment
Step 1 Entry
Plasma
membrane
Endosome
Nucleus
Lysosome
Step 3. Uncoating
The receptor binding site on the H3 HA is a pocket at the distal end of the HA1 
molecule and its constitutive residues are highly conserved (Wiley et al., 1981). The 
base of the pocket is formed by a phenolic hydroxyl residue, Tyr 98 and the aromatic 
ring from Trp 153. The rear of the pocket is formed by residues Glu 190, Leu 194, 
His 183 and Thr 155, whilst the left hand side and right hand sides of the pocket are 
formed by residues 134 to 138 and 224 to 228 respectively. Single amino acid 
substitutions correlate with alterations of receptor specificity. A change from leucine 
to glutamine at position 226 correlates with a change in linkage specificity from 
NeuAca-2,6- to NeuAca-2,3-, while the opposite mutation reverses this effect 
(Rogers et al., 1983; Rogers et al., 1985). However, position 226 is not an exclusive 
determinant of receptor linkage specificity, as in HI strains position 226 does not 
appear significant, and also a study of a large number of H3 isolates indicated 
receptor linkage specificity correlated with position 226 in concert with changes at 
position 228 (Daniels et al., 1987; Connor et al., 1994).
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Recent studies have suggested a role for the cellular protein annexin V, in 
influenza virus attachment, perhaps as a secondary receptor after the initial sialic acid 
contact. However, a definitive role of annexin V in the influenza infectious cycle has 
not been elucidated (Otto et al., 1994; Huang et al., 1996). Also anti-HA antibodies 
can cause Fc receptor mediated uptake of influenza viruses into macrophages 
(Tamura etal., 1991).
3.3 Virus entry (internalisation).
Endocytosis is the uptake of ligands and solutes into vesicles that bud into the 
cytoplasm from the plasma membrane. There are four distinct types of endocytosis:
(1) clathrin-mediated endocytosis, (vesicles of 100-150 nm)
(2) caveolae (50-80 nm)
(3) macropinocytosis (500-2000 nm), and
(4) micropinocytosis (95-100 nm) (reviewed by Bishop, 1997)
Internalisation of influenza A virus occurs by receptor-mediated endocytosis
via clathrin-coated pits (Matlin et al., 1981; Marsh, 1984; Patterson and Oxford, 
1986). These specialised vesicles have a layer of the protein, clathrin, on the 
cytoplasmic side of the plasma membrane. The coat forms from lattices of hexagons 
and pentagons of the clathrin protein made from the functional unit called the 
triskelion. This complex event is triggered when clathrin is recruited to the plasma 
membrane by the AP-2 adapter complex, forming clathrin coated pits where virus- 
receptor complexes accumulate (AP-2 also recruits the membrane bound receptors to 
the coated pits). These pits eventually expand inwards and pinch off into the 
cytoplasm forming coated vesicles (reviewed by Mellman, 1996). Following 
internalisation virus containing vesicles are uncoated and fuse with endosomes.
Receptor-mediated endocytosis can be inhibited by a number of treatments 
including (1) potassium ion depletion, (2) treatment with a hypertonic medium and 
(3) cytosol acidification (Heuser and Anderson, 1989; Heuser, 1989; Hansen et al., 
1993). These treatments inhibit different stages of the endocytosis pathway. The K+ 
ion depletion and hypertonic treatments are thought to remove membrane-associated 
clathrin lattices so that they form abnormal empty microcages in the cytoplasm,
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whilst cytosol acidification interferes with the clathrin-coated pit budding from the 
membranes (Hansen et al., 1993). Endocytosis is also temperature-dependent, being 
inhibited at 4°C (Matlin et al., 1981; Richman et al., 1986).
Virus entry into cells is rapid with a halftime of approximately 10 minutes, but 
this is virus strain and cell-type specific (Matlin etal., 1981; Yoshimura et al., 1982). 
There has also been one report that influenza can be internalised via non-clathrin 
coated vesicles in MDCK cells (Marsh and Helenius, 1989). However, it is unknown 
whether this represents a significant entry pathway for influenza virus.
3.4 Virus uncoating
Influenza A virus undergoes a two-stage uncoating process involving:
(1) Primary uncoating in which viral envelope fuses with endosomal vesicle 
membrane
(2) Secondary uncoating in which matrix protein is removed from the RNPs.
3.4.1 Primary uncoating
Primary uncoating involves the fusion of the virus envelope with the host cell 
endosomal membrane and release of the viral core into the cytoplasm. Fusion of the 
virus and endosome is mediated by the viral HA and is low pH-dependent. 
Acidification of the endosome occurs via the action of V-ATPase proton pumps in 
the endosomal membrane and results in an irreversible conformational change of the 
viral HA which triggers fusion (Wiley and Skehel, 1987; Stegmann et al., 1989; 
Bullough et al., 1994; Guinea and Carrasco, 1995). The ultimate mechanism of 
fusion of two membranes, remains obscure. However, many years of research, have 
elucidated many of the key steps.
The low pH-induced conformational changes of the HA are required to release 
the hydrophobic fusion peptides which are buried into the trimer structure at pH 7 
(Wilson et al., 1981; Bullough et al., 1994). The crucial role of the fusion peptide in 
the fusion process has been demonstrated by site-specific mutations in the peptide, 
which modified or abolished fusion activity (Daniels et al., 1985; Gething et al., 
1986a). Dissociation to some extent of the HA1 globular heads of the HA trimer is
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required for exposure of the previously cryptic fusion peptides and the fusion process 
itself, as demonstrated in studies which engineered intermonomer disulphide bonds 
to crosslink the HA1 domains (Godley et al., 1992; Kemble et al., 1992). 
Biochemical, biophysical and immunological studies also provided support for 
dissociation of the globular heads being a requirement for fusion (Dorns, 1993; 
Gaudin et al., 1995). This was also correlated with a disordered spike morphology of 
the HA at low pH and 37°C in cryo-electron microscopic studies (Puri et al., 1990). 
However, studies with the HAs of X:31 (H3 subtype) at 0°C and A/Japan (H2 
subtype) at 37°C indicated that dissociation of the globular heads was not required 
for fusion (Puri et al., 1990; Stegmann et al., 1990). In fact, as fusion was found to 
be more efficient at 0°C with the X:31 HA than at 37°C, it was suggested that the 
HA with maximal separation/dissociation of the globular heads was fusion-inactive 
and that the fusion-active conformation was an intermediate. It was proposed that 
the fusion-active intermediate HA, possesses a rearranged HA2 stem domain with 
exposure of the fusion peptides to the sides of the trimer, but maintains its native 
state globular head domain (i.e. no dissociation) ((Stegmann et al., 1990; Stegmann 
and Helenius, 1993). However, alternative studies proposed a two-stage model of 
the low pH-induced conformational changes of the X:31 strain HA, based on 
immunological probing (White and Wilson, 1987; Kemble et al., 1992). Stage I of 
the model consisted of a partial dissociation of the globular head domains and 
exposure of the fusion peptide, and this was followed by stage II represented by 
complete (maximal) dissociation of the headgroups (Kemble et al., 1992). Recently, 
this model has been revised to a 3-state model, which describes the pH-driven 
transition from the native tense (T) state to a relaxed fusion-active (R) state, followed 
by the desensitised (D) state (Korte etal., 1999).
A leap forward in the understanding of the conformational changes that occur 
during fusion came with the determination of the X-ray crystallographic structure of 
a derivative of the low pH HA, called TBHA2 (Bullough et al., 1994) (Figure 3.2 B). 
The TBHA2 fragment was constructed by incubating bromelain-released HA (BHA) 
at low pH, followed by digestion with trypsin to cleave off the globular heads and 
finally by digestion with thermolysin to digest the fusion peptides. The crystal 
structure of the fragment revealed massive rearrangements of the HA2. The most
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Figure 3.2 The low pH-induced conformational change in HA. (A) The 
structure of the TBHA2 monomer in schematic form at neutral pH, and (B) the 
corresponding region of the TBHA2 monomer following the low pH 
conformational rearrangements (Bullough et a/., 1994; taken from Schofield, 
1996). The regions of the HA2 chain are labelled A-H. The first strand of the HA1 
chain is also shown (grey arrow). The disulphide bond between 14] and 1372 is 
shown as a black line. The two structures are aligned upon the C region, which is 
unaffected by the conformational change. Arrow structures represent P-sheet 
domains and rectangles represent a-helical domains.
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striking change was that a loop, designated B (Figure 3.2 A and B), had been 
transformed into an a-helix. This connected to existing a-helical regions A and C 
and probably acts to project the fusion peptide approximately 100A away from the 
virus surface. Also residues 106-112 convert from a helical configuration to an 
extended loop which causes the D helix to be flipped by 180°C. Interestingly, 
approximately 20 C-terminal amino acids which should not be present in the TBHA2 
fragment were not resolved indicating that they possessed a disordered or flexible 
conformation and suggested that they may form the connection to the transmembrane 
region. (Bullough et al., 1994; Hernandez et al., 1996). Electron microscopic study 
of HA containing virosomes which had been pre-treated at low pH and reacted with 
an antibody that binds to residues surrounding HA2 107 indicated that this region 
had been inverted 180° and was now approximately llOA from the viral envelope 
(Wharton et al., 1995). The inverted structure is supported by a study that showed 
that treatment of virus at low pH in the absence of target membrane released fusion 
peptides that inserted in to the viral envelope and resembled its own HA2 
transmembrane domain (Weber etal., 1994).
Fusion activity is variable between influenza strains. HI, H2 and H3 HA 
subtypes have different kinetics of inactivation of their fusion activity after 
incubation at low pH at different temperatures, and this has correlated with 
differences in conformational changes in the HAs (Puri et al., 1990; Stegmann et al., 
1990; Korte et al., 1999). The subtypes also show differences in the temperature- 
dependence of their fusion activity. X:31 HA is fusion active at 0°C, whilst A/PR/8 
HA (HI subtype) does not show any fusion activity below 15°C (Tsurudome et al., 
1992; Pak et al., 1994). However, most fusion studies have concentrated on the X:31 
HA and numerous models to explain HA-mediated membrane fusion are based on 
observations of this strain.
In this review I will concentrate on only one of the numerous proposed models, 
as this in my opinion, has been afforded the most support through experimental data, 
but I will highlight major differences compared with other models. This model, 
proposed by Stegmann et al (1990) is based on observations of X:31 HA and 
suggests a pathway to the fusion of the two membranes without dissociation of the 
globular heads. The individual steps of the fusion model are described below (Figure 
3.3):
32
Step A: Schematic of the HA in its native conformation at pH 7.
Step B: The primary conformational change occurs rapidly after exposure to the low 
pH. This involves conformational changes in the HA2 stem region resulting in 
exposure of the fusion peptide. The globular heads do not dissociate and hence the 
fusion peptides are released to the side of the HA. An alternative model proposed by 
Hernandez et al (1996) disagreed and suggested that partial dissociation of the 
globular heads allow the spring loaded conformational change, seen in the X-ray 
crystal structure, to propel the fusion peptides towards the top of the HA.
Step C: Exposure of the fusion peptides leads to hydrophobic attachment of some of 
the HA molecules to the external bilayer leaflet of the target membrane. As the 
globular heads do not dissociate, it was suggested that a tilting of the HA allows 
insertion of the fusion peptide into both the target and viral membrane (Harter et al., 
1989; Stegmann et al., 1990; Stegmann et al., 1991; Tsurudome et al., 1992; Weber 
et al., 1994). Recent studies with isolated HA incorporated into model planar 
bilayers have shown that HA can tilt by approximately 80° at low pH and that this 
tilting is reversible upon return to pH 7 unless the HA is bound to a target membrane 
(Tatulian et al., 1995; Tatulian and Tamm, 1996). An alternative model suggested 
that tilting of the HA does not occur, but that the released fusion peptide on the sides 
of the HAs provide a hydrophobic surface that pulls lipid into the gap between the 
membranes forming a lipidic stalk intermediate that eventually breaks into a fusion 
pore (Bentz et al., 1990; Bentz et al., 1993; Lee and Lentz, 1997).
Step D: Formation of the fusion complex. After insertion of the fusion peptides into 
the target membranes there is a lag period in the fusion process that varies in length 
with temperature and virus strain (Spruce et al., 1989; Stegmann et al., 1990; Clague 
et al., 1991; Spruce et al., 1991; Stegmann et al., 1991). In fact it has been 
demonstrated that if the fusion process is interrupted at this point by return to pH 7, 
then the virus will remain in a fusion-committed state for times exceeding 60 minutes 
and will then undergo fusion at high efficiency when the temperature is elevated 
(Schoch et al., 1992). It has been suggested that during the lag phase clustering and
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Figure 3.3 Schematic model for the conformational changes and 
rearrangements of the HAs involved in the fusion process (taken from Stegmann 
etal, 1990).
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orientational changes occur in the trimers in the viral envelope, and these form a 
rosette-like fusion complex (Dorns and Helenius, 1986; Morris et ah, 1989; Ellens et 
ah, 1990; Clague et ah, 1991). The clustering of the HAs depends on their rotational 
and lateral mobility (Junankar and Cherry, 1986; Gutman et al., 1993). A study of 
the fusion activity of cell lines expressing different densities of HAs indicated that a 
minimum of three to four HA trimers are required to initiate a fusion event (Danieli 
etah, 1996).
Step E : Merger of virus and cell membrane bilayers. The bending of the HA with 
fusion peptides incorporated into the viral and target membranes brings the 
membranes into close apposition and causes bending of the membranes. The 
concerted bending action of the ring of HA trimers at the fusion site drives the outer 
leaflets of the bilayer to interact to form a restricted hemifusion intermediate (where 
only outer leaflets of the lipid bilayer mix) (Chemomordik et ah, 1998). HAs that 
had been engineered to be anchored in cell membranes via a 
glycosylphophatidylinositol (GPI) tail instead of the transmembrane domain, induced 
unrestricted primary outer leaflet lipid mixing (hemifusion), but not pore formation 
and full fusion (Kemble et ah, 1994; Melikyan et ah, 1995). The transmembrane 
domain of wild type HA is thought to restrict the flow of lipids and prevent 
expansion of the hemifusion intermediate beyond the proteinaceous ‘fence’ 
(Chernomordik et al., 1998). This is dependent on the number of HAs at the fusion 
site as if the number of activated HAs is too low to form a tight ring-like complex, 
then the growing hemifusion intermediate can break the fence and cause unrestricted 
hemifusion. Studies have indicated that the hemifusion intermediate consists of a 
lipidic stalk (Siegel, 1993; Stegmann, 1993). The molecular fence of HAs is 
proposed to focus attention within the fusion site to cause the transformation of the 
restricted hemifusion into an expanding fusion pore (Chernomordik et al., 1998). A 
flickering of early fusion pores has been observed indicating that this step is 
reversible (Spruce et ah, 1991; Melikyan et al., 1993a; Melikyan et al., 1993b). An 
alternative suggestion is that fusion occurs via a proteinaceous pore whose expansion 
leads to lipid merger (Tse et ah, 1993; Lindau and Aimers, 1995). However, 
argument against this is the recent observation of flickering fusion pores in protein- 
free lipid bilayers (Chanturiya etah, 1997).
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Step F : Dilation of fusion pore and dissociation of the ectodomains. This step of the 
pathway is very poorly understood. It is known that the initial pore undergoes a 
progressive widening with small aqueous contents being able to move through before 
large ones (Zimmerberg et ah, 1994). However, what drives the irreversible pore 
dilation is unknown. It has been suggested the further conformational change of the 
HA ectodomain desensitised (D) state, could drive this reaction, but at present there 
is no evidence for this (Stegmann et ah, 1990; Hernandez et ah, 1996).
An important question, still unanswered, about the HA-driven fusion process is 
whether the HAs that attach to cell receptors are responsible for the fusion activity. 
Numerous studies have provided evidence that receptor binding may facilitate fusion 
(Niles and Cohen, 1993; Stegmann et al., 1995). However, other studies contradict 
this, and indicate that attached HAs are not involved in fusion (Ellens et al., 1990; 
Alford et ah, 1994). One of these studies analysed the fusion activity of A/PR/8 
virus (H1N1) to liposomes containing different amounts of ganglioside receptors 
(GDIa). It was shown that fusion with liposomes containing 5 mol % ganglioside 
was greater than with liposomes containing two or three times more receptor (Alford 
et ah, 1994). The authors suggested that if the receptor bound HAs were of primary 
importance in the fusion process, then higher fusion efficiency should be seen with 
liposomes containing the greater number of receptors. In a recent study, the fusion 
of virosomes containing two antigenically distinct HAs that were activated to fuse at 
different pHs, with liposomes containing lipid-associated anti-HA monoclonal Fab 
fragments used as surrogate receptors, was analysed (Millar et ah, 1999). Using 
liposomes containing Fabs that bind to only one HA, the fusion capacities of bound 
or unbound HAs were analysed at different pH. The results showed that bound HA 
mediated fusion and secondly that a high density of non-specific Fab actually 
inhibited fusion by a process they termed “molecular overcrowding”. This study 
represents the strongest evidence yet that fusion is mediated by receptor-bound HA, 
and this in turn suggests that the attachment of receptor to HA may alter the fusion 
pathway, perhaps by altering the extent or rate of conformational changes 
(Tsurudome et ah, 1992). However, it should be stressed that the Fab surrogate 
receptors may not behave like sialic acid containing receptors, and that HAs can 
drive the fusion of receptor-free liposomes (Millar et ah, 1999).
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3.4.2 Secondary Uncoating
Secondary uncoating involves the dissociation of the Ml from the RNP. The 
dissociation is necessary for nuclear import of the RNP complexes (Martin and 
Helenius, 1991; Whittaker et a l, 1996). This has also been strongly supported by 
studies of the anti-influenza drugs amantadine and rimantadine, which inhibit Ml 
dissociation from vRNP during virus entry and inhibit vRNP transport to the nucleus 
(Bukrinskaya et a l, 1982; Martin and Helenius, 1991). These drugs inhibit the acid- 
activated M2 ion channel which is thought to permit flow of H+ ions into the virus 
interior channel (Hay et a l, 1985; Pinto et a l, 1992), indicating that acidification of 
the virus core was required for Ml dissociation. Acidification of vRNPs in vitro and 
in vivo has been shown to cause Ml dissociation (Zhirnov, 1990; Bui et a l, 1996). 
These studies have shown that acidification is the switch that allows the Ml to carry 
out its uncoating, nuclear transport and vRNP assembly functions. Transport of RNP 
to the nucleus after Ml dissociation is rapid (50% of total input NP antigen 
accumulated in nucleus in approximately 10 minutes in CHO cells), with the import 
of NP into the nucleus via nuclear pores being an active process dependent on ATP 
(Martin and Helenius, 1991; Kemler et a l, 1994). However, acidification of the viral 
core is not required for transcription of vRNP as purified RNPs treated at either 
neutral or acidic pH were transcribed (Kemler et a l, 1994).
3.5 Primary transcription of vRNA to mRNA
The RNA transcriptase and replicase functions of the virus are carried out by proteins 
PB1, PB2 and PA in association with the NP protein, which form the RNP complex. 
This complex transcribes the vRNA into mRNAs that are capped at the 5’ end and 
polyadenylated at the 3’ end (Glass et a l, 1975; Plotch and Krug, 1977). 
Transcription occurs by a unique cap-snatching process, in which the PB2 
component of the polymerase complex acts as an endonuclease and cleaves capped 
cellular RNAs 10 to 13 nucleotides from their 5’ ends, preferentially at a purine
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residue (Plotch et al., 1981) (Figure 3.4). The 5’ methylated cap fragments prime the 
transcription process by causing an allosteric modification of the polymerase 
complex (Kawakami et al., 1985). Transcription is initiated by the incorporation of a 
guanidine (G) residue onto the 3’end of the resulting fragments and is then elongated 
by the PB1 subunit of the polymerase protein until a stretch of 5 to 7 uridine (U) 
residues is reached, 15 to 22 nucleotides before the 5’ ends of the vRNA. 
Termination occurs by stuttering at the stretch of U residues causing the addition of 
poly(A) tail to the 3’ end (Plotch etal., 1981; Kitson et al., 1991; Zheng et al., 1999). 
The polyadenylation reaction has recently been shown to require a hairpin loop at the 
5’ end of the vRNA (Pritlove et al., 1999). The 3’ and 5’ ends of each of the RNA 
segments have a conserved 12 and 13 residues respectively that show inverted 
complementarity and form a panhandle structure (Desselberger et al., 1980; Hsu et 
al, 1987). This structure may have a regulatory role in transcription, replication, the 
endonuclease activity of the polymerase complex, and packaging of the RNA into 
virus particles (Hsu et al., 1987; Hagen et al., 1994).
3.6 Replication of vRNA
The synthesis of vRNA is dependent upon the production of viral proteins (Hay, 
1982). Replication of the vRNA occurs by initial synthesis of full length copies of 
vRNAs to form template RNAs, which are then copied into vRNA. The template 
RNAs are complete copies of the vRNA and lack the polyadenylated tail. As a result 
a change in the properties of the polymerase complex is required so that they switch 
from mRNA to cRNA synthesis. This involves changing from capped RNA-primed 
initiation on unprimed initiation and to anti-terminate at the poly(A)-site (Beaton and 
Krug, 1984). It has been determined that free NP interacts with the polymerase 
complex and is responsible for the switch to cRNA and anti-termination (Beaton and 
Krug, 1986; Shapiro and Krug, 1988; Mena et al., 1999). The NP is thought to bind 
to the RNA phosphate sugar backbone, and possibly melts the RNA secondary 
structure responsible for termination (Baudin et al., 1994).
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Figure 3.4 Mechanism for priming of influenza viral RNA transcription by 
capped cellular RNAs (taken from Lambkin, 1994).
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3.7 Translation of viral proteins
Production of new viral proteins is detected in infected cells after one hour of 
infection and is associated with a decrease in host cell protein synthesis which is 
complete after approximately 3 hours (Skehel, 1972; Skehel, 1973; Katze et al, 
1986). Translation of viral proteins is temporally regulated with NP and NS1 
proteins predominantly synthesised in the early stage of infection, whilst during late 
stages the NS1 production decreases and Ml, HA and NA production increases 
(Skehel, 1973; Meier-Ewert and Compans, 1974; Avery and Dimmock, 1975; Lamb 
and Choppin, 1976; Inglis and Mahy, 1979). The production of NS1 is thought to be 
important in host cell shut-off and in translation of viral gene products. Two 
different mechanisms have been proposed to explain shut-off of cellular protein 
synthesis:
(1) Degradation of pre-existing cellular mRNAs (Inglis, 1982; Beloso et al., 1992). 
It is thought that the degradation is initiated by cleavage of the 5’ methylated 
caps of cellular mRNAs which leaves them more susceptible to cellular 
nucleases.
(2) NS1 down-regulates cellular mRNA maturation at the point of polyadenylation- 
site cleavage (Shimizu etal., 1999). Inhibition of cellular pre-mRNA maturation 
results in a lack of export to the cytoplasm.
The level of translation in cells is dependent on the phosphorylation of the a-subunit 
of the initiation factor eIF-2. Influenza virus infection induces the phosphorylation 
of eIF-2 by an TNA-activated P68 kinase, (PKR) which suppresses translation 
(Katze et a l, 1986). However, NS1 protein is able to circumvent this host defence 
mechanism by binding to and preventing activation of the PKR (Lu et al, 1995; 
Hatadaefa/., 1999).
A number of the viral proteins undergo post-translational modification. The 
HA and NA are co-translationally inserted into the rough endoplasmic reticulum 
(RER) and the transported to the golgi complex for further post-translation 
processing (reviewed in Lamb and Choppin, 1983) (Figure 3.5). The HA trimer is 
formed in the RER before transit to the Golgi apparatus (Copeland, 1986; Gething, 
1986).
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Figure 3.5 The post-translational processing of the HA (taken from Schofield, 
1996).
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The M2 protein has a critical role in the maturation of the HA trimer as it 
regulates the intracompartmental pH in the trans-Golgi network and associated 
transport vesicles. This maintains the pH above the threshold at which the 
conformational changes of the HA occur that are responsible for fusion, and hence 
maintains infectivity of budding virus (Sugrue et al., 1990; Ciampor et al., 1992).
3.8 Assem bly and release of progeny virus
Influenza A viruses bud from the plasma membrane. Host cell proteins are excluded 
from the virions indicating the existence of unknown selection processes (Wang et 
al., 1976). The selection process is further apparent with some viral proteins, such as 
the M2 which is greatly underrepresented in the virion compared to its plasma 
membrane expression (Lamb et al., 1985; Zebedee and Lamb, 1988). It has recently
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been demonstrated that incorporation of the HA is affected by the length of its 
cytoplasmic tail, with mutant HAs possessing elongated tails being excluded from 
virions (Zhou et al., 1998). The Ml proteins form a layer beneath the plasma 
membrane and are associated with RNPs (Patterson et al., 1988). Interaction of Ml 
with the RNPs, may cause the Ml to polymerise and the membrane to bulge out 
(Simons and Garoff, 1980). The Ml-RNP interaction has not been detected near 
budding viruses, suggesting that budding is rapid (Patterson e ta l, 1988).
The process of viral budding is poorly understood. Influenza viruses are highly 
pleomorphic, with particles exhibiting spherical or filamentous morphology 
(Kilboume and Murphy, 1960). The filamentous morphology depends on interaction 
between the Ml and M2 proteins, suggesting an important role for these proteins in 
virion assembly and budding (Roberts et al., 1998). High virus yields have also 
previously been associated with the RNA segment 7 (M proteins) (Baez et al., 1980). 
The NA spikes play an important role in release of virus from the cell surface and 
preventing aggregation by destroying the cell membrane-associated sialic acid 
(Griffin et al., 1983). The importance of this activity has been underlined recently by 
the new anti-viral drug Zanamivir that inhibits neuraminidase activity and causes 
aggregation of virions at the cell surface (McKimm-Breschkin et al., 1998).
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4 Antibodies and the humoral response to influenza 
A virus
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4.1 Antibodies : Structure and function
4.1.1 Overview
There are five isotypes of immunoglobulin: IgA, IgD, IgE, IgG and IgM. All 
antibodies have a common core structure of two identical light chains (approximately 
25kD) and two identical heavy chains (approximately 50kD). The heavy chains are 
linked together and one light chain is attached to each heavy chain by disulphide 
bridges (i.e. HL+HL) forming a structure with bilateral 2-fold symmetry. All of the 
immunoglobulin classes have this structure, with the IgA and IgM consisting of 
multimers of this structure. Both types of chain consist of a series of repeating 
homologous units, each about 110 amino acids in length. These fold independently 
into a characteristic globular domain, known as an immunoglobulin domain. Many 
molecules of the immune system contain this globular domain and are said to belong 
to the Ig superfamily.
All Ig domains possess two layers of P-pleated sheet with three or four strands 
of anti-parallel polypeptide chain (reviewed in Abbas et al., 1994). Each chain has 
an amino terminal variable domain (Vl and Vh) and a carboxy-terminal constant 
domain (Cl and Ch). Each variable domain has three regions of hypervariability, 
called complementarity-determining regions (CDR) surrounded by framework 
regions. The pairing of the Vl and Vh domains form the antibody paratope that 
recognises the epitope of the antigen. The framework regions hold the CDRs in the 
correct position for epitope binding, although they have in some cases been found to 
contribute to epitope binding (Wilson and Stanfield, 1993). In both Vh and Vl 
regions there are three CDRs, but generally the heavy chain CDRs have most 
involvement, particularly the CDR-H3.
The Ch region has 3 or 4 domains and the first of these domains are separated 
by a hinge region (Figure 4.1). This structure can be cleaved at the hinge region can 
be cleaved by the proteolytic enzyme papain, producing 3 separate pieces. Two 
pieces are identical, consisting of the complete light chain and the Vh-Ch1 heavy 
chain fragment, is capable of binding antigen and are called the Fab fragments 
(approximately 50kD). The remaining piece is the Fc fragment consisting of the 
Ch2-3/4 domains. Alternatively, the enzyme pepsin cleaves neat the Ch2 domain, so 
the Fab regions retain the hinge and the fragment is known as F(ab)2.
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Figure 4.1 Schematic diagram of an IgG molecule, including its modes of 
flexibility (taken from Burton, 1990).
Fab arm waving
Fc wagging
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4.1.2 Immunoglobulin isotypes
4.1.2.1 IgG (murine) -  subtypes IgGl, IgG2a, IgG2b and IgG3.
IgGs are monomeric antibodies (approximately 160kD), constituting approximately 
70-75% of the plasma pool. They play a major role in the secondary response to 
infection. Murine IgG (used exclusively in this thesis) are segregated into 4 isotypes, 
IgGl, IgG2a, IgG2b and IgG3, based on differences in their sequence, carbohydrate 
content and disulphide bonding (Figure 4.2). Humans also have 4 subtypes of IgG, 
IgGl, IgG2, IgG3 and IgG4.
IgG possesses a large degree of structural flexibility (Figure 4.1). The Fab 
arms are capable of bending at the elbow region, and the angle of bend has been 
determined to range from 127.2° to 175.1° (reviewed by Padlan, 1994). If the IgG is 
bound monovalently to an antigen then the second Fab unit has rotational freedom 
about the hinge, thus displaying a propeller-like movement. Crystal structures of a 
murine IgG2a MAb revealed a large degree of flexibility with Fab regions loosely 
tethered to a mobile Fc region (movements of the Fc region have been termed 
‘wagging’) (Figure 4.1) (reviewed by Burton, 1990; Harris et al., 1992). Flexibility 
of the Fc region has been correlated with activation of complement (Oi et al., 1984). 
The IgG subtypes have different efficiencies of complement fixation, due to the 
flexibility of their Fc region. Their ability to fix complement are ranked 
IgG2b>IgG2a>IgG3>IgGl (Nisonoffet«/., 1975).
4.1.2.2 IgA
IgA represents 15-20% of the immunoglobulin plasma pool and is primarily involved 
in mucosal immunity. The majority of IgA is dimeric and is predominantly found in 
the seromucous secretions, such as saliva, tracheobronchial secretions, colostrum, 
milk and genito-urinary secretions (reviewed by Underdown and Schiff, 1987). The 
IgA dimer consists of two immunoglobulin units linked by disulphide bonds to a 
non-immunoglobulin J-chain (Mr = 15k). The IgA found in external secretions is 
known as secretory IgA (slgA) and contains an additional polypeptide, called the 
secretory component (Mr = 70k). The secretory component is initially part of the 
IgA receptor on epithelial cells, which the IgA binds to when it is transported to the
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Figure 4.2 Schematic representation of the structure of the four murine IgG 
subclasses (taken from Nisonoff et al, 1975).
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apical surface of the cell. The receptor is cleaved to form the secretory component 
and allows release of the antibody from the cell surface (Kuhn and Kraehenbuhl, 
1981).
4.1.2.3 IgM
The IgM accounts for most of the primary immune response to infection. It has a 
lower prevalence than IgG or IgA and is found exclusively in the serum. The IgM is 
a pentameric molecule consisting of five immunoglobulin units connected and 
stabilised by a J-chain (Davis and Schulman, 1989). In solution it has a star-like 
conformation, but can if interacting with a multivalent antigen, adopt a crab-like 
conformation. The IgM is very efficient at activating the complement cascade.
4.1.2.4 IgD
IgD accounts for only a small percentage (<1%) of the total plasma immunoglobulin. 
Membrane-bound IgD is found at high concentrations on the surface of circulating 
mature B-cells and may play a role in antigen-triggered lymphocyte differentiation 
(Roitt e t a l 1993).
4.1.2.5 IgE
IgE is responsible for defence against metazoan gut parasites and immediate 
hypersensitivity reactions to specific proteins, referred to as allergens, and cause 
chronic allergic conditions such as asthma and hay fever (Metzger, 1978; Mitchell, 
1979). IgE are found only in very limited quantities in the serum, but are found 
associated with the surface of basophils and mast cells due to the presence of IgE 
receptors. An allergen that cross-links IgE molecules on the surface, of mast cells 
triggers the release of ‘mediators’ that are responsible for the pathology of allergic 
disease (Metzger, 1978).
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4.2 Humoral Immune response to Influenza A
4.2.1 Overview
Infection with influenza A virus results in the production of antibodies to HA, NA, 
NP and M proteins (Kilbourne, 1987). However, only antibodies generated to the 
HA and NA glycoproteins are associated with resistance to infection (reviewed by 
Murphy and Clements, 1989).
Infection of immunologically naive children with a live attenuated influenza 
vaccine resulted in HA-specific IgA, IgM and IgG antibodies in nasal wash 
specimens by two weeks post-infection (Murphy et al., 1982; Murphy and Clements, 
1989). The IgM and IgA serum and nasal wash titres peaked at two weeks post­
infection and the IgM then declined. The serum IgG response peaked between four 
to seven weeks and in 50% of the children this coincided with a peak of nasal IgG 
response. Comparison of the specific activity of antibody in the nasal wash and 
serum, indicated that IgA is actively secreted to the nasal mucosa, because of the 
secretory component-mediated active transport of immunoglobulins possessing a J 
chain (Brandtzaeg, 1981). However, IgG present in the nasal wash is usually a 
transudate from serum (Wagner etal., 1987).
The secondary response to influenza is dominated by IgA and IgG, with IgM 
occurring variably, probably in relation to the degree of antigenic variation between 
viruses (Gonchoroff et al., 1982). Serum HI titres gradually decrease over the first 
six months, but may persist due to infection with related antigenic drift variants. The 
secondary response generates a greater degree of cross-reactive antibodies compared 
to the primary response, for example, in unprimed children (reviewed by Ada and 
Jones, 1986).
4.2.2 The role o f antibody in the recovery from influenza A virus infection
Infection results in a peak virus titre after 3 to 4 days, which then declines (Dhar and 
Ogra, 1985). The humoral response to HA does not peak until the second week post­
infection, which suggested that immunoglobulins had only a minimal role in 
recovery (Mims and White, 1984). This traditional view was supported by studies
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with athymic mice, which are unable to control infection and eventually succumb to 
it (Wells etal., 1981). These studies vindicated the importance of T-cell response in 
influenza infection and it has since been determined that both CD8- and CD4- 
positive T-cells play a role in the recovery of immunocompetent mice from primary 
infection (reviewed by Doherty etal., 1992; Topham etal., 1996b). However, other 
work has indicated that the B-cell response is indispensable and plays an equally 
important role in recovery from influenza virus infection (reviewed by Gerhard et al., 
1997). An early investigation of B-cell deficient mice indicated that there were two 
phases to the recovery process -  (1) a T-cell-dependent early phase (day 5-7) that 
resulted in a rapid decrease in virus titre and, (2) a B-cell-dependent late phase (day 7 
onwards), that eventually resulted in clearance (Iwasaki and Nozima, 1977). B-cell 
deficient mice showed the biphasic course of infection, but could not clear the 
infection and a steady increase in virus titre was followed by death. Further analysis 
with B-cell deficient pMT mice showed that they were more susceptible to highly 
pathogenic strains of influenza, such as A/PR/8/34 (H1N1) and A/Japan/305/57 
(H2N2), but were as susceptible as immunocompetent mice to the low pathogenic 
strain X:31 (an H3N2 reassortant) (Topham et al., 1996a; Gerhard et al., 1997). 
These studies demonstrated that the B-cell antibody response was of similar, if not 
greater importance, for recovery of primary influenza infection than CD8 T-cells.
The specific role of antibodies in the recovery from influenza virus has been 
analysed by passive transfer of HA-specific MAbs into severe combined 
immunodeficient (SCID) mice. An initial study showed that treatment with a 
mixture of MAbs resulted in complete clearance of infection (Scherle et al., 1992), 
Individual MAbs also showed a therapeutic activity which was greatly dependent on 
the immunoglobulin-isotype (Palladino et al., 1995), Intraperitonal administered 
virus-specific IgA or IgM MAbs could not cure viral pneumonia, despite having 
good neutralizing activity in vitro. Recovery from viral pneumonia was only 
possible by administration of IgG MAbs. It is thought that IgA and IgM antibodies 
have only a restricted access to the lower respiratory tract compartments hence their 
therapeutic activity may be restricted in a viral pneumonia (Palladino etal., 1995).
IgG MAbs contribute to the resolution of influenza virus infection in two 
principal ways (1) cell targeting (CT) activity, in which their binding to infected cells 
reduces the production of progeny virus, (2) virus neutralizing (VN) activity, in 
which binding to progeny virus inhibits further spread of infection (Mozdzanowska
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et al., 1999). Recent observations have indicated that MAbs with no VN activity in 
vitro fail to clear an influenza virus infection in SCID mice but reduce pulmonary 
virus titres. Therefore, CT activity is therapeutic, but MAbs resolve the infection to a 
greater extent by their VN activity (Mozdzanowska el al., 1997).
4.2.3 The role o f antibody in the protective from re-infection by influenza virus
The serum IgG response correlates closely with protection from influenza infection 
in humans (Couch and Kasel, 1983). Resistance to infection induced by a live 
attenuated virus correlated with levels of HA-specific IgG and IgA antibodies 
(Clements et al, 1986). Resistance to infection can also be conferred by passive 
administration of neutralizing antibodies. This has been shown with administration 
of anti-HA polyclonal and monoclonal antibodies in immunologically naive mice 
(Ennis, 1982; McLain and Dimmock, 1989). Protection against influenza virus 
challenge was also demonstrated with passively transferred anti-HA MAbs in SCID 
mice (Palladino et al., 1995). The protective activity was found not to be isotype- 
dependent, unlike that seen in recovery of influenza infection, with IgA, IgM and 
IgG all conferring protection to subsequent challenge. Interestingly, a recent study 
of IgA knockout mice (IgA'7'), showed that IgA is not required for prevention or 
recovery from influenza disease, as a control IgA+/+ mice showed similar levels of 
pulmonary virus replication and rate of clearance as the knockout IgA’7' mice 
(Mbawuike et al., 1999). This indicated that IgG and IgM responses could 
effectively replace IgA and protect from infection. However, passive transfer of 
polymeric IgA could protect from challenge, in agreement with previous studies 
(Palladino et al., 1995). This supports the idea that protective immunity is not 
immunoglobulin-class specific and underlines the importance of stimulating both 
systemic and mucosal immunity in vaccination strategies (Mbawuike etal., 1999).
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Neutralization can be accomplished by either antibody alone, termed simple 
neutralization, or by the interaction of the antibody with a number of secondary 
effectors, such as complement.
Simple neutralization can be defined as the in vitro process in which antibody 
interacts with virus and results in a loss of infectivity. The mechanism of 
neutralization is a complex process, in which antibodies can interfere with events at 
various stages of the virus infectious cycle. The mechanism of neutralization is 
dependent on a number of variables, including intrinsic properties of the virus and 
neutralization epitope, the isotope of the antibody, the cell receptor and the 
virus:antibody ratio. As a result, depending on the conditions, neutralization may 
occur by only one mechanism or by two or more mechanisms that occur 
simultaneously (reviewed by Dimmock, 1993; Dimmock, 1995). Numerous studies 
with HA-specific MAbs have correlated loss of infectivity, with loss of particular 
viral functions essential in the initial stages of infection and these are described in the 
following section..
4.3 Mechanisms of neutralization of influenza A virus.
4.3.1 Neutralization without involvement o f  the cell
4.3.1.1 Aggregation of virions -
Aggregation is due to crosslinking of viruses by antibody, which reduces infectivity 
by decreasing the number of infectious units present. It is dependent on the 
antibody:virus ratio, as it requires antibodies to have an available paratope and 
crosslink two or more viruses. Saturating concentrations of antibody form minimal 
aggregates as there are limited free epitopes (Dimmock, 1993).
Aggregation of influenza virus has been demonstrated with IgG, IgA and IgM 
(Taylor and Dimmock, 1985; Taylor and Dimmock, 1985; Armstrong et al., 1990; 
Outlaw et al., 1990; Armstrong and Dimmock, 1992). Aggregates formed by either 
of the immunoglobulin types were unstable and could be dispersed by vortexing 
(Armstrong et al., 1990). Aggregation of influenza A/fowl plague/Rostock/34
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(H7N1) (FPV/R) by IgG was concentration-dependent (Outlaw et al., 1990). For 
example, maximum aggregation by the HC2 antibody occurred as a sharp peak at a 
ratio of 0.1 HIU:1 HAU and then decreased with increasing concentration of 
antibody. The maximum aggregate size was 6.3 virus particles and this level could 
theoretically account for 79% neutralization, which correlated well with the actual 
percentage neutralization. However, as neutralization increased (>99%) with 
increasing antibody, the level of aggregation decreased indicating that the antibody 
was neutralizing by mechanisms other than aggregation. Similar results were also 
obtained for HC61 IgG, but HC10 IgG gave maximal aggregation without any loss 
of infectivity, suggesting that these aggregates were highly unstable.
Aggregation of influenza A/PR/8/34 virus by a polymeric IgA MAb was also 
concentration-dependent (Outlaw and Dimmock, 1990; Armstrong and Dimmock, 
1992). Maximal aggregation by the IgA gave >50 particles/aggregate. However, the 
maximum theoretical neutralization was only 41% from a total of >99% 
neutralization of infectivity. Similar observations were made with an anti-FPV/R 
IgM MAb, which aggregated virus, but theoretical neutralization levels could not 
account for the total actual percentage neutralization of infectivity.
Collectively, these studies indicated that aggregation could only account for a 
small proportion of the total neutralization of influenza viruses and that other 
mechanisms must account for remaining neutralization. This is especially striking at 
>99% neutralization levels at which point virus particles are monodisperse.
4.3.2 Neutralization in the context o f the cell
4.3.2.1 Inhibition of virus-cell interactions (attachment) -
Steric hindrance of the virus-cell receptor interaction has commonly been assumed to 
be the sole mechanism of neutralization of viruses by antibody. This mechanism has 
been supported by the X-ray crystallographic structure of BHA, which showed that 
the receptor-binding pocket was in close proximity to the major antigenic sites (Weis 
et al., 1988). Also it has been demonstrated that an anti-A/PR/8 HA IgG, H18-L9 
could inhibit the attachment of virus to a B-cell lymphoma line, A20 over a range of 
concentrations that correlated well with neutralization of infectivity (Eisenlohr et al.,
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1987). However, numerous other studies with IgM, IgA and IgG have indicated that 
the situation is more complex and even under conditions where antibodies can inhibit 
attachment, this is often not of sufficient extent to account for the total neutralization 
observed (Taylor and Dimmock, 1985; Taylor and Dimmock, 1985; Outlaw et al., 
1990; Outlaw and Dimmock, 1990; Armstrong and Dimmock, 1992).
Inhibition of attachment of influenza virus by a panel of six IgGs was 
dependent on concentration and cell type (Outlaw et al., 1990). At low 
concentrations, inhibition of attachment correlated relatively well with the 
percentage neutralization and increased with increasing IgG concentration. For 
example, at 63% neutralization, inhibition of attachment for the six IgGs ranged from 
30 to 55%. However, as the IgG concentration was increased to give higher levels of 
neutralization, the inhibition of virus attachment to cells was decreased, i.e. at 
>99.9% neutralization, 99% of virus attached to cells. This phenomenon was 
observed in both murine tracheal epithelial cells and BHK cells, where maximum 
inhibition of attachment was 55 and 50% respectively and then decreased with 
increasing IgG concentration. However, this was not observed with inhibition of 
virus attachment to chick red blood cells (CRBCs) in which the maximum level of 
inhibition of virus attachment did not decrease with increasing IgG. It was suggested 
that high concentrations of IgG had a restricted rotational movement due to their 
close packing on the virus surface. Also the BHK and murine tracheal cells possess 
long cell receptors in contrast to the short 5 nm glycophorin A receptors on the 
CRBCs, that allowed them to interdigitate with the fixed array of IgG allowing 
attachment (Viitala and Jarnefelt, 1985; Outlaw et al., 1990). Conversely, IgGs at 
lower concentrations are less densely packed, and so would interfere with the cell 
receptors due to their greater rotational freedom.
Inhibition of virus attachment by the anti-A/PR/8 polymeric IgA MAb, H37- 
66, was antibody concentration-dependent (Outlaw and Dimmock, 1990; Armstrong 
and Dimmock, 1992). At lower concentrations of IgA that caused up to 99% 
neutralization, no inhibition of attachment was detected (Armstrong and Dimmock, 
1992). However, at higher concentrations of IgA inhibition of virus attachment to 
cells increased to a maximum of 90%, compared with >99% neutralization of 
infectivity (Outlaw and Dimmock, 1990). As seen with the IgGs, when saturating 
concentrations of IgA were used attachment of virus to cells was restored.
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Analysis of the effect of an anti-FPV/R HA secretory IgA (slgA) purified from 
rat bile, on virus attachment to cells showed that it was concentration and 
temperature-dependent (Taylor and Dimmock, 1985). The slgA caused 90% 
inhibition of virus attachment to BHK cells and 96.5% neutralization at 4°C. 
However, when the temperature was increased to 25°C and 37°C, inhibition of 
attachment decreased to 50%, but neutralization remained high at 96.5%. The 
authors suggested that thermal agitation increased the probability of the virus 
attachment site and cell receptor interaction. Monomeric IgA, produced by 
differential reduction of the slgA, gave 98.5% neutralization, but did not inhibition 
attachment. Inhibition of virus attachment to cells by an anti-FPV/R polyclonal IgM, 
was similar to the IgA, being dependent on concentration and temperature (Taylor 
and Dimmock, 1985). At 4°C the IgM could block >95% of virus attachment to 
BHK cells, but raising the temperature to 37°C decreased this level to 53%.
In summary all of the immunoglobulin-types could inhibit virus attachment to cells, 
but this could not account for the total neutralization of infectivity and was strictly 
dependent on the prevailing conditions, such as concentration of antibody, cell type 
and temperature.
4.3.2.2 Neutralization o f virus after it has attached to cells (post-attachment
neutralization)
Post-attachment neutralization (PAN) is defined as the reduction in viral infectivity 
achieved by antibody reacting with virus that has already attached to a target cell, but 
has not yet fused with the target membrane (Armstrong and Dimmock, 1996). The 
ability to give PAN provides the most compelling evidence that antibodies can 
interfere with stages of the virus infectious cycle that occur after virus-cell 
attachment. This area of research has been neglected with influenza virus, apart from 
one study that showed that an anti-PR/8 polyclonal rabbit serum gave PAN at 4°C 
(Ishida and Ackermann, 1956). However, antibodies have been shown to give PAN 
in many other viral systems (Kjellen, 1985; Gollins and Porterfield, 1986; 
Blumenthal et al., 1987; Dietzschold et ah, 1987; Wohlfart, 1988; Farrell and 
Shellam, 1990; Vrijsen et ah, 1993; Osiowy and Anderson, 1995; Armstrong et ah, 
1996); Armstrong and Dimmock, 1996).
55
4.3.2.3 Inhibition o f virus internalisation into cells
Inhibition of the uptake of vims into clathrin coated pits has only been observed with 
polymeric IgM (Taylor and Dimmock, 1985; Outlaw and Dimmock, 1990). 
Proteinase-K digestion of IgM-neutralized vims that had attached to BHK cells, 
caused the release from the cells of >80% of RNA from 32P-labelled virions, 
compared to <20% of vRNA released from non-neutralized vims (Taylor and 
Dimmock, 1985). Bacterial neuraminidase treatment also released IgM neutralized 
vims-antibody complexes (Outlaw and Dimmock, 1990). These studies both 
demonstrate that IgM inhibited internalisation of the vims-IgM complexes into the 
cell. Vims attached to cells after neutralization with either IgG or IgA became 
progressively resistant to neuraminidase treatment during a 60 minute incubation 
indicating that neutralised vims was being internalised into cells (Armstrong and 
Dimmock, 1992; Outlaw and Dimmock, 1993)
4.3.2.4 Inhibition of virus -cell fusion (primary uncoating)
The fusion activity of enveloped vimses can be studied by labelling membranes of 
the vimses with a lipid soluble fluorescent probe, such as octadecyl rhodamine-B- 
chloride (R18) (Miller and Hutt-Fletcher, 1988). When R18 is present in lipid at 
high concentrations fluorescence is quenched, but when it is diluted by lateral 
diffusion following fusion with another membrane, fluorescence occurs 
(dequenching). This technique has been used with influenza vims to analyse the 
effect of neutralization by a panel of monoclonal IgGs on endosomal fusion in BHK 
cells (Outlaw and Dimmock, 1993). The IgGs all caused inhibition of endosomal 
fusion in a concentration-dependent manner. At concentrations required to give 63% 
neutralization, three of the IgGs, HC187, HC280 and HC19 neutralized by inhibition 
of fusion alone. However, at concentrations that gave >99.97% neutralization, two 
of the IgGs HC2 and HC61, caused partial inhibition of fusion with approximately 
20% vims-cell fusion still remaining. This suggested that these antibodies were 
capable of inhibiting a further stage of the vims infectious cycle.
A panel of IgGs have also been shown to inhibit the fusogenic activity vims 
with RBCs (Kida et al., 1983). In this study it was shown that when vims-antibody
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complexes were pre-treated at pH 5.9 prior to attachment, and then mixed with 
RBCs, the virus attached but haemolysis was inhibited. The authors concluded that 
the IgGs were inhibiting the low pH-driven conformation change of the HA required 
to initiate the fusion event.
Low concentrations of a polymeric IgA MAb, H37-66, allowed virus to attach 
and be endocytosed even though it caused >99% neutralization (Armstrong and 
Dimmock, 1992). Analysis of the intracellular distribution of viral NP indicated that 
it remained cytoplasmic, presumable in endosomes. This suggested that the IgA was 
inhibiting endosomal fusion / primary uncoating and the release of the viral core into 
the cytoplasm. In support of this was the observation that the IgA MAb could also 
inhibit cell-cell fusion under low pH conditions. The authors suggested that the 
polymeric nature of the IgA MAb was important in the fusion-inhibition activity 
based on two observations :
(1) that monomeric IgA produced by differential reduction had good neutralization 
activity but did not inhibit attachment or primary uncoating
(2) that electron microscopy showed that some IgA molecules appeared to be lying 
over on the virus surface, suggesting interactions with HAs with both its 
monomeric units (Armstrong and Dimmock, 1992).
It has been proposed that by cross-linking neighbouring HA trimers that HA mobility 
could be restricted (Schofield, 1996). Mobility of HA has been shown to be 
important in fusion as co-operativity of HA trimers seems to be critical in 
establishing a fusion pore, which is thought to comprise of a minimum of 3 to 4 HA 
trimers (Junankar and Cherry, 1986; Danieli et al., 1996). Hence, the IgA could 
inhibit HA co-operativity and mobility by cross-linking the HAs and inhibiting 
formation of a fusion pore (Schofield, 1996). However, analysis of the importance 
of valency in inhibition of fusion by IgG or IgA has not been carried out. This could 
be analysed by investigating the fusogenic activity of virus neutralized by 
monovalent Fab fragments.
4.3.2.5 Inhibition o f events which occur after primary uncoating
70% of vRNA of virus neutralized by HC2 IgG was located in the nucleus, but no 
transcription took place (Possee et al., 1982; Rigg et al., 1989). Analysis of the 
RNase resistance of vRNP from neutralized virus found it to be RNase-insensitive at
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37°C, compared to vRNP from non-neutralized virus which was 7-fold more 
susceptible to digestion (Rigg et al., 1989). Susceptibility to RNase digestion has 
previously been correlated with active transcription of vRNPs (Koff and Knight, 
1979). Therefore, it was proposed that the antibody was inhibiting a requirement for 
the vRNP to undergo a conformational relaxation, termed tertiary uncoating, which is 
required for transcription (Rigg et al., 1989). This was further supported by a study 
with the polymeric IgA, MAb, H37-66 (Armstrong and Dimmock, 1992). The IgA 
inhibits virus-cell fusion at low concentration. However, when the block to fusion 
was artificially bypassed using acidified PEG, then immunofluorescence showed a 
distribution of neutralized viral NP and Ml antigens that was indistinguishable from 
non-neutralized virus. Hence, as NP was transported to the nucleus it was assumed 
that the vRNP was present in its correct location, but that transcription did not occur.
In summary, antibody-mediated neutralization of influenza virus is a complex 
process which can occur by a single mechanism or by two or more mechanisms 
acting simultaneously. However, the properties of the antibodies that give them the 
ability to neutralize influenza virus by different mechanisms such as inhibition of 
attachment or inhibition of fusion has not been elucidated and requires further 
investigation.
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5 Materials and Methods
5.1 General Methods
5.1.1 Haemagglu tination assay
Virus was diluted in PBS to a required initial dilution and then 200 |il was added to 
row one of a 96 well round bottom plate (Greiner). This was double diluted across 
the plate to a final volume of lOOpl. 25(4,1 of chicken red blood cells (CRBCs) 
(Serotech) at 0.66% were added to each well using a dropper. This was mixed using 
a vibrator and incubated for 45 minutes at 20°C. The 50% agglutination end point 
was estimated by interpolation between complete agglutination and no agglutination; 
this being 1 haemagglutination unit (HAU). The titre is expressed as HAU per ml.
5.1.2 Haemagglutination-inhibition assay
The titre of unpurified antibodies was determined by their ability to inhibit 
haemagglutination of the CRBCs by the virus. The antibodies were initially diluted 
in PBS to the required initial dilution and then 200 pi was added to row 1 of a 96 
well round bottom plate (Greiner). This was double diluted across the plate to a final 
volume of 100 pi. 4 HAU in 25 pi of virus was then added to each well, mixed using 
the vibrator and incubated for 60 minutes at 20°C. 25 pi of CRBCs at 0.66% were 
added to each well using a dropper, mixed and incubated for 45 minutes at 20°C. 
The 50% end point is read as in the haemagglutination assay and the titre is 
expressed as Haemagglutination-inhibition units (HlU/ml).
5.1.3 Total protein quantitation
Ultra-violet absorbance
Purified protein was diluted in PBS to a final volume of 500 pi. Two quartz 
curvettes were prepared, the first containing 500 pi of PBS and the second containing 
the 500 pi of the protein sample. The two curvettes were placed in cells 1 and 2 of a 
UV Spectrophotometer set at a wavelength of 280nm and the curvette in cell 1 was 
used as a reference (to determine the background absorbance of the buffer) to set the 
instrument to zero. The curvette in cell 2 was then read and output recorded after
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allowing to stabilise. The total protein concentration was determined by reference to 
the extinction coefficient of the specific protein.
Bio-Rad dye binding assay
A standard curve of known concentrations of bovine IgG antibodies was obtained by 
using the Bio-Rad micro protein assay (Sigma). This involved adding 20 pi of IgG 
with 1 ml of Bio-Rad reagent (diluted 5-fold in distilled water and filtered through 
Whatmann filter paper) and incubating for 10 minutes. The samples were then read 
on a spectrophotometer at a wavelength of 595nm, using 1 ml of Bio-Rad reagent 
alone as the reference. The standard curve was plotted for the range of IgG 
concentrations that remained linear against absorbance. Unknown antibody 
concentrations would then be determined using the micro protein assay and the 
absorbance value used to calculate the protein concentration from the standard curve.
5.1.4 SDS PA GE analysis o f proteins
SDS PAGE analysis was carried out using the Bio-Rad Protean II mini-gel kit (Bio- 
Rad). This involved analysis of proteins on either 8, 10,or 12% polyacrylamide gels. 
lOx non-reducing or reducing (containing DTT) loading buffer was diluted 10-fold in 
the protein sample and boiled for 3 minutes. High molecular weight markers 
(Amersham) were treated identically. 20 pi of sample were loaded onto the gel, 
along with PAGE gel running buffer and run at 100 mV until dye front had just left 
the base of the gel. Gels were fixed with 40% methanol / 10% acetic acid for 30 
minutes and then stained with Brilliant Blue Colloidal Coomassie stain (Sigma). The 
gels were dried on a gel dryer at 80°C for 90 minutes.
5.2 Cell culture
5.2.1 Madin-Darby canine kidney (MDCK) and Baby hamster kidney (BHK) cell 
culture and maintenance
MDCK cells (a kind gift from Dr W. Barclay, University of Reading) were 
maintained at 37°C in a humidified atmosphere of 5% CO2 (Flow), in DMEM 
(Gibco) supplemented with 0.02 mM glutamine (Gibco) 5% v/v heat inactivated
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foetal calf serum (Gibco) and 50 pg/ml of gentamicin (Gibco). Cells were grown in 
large vented tissue culture flasks (Gibco) and subcultured when a confluent 
monolayer had formed. The cell monolayers were treated with 15 ml of 0.2% 
versene for 20 minutes, followed by 5 ml of 0.25% trypsin (Sigma) for 5 minutes at 
37°C. The cell suspension was pelleted by low speed centrifugation, resuspended at 
the appropriate dilution and aliquoted. The number of passages was recorded and the 
cells were discarded after passage 20.
BHK cells (ECACC)) were cultured under similar conditions to the MDCKs 
and were maintained in GMEM (Gibco) supplemented with 0.02 mM glutamine, 
10% heat inactivated FCS and 50 |ig/ml gentamicin. They were sub-cultured in a 
similar manner to the MDCKs except that they were removed from the flask by 
treatment with 15 ml of 0.2% versene and 1 ml 0.25% trypsin for 5 minutes at 37°C.
5.2.2 Hybridoma cell culture and maintenance (monoclonal antibody 
production)
The mouse hybridoma cell lines (a kind gift from Dr W. Gerhard, Wistar Institute, 
Philadelphia,USA) were maintained at 37°C in a humidified atmosphere of 5% CO2, 
in RPMI 1640 (Gibco) supplemented with 10% heat inactivated FCS, 2 mM 
glutamine and 50 pg/ml gentamicin. The cells were grown in either large vented 
tissue culture flasks (Gibco) or large Integra Cell 2000 flasks (Integra). The cells 
grown in the large vented flasks were subcultured when confluent by shaking the 
flasks vigorously to form a single cell suspension. The cells were pelleted by low 
speed centrifugation and then resuspended in an appropriate dilution and aliquoted.
Hybridoma cells secrete monoclonal antibody (MAb) into the media during 
growth, hence supernatant was recovered after low speed centrifugation and also 
harvested 14 days after subculturing. The tissue culture fluid was clarified by low 
speed centrifugation and the supernatant (containing MAb) was decanted and stored 
at -20°C.
The large Integra Cell Line 2000 system was used for production of milligram 
quantities of MAb. The cell compartment of the flask was seeded with lOxlO6 
hybridoma cells and maintained in 15 ml of RPMI 1640 (Gibco) supplemented with 
15% FCS, 2 mM glutamine and 50 pg/ml gentamicin. The nutrient compartment 
contained 1 litre of RPMI 1640 supplemented with 1% FCS, 5 mM glutamine and 10
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pg/ml gentamicin and the flask was incubated in a humidified atmosphere of 5% 
CO2 at 37°C. The cells were subcultured every 3 days by removing the litre of 
nutrient medium and then pipetting the 15 ml of cell media from the cell 
compartment. This was diluted 1 in 2 with fresh cell media and pipetted back into 
the cell compartment, followed by a fresh litre of nutrient media. The remaining 
volume of cell suspension was pelleted by low speed centrifugation and the cell 
pellet was discarded. The supernatant was stored at -20°C.
5.3 Antibodies
5.3.1 Monoclonal antibodies
The hybridoma cell lines for the anti-Hl HA of influenza A/Puerto Rico/8/34 
secreting the MAbs (1) H36-4.5-2 (site Sb,IgG2a), (2) H9-D3-4R2 (site Cb, IgG3 -  
also secretes non-specific IgGl heavy chains), (3) H37-45-5R3 (site Ca2, IgG3), (4) 
H16-S53-1 (site Sa, IgG2b -  also secretes non-specific IgGl heavy chains) and (5) 
H37-66-1 (site Sb. IgA) (Caton et al., 1982; Staudt and Gerhard, 1983) were kindly 
provided by Dr W. Gerhard (Wistar Institute, Philadelphia, USA). The hybridoma 
cell lines for the anti-NP MAbs, HB-65 (IgG2a) and HB-67 (IgGl) were obtained 
from R.G. Webster (St Jude Children’s Research Hospital, Tennessee).
The ascitic fluids containing the anti-Hl HA from influenza A/Puerto 
Rico/8/34 MAbs (1) Y8-10C2 (site Sb, low pH HA conformation), (2) H3-4C5 (site 
Ca2, low pH HA conformation), (3) H2-4C2 (site Cb, low pH HA conformation), (4) 
H18-S13 (site Cb, low pH HA conformation) and (5) H17-L2 (site Ca2, native HA 
conformation) (Yewdell e ta l, 1983) were kindly supplied by Dr W. Gerhard (Wistar 
Institute, Philadelphia, USA). The ascitic fluids were aliquoted and stored at -20°C.
5.3.2 A ntibody Purification
The tissue culture fluids containing IgG MAbs were purified by affinity 
chromatography, using protein A-Sepharose (Sigma) column under low salt 
conditions. The tissue culture fluid was adjusted to pH 8 by addition of 100 mM 
Tris/HCL (pH 8) and then passed through the column approximately 5 to 6 times.
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The column was washed by the addition of 10 column volumes of 100 mM Tris/HCL 
(pH 8), followed by 10 column volumes of 10 mM Tris/HCL (pH 8). The bound IgG 
was eluted in 1ml fractions of 100 mM glycine (pH 3) and the pH of the fractions 
was raised by the addition of 100 pi of 1M Tris/HCL (pH 8). The protein content of 
the fractions was then analysed by the Bio-Rad dye binding assay and the peak 
fractions were pooled.
The fractions were then concentrated using an Amicon 8010 stirred pressure 
concentrator (Amicon) with a 10 KD molecular weight cut-off filter. The final 
concentrated antibody was dialysed overnight in 3 changes of PBS and then 
quantified using A280nm analysis.
5.3.3 Production o f  Fabs by proteolytic digestion o f IgG
Protein A purified IgG was used in 1 mg aliquots in the production of Fabs with 
immobilised papain (Sigma).
Reaction conditions for digestion ofIgG2aMAb
6.2 pi fresh 0.01 M cysteine (Sigma), 20 pi of EDTA and 1U of agarose immobilised 
papain (10U rehydrated with 1 ml PBS) was added to 1 mg of IgG2a and the final 
volume made up to 1 ml with 200 mM sodium acetate, pH 5.5. This was incubated 
for 3 hours in a shaking water bath at 37°C.
Reaction conditions for digestion o f IgG 3 MAbs
6.2 pi fresh 1 M cysteine (Sigma), 20 pi of EDTA and 1U of agarose immobilised 
papain (10U rehydrated with 1 ml PBS) was added to 1 mg of IgG2a and the final 
volume made up to 1 ml with 200 mM sodium acetate, pH 5.5. This was incubated 
for 1 hour in a shaking water bath at 37°C.
Both types of reactions were stopped by brief microcentrifugation to pellet 
immobilised papain, followed by 100 pi of 55 mM Iodoacetamide (Sigma) and 100 
pi 1 M Tris/HCl (pH 8). The Fab samples were repeatedly passaged down a protein 
A column to remove undigested IgG and Fc fragments, followed by dialysis 
overnight in two changes of PBS. The Fabs were concentrated in the Amicon 
concentrator using a filter with a 10KD molecular weight cut-off and the protein 
concentration was determined spectrophotometrically. The Fab preparation was then 
analysed by PAGE and stained with sensitive colloidal coomassie to check purity of 
sample (Figure 5.1). All Fab preparations had undetectable levels of IgG
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contamination which in this system was <50 ng/ml of IgG. This was assumed to be a 
negligible quantity in terms of biological activity.
Figure 5.1 PAGE gel analysis to show level of contaminating IgG in (A) a H36 
Fab preparation and (B) a H36 F(ab)2 preparation. Fab was analysed on an 8% 
PAGE gel, whilst F(ab) 2  were run on a 10% PAGE gel. All samples were mixed 
with non-reducing loading buffer and stained for protein with colloidal coomassie 
brilliant blue G25 (Sigma). Lane 1, IgG (Mr ~ 160K); 2, Fab (Mr ~ 55K); 3, F(ab)2  
(Mr ~ 110K); 4, IgG (Mr ~ 160K).
220K
97.4K
66K
46K
(A)
66K
46K
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5.3.4 Production o f F(ab)2 by proteolytic digestion o f IgG
Protein A purified IgG was used in 0.5 mg aliquots in the production of F(ab)2 with 
immobilised pepsin (Sigma).
Reaction conditions for digestion of!gG2aMAb
500U of pepsin (10000U rehydrated with 5 ml PBS) was added to 0.5 mg of IgG and 
made up to 1 ml with 0.1 M sodium citrate, pH 3.5. This was incubated for 8 hours 
in a shaking water bath at 37°C.
The reaction was stopped by brief microcentrifugation to pellet immobilised pepsin, 
followed by 100 pi 3 M Tris/HCl (pH 8) to neutralize the pH. The F(ab)2  samples 
were repeatedly passaged down a protein A column to remove undigested IgG, 
followed by dialysis overnight in two changes of PBS. They were concentrated in 
the Amicon concentrator using a filter with a 10KD molecular weight cut-off and the 
protein concentration was determined spectrophotometrically.
5.4 Viruses and virological methods
5.4.1 Influenza A virus and production
The mouse adapted human strain of influenza A/Puerto Rico/8/34 (H1N1) (PR/8) 
was grown up from the #593 stock preparation (Dr S. Armstrong, University of 
Warwick) in the allantoic cavity of 10 day old embryonated chicken eggs (Poynden 
Egg Farm) and incubated for 48 hours at 33°C. The allantoic fluid was collected 
after chilling the eggs overnight at 4°C, clarified by low speed centrifugation and 
stored at -70°C.
5.4.2 Assessment o f titre o f influenza A
(1) Haemagglutination assay
As described previously to determine the haemagglutination units per ml 
(HAU/ml) of the new virus stock (this value gives approximate virus particle
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numbers, as 1 HAU = 106 virus particles, but does not provide any information 
on the infectivity of the virus preparation) (Barrett and Inglis, 1985).
(2) Plaque assay
MDCK monolayers were grown overnight on 6-well cell culture plates (Falcon) 
and washed with PBS. The virus was serially diluted in PBS and then 100 pi 
was inoculated (in duplicate) onto the MDCK monolayers and incubated for 45 
minutes at 20°C. The infected monolayers were then overlaid with 0.9% agar 
(Gibco) in 199 medium (buffered with 5 to 8ml of sodium bicarbonate) 
containing 0.2% (v/v) bovine serum albumin (BSA) in PBS (Sigma), 0.01% 
(v/v) DEAE dextran (Sigma) in PBS, 100 U/ml penicillin/100 pg/ml 
streptomycin and 30 U/ml TPCK trypsin (Sigma). The infected monolayers 
were incubated for 3 days at 33°C in a humidified atmosphere of 5% CO2 in air 
before fixing with 10% formal-saline for 10 minutes and staining with 1% 
Toluidine blue (BDH). The infectivity was expressed as plaque forming units 
per ml (pfu/ml).
5.4.3 Purification o f influenza A
The allantoic fluid was clarified by low speed centrifugation to remove cell debris. 
The virus was then pelleted in a type 19 fixed angle rotor (Beckman) at 60000-x g 
for 120 minutes in a Beckman ultra-centrifuge. The pellets were soaked overnight in 
500 pi of PBS, resuspended and then vigorously vortexed. This was loaded onto a 
10-45% (w/v) linear sucrose gradient and centrifuged at 60000-x g for 90 minutes. 
The visible bands were harvested and tested by HA assay to determine peak virus 
band. This band was pelleted at 110000-x g for 90 minutes and pellets were soaked 
in 200 p,l of PBS overnight. The pellets were resuspended, vortexed vigorously and 
loaded onto a 20-70% (w/v) linear sucrose gradient. This was centrifuged at 60000-x 
g for 16 hours and the visible virus band was harvested. The harvested band was 
diluted in PBS and pelleted at 110000-x g for 90 minutes. The pellet was soaked in 
100 pi PBS overnight, resuspended, aliquoted and stored at -70°C.
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5.4.4 Influenza A neutralization assay
5.4.4.1 Neutralization assay by reduction o f cytopathic effect
100 pfu/ml of influenza A was mixed with an equal volume of dilutions ofMAb for 
60 minutes at 37°C to allow neutralization to occur. 100 pi of the virus/MAb mix 
was inoculated onto the centre of washed MDCK monolayers in 6-well plates (or 
BHK) (grown overnight) and incubated for 45 minutes at 20°C. The monolayers 
were overlaid with a 1 to 1 mix of 0.9% agar (Gibco) and 199 medium (buffered with 
5 to 8ml of sodium bicarbonate), containing 0.2% (v/v) bovine serum albumin (BSA) 
in PBS (Sigma), 0.01% (v/v) DEAE dextran (Sigma) in PBS, lOOU/ml penicillin / 
100 pg/ml streptomycin and 30 U/ml TPCK trypsin (Sigma). The infected 
monolayers were incubated for 3 days at 33°C in a humidified atmosphere of 5% 
C02 in air before fixing with 10% formal-saline for 10 minutes and staining with 1% 
Toluidine blue (BDH). The number of plaques were counted for each antibody 
dilution and calculated as a percentage of the virus control (virus incubated with an 
equal volume of PBS) and subtracted from 100 to give the percentage neutralization.
5.4.4.2 Neutralization Enzyme-Linked Immunosorbent assay (ELISA)
This ELISA was adapted from (Benne et a l, 1994). Virus in 0.5% BSA/PBS was 
incubated with an equal volume of dilutions of MAb in 0.5% BSA/PBS for 60 
minutes at 37°C to allow neutralization to occur. 100 pi of the virus/MAb mix was 
inoculated onto a washed MDCK monolayer in a 96 well cell culture plate (Gibco) 
and incubated for 25min at 4°C. The plate were washed three times by hand with 
DMEM and then 100 pi of warm DMEM, supplemented with 1% FCS, 2 mM 
glutamine and 20 pg/ml gentamicin (maintenance media) was added and the plate 
were incubated overnight at 37°C in an humidified atmosphere to allow one 
replication cycle of the attached infectious virus. The cells were washed by hand 
with DMEM and fixed by the addition of 100 pi of 2% paraformalehyde for 15 
minutes. The fixed plates were washed using a plate washer on a fixed programme 
that washed the plate 4 times in TBS/tween and then the plate was blocked with 3% 
BSA/TBS for 90 minutes at 20°C. The de novo expressed HA on the cell surface 
was then used as a marker of virus replication and detected by the addition of 100 pi
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of mouse anti-HA IgA (H37-66-1) in l%BSA/TBS-tween for 90 minutes at 37°C. 
The plate was washed with the plate washer and the bound IgA was detected by the 
addition of 100 pi of anti-IgA alkaline phosphatase conjugate (Sigma) diluted 1 in 
30000 in 1% BSA/TBS-tween for 60 minutes at 37°C. The final wash using the 
plate washer was followed by the addition of 100 pi of p-nitrophenyl phosphate 
(PNPP) alkaline phosphatase substrate tablets, diluted 2 tablets to 10 ml of 
diethanolamine buffer at 37°C. The plate was read every 15 minutes on a titertek 
Lab systems optical plate reader (Life Sciences International) with a 405nm filter 
until the virus control had an optical density of approximately 1.0 to 1.2.
5.4.5 Post-attachment neutralization (PAN) assay
5.4.5.1 PAN by plaque reduction
100 pi of 50 pfu/ml of cold virus was inoculated onto the centre of a washed MDCK 
(or BHK) monolayer, that had been pre-chilled, and incubated for 20 minutes at 4°C. 
The monolayer was washed 3 times with cold DMEM and then inoculated with 100 
pi of a series of MAb dilutions for 60 minutes at 37°C (or 120 minutes at 4°C). The 
monolayers were washed 3 times with DMEM by hand and overlaid as described in 
section 5.5.4.1. The infected monolayers were incubated for 3 days at 33°C in a 
humidified atmosphere of 5% C02 in air before fixing with 10% formal-saline for 10 
minutes and staining with 1% Toluidine blue (BDH). The number of plaques were 
counted for each antibody dilution and calculated as a percentage of the virus control 
(virus incubated with an equal volume of PBS) and subtracted from 100 to give the 
percentage neutralization.
5.4.5.2 Post-attachment neutralization ELISA
Virus was pre-chilled at 4°C and 100 pi was inoculated onto a MDCK (or BHK) 
monolayer in a 96 well cell culture plate (Gibco) for 20 minutes at 4°C. The plate 
was washed 3 times by hand with cold DMEM and then inoculated with 100 pi of a 
series of dilutions of MAb for 60 minutes (or 120 minutes at 4°C) at 37°C. The plate 
was washed three times by hand with DMEM and then 100 pi of warm DMEM, 
supplemented with 1% FCS, 2 mM glutamine and 20 pg/ml gentamicin
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(maintenance media) was added and the plate were incubated overnight at 37°C in an 
humidified atmosphere to allow one replication cycle of the attached infectious virus. 
The cells were washed by hand with DMEM and fixed by the addition of 100 pi of 
2% paraformaldehyde for 15 minutes. The fixed plates were washed using a plate 
washer on a fixed programme that washed the plate 4 times in TBS/tween and then 
the plate was blocked with 3% BSA/TBS for 90 minutes at 20°C. The de novo 
expressed HA on the cell surface was then used as a marker of virus replication and 
detected as described previously in section 5.5.4.2.
5.5 Mechanisms of neutralization assays
5.5.1 Influenza attachment detection ELISA
1000 HAU/ml of virus in 0.5% BSA/PBS was incubated with an equal volume of 
dilutions of MAb in 0.5% BSA/PBS for 60 minutes at 37°C to allow neutralization to 
occur. 100 pi of the virus/MAb mix was inoculated onto a washed MDCK 
monolayer in a 96 well cell culture plate (Gibco) and incubated for 25 minutes at 
4°C. The plates were washed three times by hand with cold DMEM and then the cell 
monolayers and attached virus was fixed and permeabilised with 100 pi of methanol 
at -20°C for 20 minutes. The fixed plates were washed using a plate washer on a 
fixed programme that washed the plate 4 times in TBS/tween and then the plate was 
blocked with 3% BSA/TBS overnight at 4°C. The next stage involved detection of 
the internalised nucleoprotein of the attached permeabilised virus. Therefore, after 
the plates were washed, 100 pi of 5 pg/ml of anti-NP MAb (either HB-65, IgG2a or 
HB-67, IgGl, depending on the isotype of MAb used to neutralize the virus) in 1% 
BSA/TBS-tween was added for 90 minutes at 37°C. After a further wash using the 
plate washer, 100 pi of a 1 in 2000 dilution in 1% BSA/TBS-tween of either rabbit 
anti-mouse IgGl or IgG2a was added and incubated for 60 minutes at 37°C. 
Following washing, the bound anti-species antibody was detected by the addition of 
100 pi of goat anti-rabbit alkaline phosphotase conjugate (Dako) diluted 1 in 2000 in 
1% BSA/TBS-tween for 60 minutes at 37°C. The final wash was followed by the 
addition of 100 pi of PNPP alkaline phosphatase substrate tablets diluted 2 tablets to
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10 ml of diethanolamine buffer diluted five-fold in distilled water at 37°C. The plate 
was read every 15 minutes on a titertek Lab systems optical plate reader with a 
405nm filter until the virus control had an optical density of approximately 1.0 to 1.2.
5.5.2 Endosomal internalisation detection ELISA
1500 HAU/ml of virus in 0.5% BSA/PBS was incubated with an equal volume of 
dilutions of MAb in 0.5% BSA/PBS for 60 minutes at 37°C to allow neutralization to 
occur. 100 pi of the virus/MAb mix was inoculated MDCK (or BHK) monolayer in 
a 96 well cell culture plate (Gibco) and incubated for 20 minutes at 4°C. The plates 
were washed three times by hand with cold DMEM, followed by the addition of 100 
pi of warm DMEM for 30 minutes at 37°C, to allow the attached virus to internalise 
into the cell. The plates were again washed 3 times with cold DMEM and then in 
order to remove uninternalised virus they were treated with 50 pi of 0.5 U/ml of 
neuraminidase (from clostridium perfrinigens) (Sigma) in PBS for 10 minutes at 
37°C. This was repeated and the cell monolayers were freeze-fractured by 
incubating at -20°C for lOminutes, followed by an incubation at 37°C for 5 minutes. 
This was repeated twice and the cells were fixed and permeabilised by the addition 
of 100 pi of methanol for 30 minutes at -20°C. The fixed plates were washed using 
the plate washer on a fixed programme that washed the plate 4 times in TBS/tween 
and then the plate was blocked with 3% BSA/TBS overnight at 4°C. The plates were 
washed , followed by the addition of lOOpl of 5pg/ml of anti-NP MAb (either HB- 
65, IgG2a or HB-67, IgGl) in 1%BSA/TBS-tween for 90 min at 37°C, to detect the 
internal nucleoprotein of internalised virus. The bound anti-NP MAb was detected as 
described in section 5.6.1.
Controls used in this assay to show that the signal detected was indeed 
internalised virus antigen included (1) incubation at 4°C so that internalisation was 
not permitted (Matlin et a l, 1981; Richman et a l, 1986) and (2) pre-incubating the 
cell monolayer with a hypertonic medium (0.45 M NaCl / HBS) for 30 minutes at 
20°C before inoculation of virus as this treatment prevents formation of correct 
clathrin lattice and hence inhibits receptor-mediated endocytosis (Heuser and 
Anderson, 1989; Hansen et a l, 1993).
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5.5.3 Fusion assays
5.5.3.1 Inhibition of hemolysis o f CRBCs by influenza virus
Hemolysis and hemolysis inhibition assays were adapted from (Sato et al., 1983). 
Neat (8%) CRBCs (Serotec) were pelleted at 2500-x g for 1 minute and washed with 
cold PBS. 10000 HAU/ml of virus was mixed with 200 (¿1 of washed CRBCs and 
incubated for 30 minutes at 4°C on a rotating blood mixer. Unattached virus was 
removed by pelleting the CRBCs by brief centrifugation and washing in 1 ml of cold 
PBS. This was repeated and then 200 pi of a series of dilutions of MAb was mixed 
with the cells for 60 minutes at 37°C. The CRBCs were then pelleted and washed as 
described previously, followed by the addition of 250 pi of citrate buffer, pH 5 for 45 
minutes at 37°C. The cells were then pelleted and 200 pi of the supernatant was 
placed into a 1 ml plastic cuvette. The supernatants from the hemolysed samples 
were diluted with 800 pi of PBS and then the OD read at 520nm on a 
spectrophotometer. The percentage inhibition of hemolysis was calculated by 
comparing the extent of hemolysis in the virus control to the reduction of hemolysis 
caused by the neutralizing MAb.
5.5.3.2 Analysis o f fusion inhibition by MAbs with octadecyl rhodamine-B- 
choride (R18) labelled virus
(1) Preparation of R18 labelled virus stock -
500 pi of 250xl05 HAU/ml of freshly prepared purified virus was mixed with 5 
pi of R18 (Molecular probes, Europe) for 60 minutes at 20°C in the dark (final 
concentration of 85.5 pM). The virus-R18 mix was centrifuged at 10000-x g 
for 2 minutes to pellet precipitate. Pelleting the virus through a 20% sucrose 
cushion at 110,000g for 90 minutes was carried out to remove free R18 label. 
The remaining pellet was resuspended in 100 pi of PBS and then stored at - 
70°C. Solubilisation of the labelled virus in 1% Triton X-100 (BDH) led to an ~ 
150-fold increase in fluorescence, indicating that the R18 was highly self- 
quenched and incorporated into the virus lipid bilayer.
(2) Fusion assay using R18 labelled virus -
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100 pi of 2000 HAU/ml of non-neutralized or neutralized R18 labelled virus was 
inoculated onto the middle of MDCK or BHK cell monolayer in a 3 cm dish and 
allowed to attach for 25 minutes at 4°C. Unbound virus was removed by 
washing 3 times by hand with cold DMEM, followed by the addition of 200 jj.1 
of warm DMEM for 30 minutes at 37°C. After a further wash with cold DMEM 
500 pi of cold versene was added to the cells for 5 minutes at 20°C. The cells 
were then suspended by scraping, pelleted at 2500-x g and resuspended in cold 
2% paraformaldehyde on ice in the dark. Fluorescence was determined using a 
Perkin-Elmer fluorescence spectrophotometer, exciting at 560nm and emitting at 
590nm, with a slit length of 10cm.
Negative controls used to determine that increase of fluorescent signal was 
due to virus-cell fusion was (1) labelled virus and cells kept at 4°C to inhibit 
fusion and (2) cells were pre-treated with 500 nM bafilomycin-Al (from 
Streptomyces griseus) (Calbiochem) for 15min at 37°C prior to infection 
(Yoshimori et al., 1991; Palokangas et al., 1994; Guinea and Carrasco, 1995). 
The bafilomycin is a potent V-ATPase inhibitor and prevents acidification of 
endosomal vesicles in the cell, which inhibits low pH activated fusion.
5.6 Assays to investigate the nature of the inhibition of fusion by 
MAb and Fab fragments
5.6.1 Inhibition o f  hemolysis o f  CRBCs by influenza virus at a pre-fusion 
intermediate stage
Neat (8%) CRBCs (Serotech) were pelleted at 2500-x g for 1 minute and washed 
with cold PBS. 10000 HAU/ml of virus was mixed with 200 pi of washed CRBCs 
and incubated for 30 minutes at 4°C on a rotating blood mixer. Unattached virus was 
removed by pelleting the CRBCs by brief centrifugation and washing in 1 ml of cold 
PBS. This was repeated and followed by the addition of 200 pi cold citrate buffer, 
pH 5 for 30 minutes at 4°C, in order to trigger the pre-fusion intermediate 
(Tsurudome et al., 1992; Pak et al., 1994). The virus-CRBC complexes were then 
pelleted and washed twice with 1 ml of cold PBS, pH 8. 200 pi of a series of
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dilutions of MAb in PBS, pH 7.5, were mixed with the cells for 60 minutes at 37°C. 
The CRBCs were then pelleted and washed as described previously, followed by the 
addition of 250 pi of citrate buffer, pH 5 for 45 minutes at 37°C. The cells were then 
pelleted and 200 jj.1 of the supernatant was placed into a 1 ml plastic cuvette. The 
supernatants from the hemolysed samples were diluted with 800 pi of PBS and then 
the optical density read at 405nm on a spectrophotometer. The percentage inhibition 
of hemolysis was calculated by comparing the extent of hemolysis in the virus 
control to the reduction of hemolysis caused by the neutralizing MAb.
5.6.2 Low pH  conformational change detection ELISA
1000 HlU/ml of anti-HA IgA (H37-66-1) in PBS was coated to an ELISA plate 
overnight at 4°C. This was washed using the plate washer and blocked with 3% 
BSA/TBS-tween for 120 minutes at 20°C. The IgA coated plate was then used to 
capture virus by adding 100 pi of 1000 HAU/ml of virus for 45 minutes at 4°C. This 
experiment was also carried out using a monolayer of paraformaldehyde-fixed 
MDCK cells to capture virus in order to determine if binding to the cell receptor had 
an influence on HA conformation. The unbound virus was removed by washing 3 
times by hand with DMEM and the remaining bound virus was neutralized with 50 
pi of Fab for 60 minutes at either 4°C or 37°C. This was washed 3 times by hand 
and then 100 pi of citrate buffer was added, with half the plate being treated with pH 
5 and the other control half being treated with pH 7.5, for 30 minutes at either 4°C or 
37°C. The pH was neutralized by washing 3 times with PBS, pH 8, followed by 100 
pi of a series of dilutions of the conformation-specific MAbs in 1% BSA/TBS-tween 
for 60 minutes at 4°C. The unbound MAb was removed by washing 3 times with 
DMEM and then the plates were fixed with methanol for 20 minutes at -20°C. The 
fixed plates were blocked with 3% BSA/TBS-tween for 90 minutes at 20°C and then 
washed using the plate washer. The bound conformational MAbs were detected 
using a 1 in 30000 dilution of rabbit anti-mouse IgG Fc region alkaline phosphatase 
conjugate in 1% BSA/TBS-tween (Sigma) for 90 minutes at 37°C. The final wash 
was followed by the addition of 100 pi of PNPP alkaline phosphatase substrate
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tablets diluted 2  tablets to 1 0  ml of diethanolamine buffer diluted five-fold in 
distilled water at 37°C.
5.6.3 Proteinase-K digestion resistance assay
Purified virus at 200,000 HAU/ml was neutralized with an equal volume of MAb or 
Fab for 60 minutes at 37°C. The pH of the neutralization mix was then either 
lowered to pH 5 by the addition of 0.1 M HC1, or kept at pH 7.5 (for the controls) 
and incubated for 30 minutes at 37°C. The pH of the neutralization mix was 
increased to pH 7.5 by the addition of 0.1 M Tris/HCl, pH 8 . In order to determine 
whether the treatment had caused the virus HA to adopt its low pH conformation or 
whether this change had been inhibited by the antibody, an equal volume of 
proteinase-K was added at 1 pg/ml in PBS for 30 minutes at 37°C. The HA is only 
susceptible to cleavage by this enzyme in its low pH conformation and hence the 
ability to cleave the HA of neutralized virus can act as a marker of whether the 
antibody can inhibit the low pH-induced conformational changes. The digestion 
reaction was stopped by the addition of lOx cracking buffer and the reaction mix 
could then be stored at -70°C. To analyse the digestion, 25 pi of the mix was run on 
a 12% PAGE gel under reducing conditions and then stained with Brilliant-Blue 
colloidal coomassie.
5.6.4 Determination o f acid sensitivity o f  MAb binding by ELISA
An IgA coated ELISA plate was prepared as described previously and then blocked 
with 3% BSA/TBS-tween for 90 minutes at 20°C. 100 pil of virus at 1000 HAU/ml 
was then added to the plate and incubated for 45 minutes at 37°C. Unbound virus 
was removed by washing 3 times by hand with DMEM, followed by 100 pi of citrate 
buffer at either pH 5 or pH 7.5 for 30 minutes at 37°C. The pH was the increased to 
pH 7.5 by washing 3 times in PBS at pH 7.5, The captured virus was neutralized 
with the addition of 50 pi of MAb for 60 minutes at 37°C. Following MAb binding 
unbound MAb was removed by washing 3 times with DMEM and then the virus -  
MAb complexes were fixed by the addition of methanol at -20°C. The fixed plates 
were blocked with 3% BSA/TBS-tween for 90 minutes at 20°C and then washed 
using the plate washer. The bound MAbs were detected using a 1 in 30000 dilution
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of rabbit anti-mouse IgG alkaline phosphatase conjugate in 1% BSA/TBS-tween 
(Sigma) for 90 minutes at 37°C. The final wash using the plate washer was 
followed by the addition of 100 pi of PNPP alkaline phosphatase substrate tablets 
diluted 2  tablets to 1 0  ml of diethanolamine buffer diluted five-fold in distilled water 
at 37°C. Determination of the effect of the low pH HA conformation on MAb 
binding was made by comparing binding levels on pH 7 virus and pH 5 virus.
5.7 Kinetic analysis of the MAbs and their Fab fragments using the 
BIAcore 2000
Method for kinetic analysis of MAbs was adapted from Schofield and Dimmock, 
(1996).
5.7.1 Surface immobilisation
MAb H37-45-5R3 was covalently coupled to a biosensor chip, CM5, by an amine 
coupling procedure. Initially the chip surface was normalised by washing the surface 
with a 40% glycerol solution, in order to equalise the dextran polymer coating on the 
chip surface to reduce non-specific binding of the ligand and to equalise the 
responses of the 4 lanes. Activation of the bonds on the dextran polymer coated chip 
surface was carried out by the injection of 40 pi of a 1 to 1 mix of EDS and NHS 
(BIAcore) over the chip surface at a flow rate of 10 pl/min. MAb H37-45-5R3 at 50 
pg/ml in sodium acetate buffer, pH 5, was injected only over lane 2 of the sensor 
chip at a flow rate of 1 0  pl/min, using the manual injection system so that the amount 
of MAb bound to the chip surface could be monitored and stopped at 9000 resonance 
units (RU) Remaining active sites on lanes 1 and 2 were blocked by the injection of 
40 pi of ethanolamine buffer (BIAcore) at a flow rate of 10 pl/min, with the 
extraclean command which washing the flow cells with buffer at 1 0 0  pl/min for a 
couple of seconds. MAb bound unspecifically was removed by injecting 30 pi of 
0.05 M triethylamine (Sigma) at a flow rate of 2 0  pl/min.
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5.7.2 Virus capture
40 pi of purified virus at 8000 HAU/ml, diluted in 100 mg/ml CM5 dextran/HBS 
(prevents non-specific interactions with chip surface) (BIAcore) was injected over 
lanes 1 and 2 in the 2 -1  detection mode at a flow rate of 20 pl/min. The 2-1 
detection mode subtracts signal from the blank control, lane 1 , from signal in lane 2 , 
so that bulk refractive index changes are removed and the sensorgram 2 -1  shows 
actual binding events. Following the injection the flow cells were washed using the 
extraclean command and the virus baseline was left to stabilise for 300 seconds. 
Approximately 700 RU of virus was bound and used for kinetic analysis of MAbs 
and Fabs.
5.7.3 Measurement o f kinetic binding
Kinetic measurements for each of the MAb/Fab pairs were made simultaneously on 
the same chip surface (separate chip for each MAb/Fab pair) to minimise effect of 
surface differences on kinetics and over at least 3 different concentrations. 40 pi of 
the antibodies, diluted in HBS buffer, was injected over lanes 1 and 2 using the 
kininject command, at a flow rate of 2 0  pl/min and a dissociation time of 600 
seconds. After the dissociation the chip surface was regenerated back to the 
covalently coupled H37 baseline by 2 injections of 30 pi of 0.05 M triethylamine and 
1 injection of 2 0  pi of 0.05 M triethylamine at a flow rate of 20 pl/min. At this stage 
the sensorgram cycle was stopped and before a new cycle started the Flush command 
was used to wash the IFC and flow cells with HBS buffer to remove any 
contaminating triethylamine.
S. 7.4 Data evaluation
The kinetics of the binding of the MAbs and Fabs was analysed using the BIA 
evaluation software package (version 2.2). The data for each concentration of 
antibody was fitted locally to a Langmuir 1 to 1 binding model, with the dissociation 
and association rates being calculated separately. Initially the rate of dissociation 
(kd) was calculated by selecting 300 seconds of dissociation data (kept constant to 
compare MAbs and Fabs) and this rate was used along with the analyte concentration 
in moles (M) to determine the association rate (kà). The mean of the equilibrium
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dissociation constants (Kd) for the antibody was calculated to determine the overall 
affinity.
5.8 Reversibilty of neutralization and HI with ammonium 
hydroxide (AmOH)
5.8.1 Reversibilty o f  neutralization and H I o f virus neutralized in solution
The method was adapted from Schofield (1996). 100 pi of virus at 20000 HAU/ml 
was incubated with an equal volume of MAb in PBS for 60 minutes at either 4 or 
37°C. The virus-antibody mix was then added to an equal volume of 0.1 M AmOH, 
pH 11.5 for 30 minutes at 4°C. The virus and antibody were then separated by 
passing 1 0 0  pi down a Sephacryl SI000 (5cm3 gel bed volume), which had 
previously been equilibrated with 0.1 M AmOH, pH 11.5. The virus, due to its size, 
was eluted in the void volume of the column and collected in 1 0 0  pi fractions of 0 .1  
M AmOH, pH 11.5. The fractions were then neutralized by the addition of 25 pi of 1 
M Tris/HCl, pH 8  and the presence of virus assayed by the HA assay. The 3 peak 
fractions were then diluted between 100- and 10000-fold in PBS and the infectivity 
determined by plaque assay.
5.8.2 Reversibilty o f  neutralization and H I o f virus attached to a cell receptor 
1 0 0  pi of virus at 20000 HAU/ml was mixed with 200 pi of CRBCs at 8 % (pre­
washed in PBS) for 30 minutes at 4°C on a rotary blood mixer. Unbound virus was 
removed by pelleting the CRBCs by brief centrifugation and washing in 1 ml of cold 
PBS. This was repeated twice and then the pellet of CRBCs were resuspended in 
200 pi of MAb, diluted in PBS, for 60 minutes at either 4 or 37°C. The CRBC- 
virus-antibody complexes were washed as described above and then resuspended 
with 200 pi of 1 U/ml of neuraminidase (from Clostridium perfrinigens) (Sigma) in 
PBS for 60 minutes at 37°C, to elute the virus-MAb complexes from the cell surface. 
The CRBCs were pelleted by brief centrifugation and the supernatant containing the 
virus was mixed with an equal volume of 0.1 M AmOH, pH 11.5, for 30 minutes at 
4°C. The virus and antibody were then separated by passing 100 pi down a
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Sephacryl SI000 (5cm3 gel bed volume), which had previously been equilibrated 
with 0.1M AmOH, pH 11.5. The virus due to its size was eluted in the void volume 
of the column and collected in 100 |al fractions of 0.1M AmOH, pH 11.5. The 
fractions were then neutralized by the addition of 25 pi of 1 M Tris/HCl, pH 8 and 
the presence of virus assayed by the HA assay. The 3 peak fractions were then 
diluted between 100- and 10000-fold in PBS and the infectivity determined by 
plaque assay.
The effect of temperature on the reversibility of HI and neutralization of virus 
attached to CRBCs was investigated by incubation by the CRBC-virus-antibody 
complexes in waterbaths set at different temperatures.
The reversibility of HI and neutralization of virus attached to different cell types and 
a soluble receptor was also analysed using the following -
(1 )  5x1 O' 6 MDCK cells/ml
(2) 4xl06 H9 T-cells/ml
(3) 4 mg/ml fetuin (Sigma)
5.8.3 Kinetics o f the reversibility o f  H I and neutralization o f virus attached to 
CRBCs.
Virus was attached to CRBCs at 4°C as described above. Ten individual samples 
were prepared to represent each of the time points. Unbound virus was removed by 
pelleting the CRBCs by brief centrifugation and washing in 1 ml of cold PBS. This 
was repeated twice and then the pellet of CRBCs were resuspended in 200 pi of 
MAb, diluted in PBS, for 60 minutes at either 4°C. Unbound MAb was removed by 
pelleting the CRBCs by brief centrifugation and washing in 1 ml of cold PBS. The 
CRBC-virus-MAb complexes were resuspended in warm PBS and placed in a 37°C 
waterbath. At 2 minute intervals a sample was removed and 200pl of 1 U/ml 
bacterial neuraminidase was added for 30 minutes at 37°C. The CRBCs were then 
pelleted and the supernatant containing the released virus was stored at 4°C. At the 
end of the time course each of the supernatants was mixed with an equal volume of
79
0.1M AmOH, pH 11.5 for 30 minutes at 4°C. The virus and MAb were separated 
and sampled as described above.
5.8.4 Quantitation o f the removal o f virus from the CRBCs by bacterial 
neuraminidase.
5.8.4.1 Biotinylated virus detection ELISA.
2 mg of freshly prepared and purified virus were biotinylated using the Sulfo-NHS 
biotinylation kit according to the manufacturer’s instructions. ELISA plates were 
coated overnight with the HA specific HI6  IgG at 10 pg/ml in PBS, followed by 
blocking with 3% BSA/TBS-T for 120 minutes. Biotinylated virus was used then in 
the reversibility of neutralization of virus attached to CRBCs as described 
previously. The supernatant containing released virus after treatment of the cells 
with bacterial neuraminidase was serial diluted in PBS and added to the ELISA plate 
overnight at 4°C. The plates were then washed four times using the plate washer, 
followed by 100 pi of a 1 in 5000 dilution in 1% BSA/TBS-T of streptavidin-alkaline 
phosphatase conjugate for 60 minutes at 37°C. The plate was again washed using 
the plate washer and then 100 ju.1 of PNPP alkaline phosphatase enzyme substrate 
was added and incubated at 37°C. Quantitation of the recovery of virus from the 
CRBCs was made possible as known concentrations of biotinylated virus were used 
as positive controls and used to draw a standard curve of optical density at 405nm 
and HAU.
5.8.5 Neuraminidase assay.
The method was carried out as described by (Barrett and Inglis, 1985). Briefly, 1 0 0  
111 of a virus sample was added to 10 mg/ml of the fetuin substrate in 0.2 M sodium 
phosphate buffer, pH 6  and incubated for 120 minutes at 35°C. 100 pi of periodate 
reagent was added for 20 minutes at 20°C, followed by 1 ml of arsenite reagent. 
This was followed by 2.5 ml of thiobarbituric acid reagent, which was vortexed and 
then placed in a boiling water bath for 15 minutes. The solution was allowed to cool 
on ice for 5 minutes, followed by the addition of 4 ml of acidified-butanol. This was
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vortexed and then centrifuged at 913-x g for 10 minutes. Results were read on a 
spectrophotometer at 549nm and compared to a calibration curve.
5.8.6 Reversibility o f  H I and neutralization o f virus attached to CRBCs and then 
treated with low pH  at 4 XL
Virus was attached to CRBCs as described in section 5.9.2. Attached virus was 
neutralized with MAb for 60 minutes at 4°C. Unbound MAb was removed by 
pelleting the cells by brief centrifugation. The CRBC-virus-MAb complexes were 
then resuspended in PBS, pH 5, and incubated for 30 minutes at 4°C. The cells were 
then pelleted and washed three times with cold PBS, pH 7.5. The CRBC-virus-MAb 
complexes were then resuspended in 1 U/ml bacterial neuraminidase for 60 minutes 
at 4°C. The recovered virus was treated with AmOH at 4°C, separated from 
antibody and assayed as described in section 5.9.2.
5.9 List of reagent suppliers
(Amicon) Amicon Ltd, Stonehouse, UK
(Amersham) Amersham International Pic, UK
(BDH) Merck Ltd, Lutterworth, UK
(Beckman) Beckman-RIIC, High Wycombe, UK
(Biacore) Biacore-AB, Uppsala, Sweden
(Bio-Rad) Bio-Rad Life Sciences, Hemel Hempstead, UK
(Calbiochem) Novabiochem (UK) Ltd, Beeston, UK
(Dako) Dako Ltd, Ely, UK
(ECACC) European Collection of Animal Cell Cultures, 
Porton Down, UK
(Falcon) Farenheit Lab supplies, Milton Keynes, UK
(Gibco) GibcoBRL Life Technologies, Paisley, UK
(Greiner) Greiner, Stonehouse, UK
(Integra) Integra Bioscience Ltd, Letchworth, UK
(Life Sciences International) Life Sciences International, Basingstoke, UK
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(Molecular probes)
(Poynden Egg Farm) 
(Serotech)
(Sigma)
Molecular Probes Europe BV, Leiden, The 
Netherlands
Poynden Egg Farm, Goss Oaks, Herts, UK 
Serotech, Kidlington, UK 
Sigma, Poole, UK
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6 Results: Comparison of the mechanism of 
neutralization of influenza A/PR/8/34 virus by 
monoclonal IgGs and their fragments.
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6.1 Introduction
This chapter examines the relevance of antibody valency, molecular mass and 
affinity on the efficiency of neutralization of virus in free solution. Previous studies 
using Fabs from polyclonal antibodies and more recently from monoclonal 
antibodies (MAbs) have shown that they have a significantly lower neutralization 
efficiency than their parent antibodies (Lafferty, 1963; Yoden et al., 1985; Kida et 
ah, 1985; Schofield etal., 1997b).
A number of explanations have been proposed. For example, a study using 
Fabs produced from polyclonal antibodies showed that dilution of the virus-Fab mix 
led to a recovery of infectivity (Lafferty, 1963). Thus neutralizing Fabs are more 
readily dissociated from their antigen than parental MAb and it was speculated that 
this was due to a loss of functional affinity resulting from reduction of valency. An 
alternative idea for the reduction in the efficiency of Fab neutralization came from 
the study of the neutralization and HI ability of a panel of Fabs and their respective 
IgGs to 4 non-overlapping antigenic regions (I -  IV) of an H7 influenza A virus 
(Yoden et al., 1985). Fabs to groups I and II displayed a 32 to 64 fold drop 
neutralization titres compared with their parent IgG, whilst Fabs to groups III and IV 
had a > 100-fold loss of neutralization and no detectable HI titre. These authors 
suggested that neutralization efficiency was lower with group III and IV Fabs due to 
the loss of bivalency, as the addition of anti-Fab anti-serum resulted in increased 
neutralization levels to coincide with that of the parent MAbs. However, no 
evidence of cross-linking of Fabs was provided and data could be also explained by 
an increased ability to inhibit attachment. In addition a study using a spin labelling 
technique indicated that an antibody to group IV (81/6), inhibited the low pH 
dependent conformational change of the HA (Kida et al., 1985; Yoden et al., 1986). 
A later study showed that MAb 81/6 did not inhibit attachment or internalisation, but 
did inhibit endosomal fusion (Imai et al., 1998). In addition electron microscopy of 
antibody binding to HA rosettes indicated that MAb 81/6 bound to the side of an HA 
trimer, in contrast to the binding to the top of the globular head seen by MAbs which 
give HI. Together these studies suggest that neutralizing activity of MAb 81/6 
requires a bivalent binding, as inhibition of fusion may be due to the inhibition of a 
conformational change of the HA, caused by the MAb binding to the side of the HA.
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This could allow the MAb to directly crosslink monomers of the HA trimer and the 
resulting inhibition of the conformational changes would be analogous to that 
occurring in a virus with engineered intermonomer disulphide bonds (Kemble et al., 
1992). However, one should be cautious when making these assumptions as the 
conformational and binding analysis was carried out on isolated HA rosettes, which 
may not behave as the HA present on virus particles.
More recently, an extensive study of neutralization and HI abilities of five anti 
H7 (FPV) influenza A monoclonal IgGs, their monovalent Fabs and bivalent F(ab) 2 
fragments was carried out by Schofield et al. (1997b). This study again found that 
neutralization required 54- to 542-fold more Fab than IgG on a molar basis. 
However, the bivalent F(ab)2s showed similar neutralizing activities to their parent 
IgGs, only requiring 1.4- to 4-fold more to neutralize. These data strongly suggest 
that bivalent interaction with the virus was necessary for efficient neutralization. A 
comparison of functional affinities of the IgGs and Fabs using SPR showed that 
affinities for two of the Fabs, HC2 and HC61 were only 3 to 4 fold lower than their 
IgGs. This suggested that for these Fabs the difference in molecular mass was 
responsible for differences in neutralization ability compared to their IgGs.
A complementary study by Schofield et a l (1997a) looked at the relationship 
between efficiency of neutralization (percentage neutralization per unit 
concentration) and affinity. In this study the authors suggested that if antibody 
affinity was the sole determinant of efficiency of neutralization then the ratio of the 
rate of neutralization (Kmur) and the equilibrium dissociation constant (KD) should 
equal 1. However, for a number of IgGs this ratio was 23 to 125 fold and it was 
concluded that factors other than the antibody affinity contribute to the efficiency of 
neutralization. One of these may have been the mechanism of neutralization.
Although there is general agreement that Fabs display a lower efficiency of 
neutralization of influenza A virus than their respective MAb, there seems to be little 
agreement over the cause of the loss of efficiency. Reductions in affinity, valency 
and molecular mass have all been proposed as possible causes. The aim of this 
section is to address this issue by comparing the mechanism of neutralization of the 
IgGs and their respective Fabs and by analysing their affinities. Differences found 
will be discussed in relation to their valency, molecular mass and affinity.
In this study I have examined the dose response relationship of neutralization, 
the mechanism of neutralization of influenza A virus, and the affinity of three
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monoclonal IgGs, three monovalent Fabs and one F(ab)2. All Fabs showed 
significantly lower neutralization efficiency than the MAbs from which they were 
derived. The MAbs all displayed a similar complex mechanism of neutralization in 
which they were able to simultaneously inhibit two stages of the influenza infectious 
cycle. In contrast, the Fabs all displayed a single mechanism of neutralization. 
Comparisons of the efficiency of neutralization were complicated by the dual 
mechanisms of the IgGs. However, the differences decreased with increasing 
concentration. The differences in of affinities of IgGs and their respective Fabs were 
small and did not account for the reduction in neutralization efficiency.
6.2 MAb H36-4.5-2
6.2.1 Comparison o f the neutralization by plaque reduction by H36 IgG, F(ab)2 
and Fab fragments.
Figure 6.1 indicates that neutralization efficiency of both the antibody fragments is 
reduced compared to the IgG. Table 6 .1 reveals that there is a difference between the 
neutralization efficiency at 50% and 90% with the Fab compared to the IgG. At 50% 
neutralization the Fab requires a 104-fold higher concentration than the IgG, but at 
90% the difference is only 15-fold. This suggests that the efficiency of neutralization 
by the Fab increases with increasing concentration compared to the IgG. A similar 
though less marked trend is seen with the F(ab) 2 as at 50% neutralization there is an 
8 -fold discrepancy, whereas at 90% neutralization there is only a 2.5-fold 
discrepancy.
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Figure 6.1 Neutralization of A/PR8 by H36 IgG, F(ab) 2 and Fab in MDCK cells.
Data are the mean of three experiments, measured by plaque reduction. The bar 
represents the SEM. Curves were generated by non-linear regression using the 
Graphpad Prism package (R = >0.98).
Table 6.1 Comparison of the neutralizing activities of H36 IgG and its Fab 
fragments. Data taken from figure 8 .1.
Antibody Concentration (nM) required to 
give neutralization of 
50% 90%
Antibody fragment : IgG ratio at 
neutralization o f 
50% 90%
H36 IgG 0.5 6 - _
Fab 52.0 90 104 : 1 15.0 : 1
F(ab) 2 4.0 15 8  : 1 2.5 : 1
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6.2.2 Analysis o f the inhibition o f attachment o f A/PR8 to both MDCK and BHK 
cells by MAb H36.
The analysis of the effect of H36 IgG on virus attachment is shown in Figure
6.2 (A and B). Neuraminidase pre-treatment reduced the level of attachment of non- 
neutralized virus by >90% and this fell away with increasing IgG, showing that the 
majority of the attachment in these attachment ELISAs is specific to sialic acid 
containing receptors and that Fc receptor capture of immune complexes was not 
involved.
Figure 6.2 (A and B) indicates that attachment of influenza to both cell types 
decreased with increasing concentration of IgG. However, decreases in attachment 
of virus did not correlate well with reduction of infectivity by the same concentration 
of IgG. If the IgG neutralized by inhibiting only attachment of virus to cell receptor, 
then one would expect the curves to be superimposable. However, Figure 6.2A 
shows that the attachment and infectivity curves diverge indicating that the inhibition 
of attachment is not the sole mechanism acting. Comparison of the attachment and 
infectivity curves by an unpaired T-test show them to be significantly different (P = 
0.005, where < 0.05 is considered significant). This suggests that a stage or stages 
after attachment must also be effected. A closer analysis of the data indicates that 
the efficiency of inhibition of attachment by H36 IgG increases relative to 
neutralization, with increasing concentration. For example, at the 90% neutralization 
point (N 9 0 ) in Figure 6.2 (A), there is 70% inhibition of attachment. This shows that 
at neutralization levels of 90% and greater, there is an increasing correlation of 
inhibition of attachment with loss of infectivity, indicating it to be the dominant 
mechanism acting. However, at the 50% neutralization point (NJ0) there is only a 
10% inhibition of attachment indicating that 40% of the virus must be neutralized by 
other mechanisms.
A comparison of Figure 6.2 (A) and (B) also reveals only minor differences in 
the extent to which inhibition of attachment correlates with loss of infectivity in both 
MDCK and BHK cells. At N50 in BHK cells there is a 5% inhibition of attachment, 
whereas at N 9 0  there is a 70% inhibition of attachment. Therefore, this demonstrates 
that the lack of correlation of inhibition of attachment, at lower neutralization levels, 
with infectivity is repeatable in two different cell lines.
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Figure 6.2 Analysis of the relationship between A/PR8 infectivity and 
attachment as a function of H36 concentration. Data with MDCK cells (A) and 
BHK cells (B) are shown. Infectivity and attachment were assayed by ELISA in 
parallel in the same batch of monolayers in 96 well plates, using the same virus- 
antibody mixtures. Inhibition of attachment of A/PR8  to neuraminidase-treated cells 
was used as the negative control Data are the mean of five experiments. Curves 
were generated as in Figure 6.1 (R = >0.98 for all attachment and infectivity data).
■  %  A ttach m en t 
▲ % In fectiv ity
* % Attachment to neuraminidase-treated cells
log (M)
89
6.2.3 Analysis o f the relationship between A/PR8 infectivity and internalisation 
in MDCK cells as a function o f  H36 IgG concentration.
Since virus neutralized at low concentrations of H36 IgG attached to the cell surface, 
the antibody must interfere with a stage of the virus infectious cycle after attachment. 
This could be internalisation of virus by receptor-mediated endocytosis or fusion of 
virus to the endosomal vesicle. Here I analysed the effect of H36 IgG on the 
internalisation of virus by MDCK cells (Figure 6.3). This assay was carried out 
simultaneously with an attachment detection assay as over the range of 
concentrations used the level of virus attachment decreases. Thus, any reduction in 
the level of internalised virus could be correlated with the reduction in virus 
attachment. Data shown are corrected for the loss of attachment caused by the H36 
IgG (see Appendix I).
This assay was controlled by (a) incubating cells at 4°C, which inhibits 
internalisation of influenza virus (Matlin et al., 1981; Richman et al., 1986) and (b) 
treatment of cells with a hypertonic solution for 15 min at 37°C prior to virus 
infection. This inhibits clathrin lattice formation and shows if virus is internalised by 
classic receptor mediated endocytosis (Heuser and Anderson, 1989; Hansen et al., 
1993). Table 6.2 shows that at 4°C internalisation of non-neutralized (N0) and 50% 
neutralized virus (N5o) was inhibited by 92% and 94% respectively compared with 
37°C. This also shows that the neuraminidase treatment protocol efficiently removes 
non-intemalised virus, and that neutralized virus is not internalised by a different 
pathway. Table 6.2 also shows that internalisation of No virus and N50 virus was 
inhibited by 81% and 85% respectively by pre-treatment of cells with hypertonic 
solution, indicating that the virus is internalised via clathrin lattice-mediated 
endocytosis.
Figure 6.3 shows that as infectivity decreases with increasing H36 IgG 
concentration the percentage internalisation (corrected for inhibition of attachment) 
stays at approximately 100%, indicating that neutralization by H36 IgG does not 
affect the receptor-mediated internalisation of influenza virus. This is in agreement 
with a previous study that failed to show any effect on internalisation of influenza
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Figure 6.3 Analysis of the relationship between A/PR8 infectivity and the 
internalisation in MDCK cells as a function of H36 IgG concentration.
Infectivity and internalisation were assayed in parallel in the same batch of 
monolayers in 96 well plates, using the same virus-antibody mixtures. Data are 
corrected for inhibition of attachment to cells measured in the same experimental 
system. All data are the mean of three experiments. The curve has been generated 
as described previously (R =>0.98).
log ( M)
▼ % Infectivity M  % Internalisation
Table 6.2 Analysis of the internalisation of non-neutralized (No) and 50% 
neutralized (Nso) virus under the negative control conditions. Data are presented 
as percentage inhibition of internalisation relative to non-neutralized virus at 37°C.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 92 (+/- 2)
Cold (4°C) -  Nso 94 (+/- 7)
Hypertonic treated - No 81 (+/- 6 )
Hypertonic treated -  N50 85 (+/- 5)
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virus by a number of monoclonal IgG antibodies (Outlaw and Dimmock, 1993; 
Outlaw, 1989).
A similar set of experiments was performed on BHK cells (data not shown) 
and preliminary results also indicated that H36 IgG did not have any effect on the 
internalisation of neutralized virus that attached to cells.
6.2.4 Analysis o f  the relationship between A/PR8 infectivity and endosomal 
fusion o f  vims to MDCK and BHK cells as a function o f  H36 
concentration.
As internalisation of virus by target cells is not affected by H36 IgG, it is possible 
that the fusion activity of neutralized virus is inhibited. Fusion was measured using 
octadecyl rhodamine-B-chloride (R18)-labelled virus. This fluorescence assay 
utilises the ability of the R18 to dissolve into the lipid envelope of the virus in vitro. 
When it reaches a sufficient density R18 is self-quenching. During virus-cell fusion 
the lipid envelope of the virus and the cell membrane mix allowing the R 18-label to 
diffuse outwards. This results in dequenching and fluorescence which is measured in 
a spectrophotometer. The two controls used in this assay were (a) fusion carried out 
at 4°C, which inhibits fusion of PR/8 (Pak et al., 1994) and (b) pre-treatment of cells 
with bafilomycin, an inhibitor of cellular V-ATPase, that reduces the endosomal pH 
required to trigger fusion of influenza virus (Palokangas et al., 1994; Guinea and 
Carrasco, 1995). Tables 6.3 and 6.4 give the extent of fusion inhibition under control 
conditions in both MDCK and BHK cells respectively. At 4°C fusion was inhibited 
by 91% in MDCK cells and 94% in BHK cells. This indicated that the majority of 
the signal was due to virus-driven fusion. Inhibition of fusion caused by bafilomycin 
was 86% in MDCK cells and 88% in BHK cells, again demonstrating the specificity 
of the fluorescent signal to low pH-dependent virus-cell fusion
Figures 6.4 and 6.5 show that as infectivity decreased with increasing 
concentration of H36 IgG the percentage fusion also decreased. This suggested a 
causal relationship between inhibition of virus-cell fusion and neutralization by H36 
IgG.
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Figure 6.4 Analysis of the relationship between A/PR8 infectivity and fusion of 
virus to MDCK cells as a function of H36 concentration. Both sets of data were 
obtained using 3 cm monolayers. Infectivity was determined by plaque reduction 
and fusion was measured by fluorescence dequenching of R18-labelled virus. Data 
are the mean of three experiments and have been corrected for inhibition of virus 
attachment to cells. Curves were generated as in Figure 6.1(R = >0.98 for all fusion 
and infectivity data).
Table 6.3 Analysis of the fusion of non-neutralized (N0) virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 91 (+/- 4)
Bafilomycin treated - N0 86 (+/- 8)
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Figure 6.5 Analysis of the relationship between A/PR8 infectivity and fusion of 
virus to BHK cells as a function of H36 concentration. Both sets of data were 
obtained using 3 cm monolayers. Infectivity was determined by plaque reduction 
and fusion was measured by fluorescence dequenching of R18-labelled virus. Data 
are the mean of three experiments and have been corrected for inhibition of virus 
attachment to cells. Curves were generated as in Figure 6.1 (R = >0.99 for all fusion 
and infectivity data).
Table 6.4 Analysis of the fusion of non-neutralized (N0) virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N„ 94 (+/- 3)
Bafilomycin treated - No 88 (+/- 5)
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The data in Figures 6.4 and 6.5 have been corrected for inhibition of 
attachment of the neutralized virus caused by H36 IgG. The level of inhibition of 
attachment of neutralized virus to cells was analysed by treating the infected cells 
with Triton-XlOO to solubilise the viral and cellular membranes. This results in 
complete diffusion of the input R18-labelled membranes and provides the maximum 
level of fluorescence of the input virus. Therefore, if virus attachment was inhibited 
by neutralizing antibody then the total level of fluorescence would be decreased 
compared to the non-neutralized control. This decrease was used to calculate the 
percentage inhibition of attachment of neutralized virus at a particular IgG 
concentration. Therefore, the level of viral fusion of the neutralized virus was 
calculated as a percentage of the amount of attached virus rather than input virus (see 
Appendix 1.2 for example of correction procedure). Comparisons of the fusion and 
infectivity curves using an unpaired T-test showed that in both MDCK and BHK 
cells that they were not significantly different (for Figure 6.4, P value = 0.101 and for 
Figure 6.5 P value = 0.268, where P = <0.05 is significant).
6.3 Fab H36
6.3.1 Analysis o f  the inhibition o f attachment o f influenza A to MDCK and BHK 
cells by Fab H36.
Fab H36-neutralized virus failed to attach to neuraminidase treated cells 
demonstrating that virus attachment was specific for sialic acid containing receptors 
on the cell surface (Figure 6.6 A and B). Figure 6.6 (A) and (B) indicates that 
attachment of virus to both types of cell decreases with increasing concentrations of 
Fab. The decrease in attachment, in contrast to the situation with the MAb, 
correlates very closely with loss of infectivity, suggesting a causal relationship. An 
unpaired T-test revealed that the attachment and infectivity curves for MDCK and 
BHK cells were not significantly different (Figure 6.6 (A) P value = 0.620 and (B) P 
value = 0.856, where P =< 0.05 is significant).
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Figure 6.6 Analysis of the relationship between A/PR8 infectivity and 
attachment as a function of Fab H36 concentration. Data with MDCK cells (A) 
and BHK cells (B) are shown. Infectivity and attachment were assayed by ELISA in 
parallel in the same batch of monolayers in 96 well plates, using the same virus- 
antibody mixtures. Inhibition of attachment of A/PR8 to neuraminidase-treated cells 
was used as the negative control. Data are the mean of five experiments. Curves 
were generated as in Figure 6.1 (R = >0.98 for all attachment and infectivity data).
▲ % Infectivity 
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6.4 Real-time kinetic binding analysis of H36 IgG and its Fab 
fragment to virus particles using surface plasmon resonance.
6.4.1 Comparison o f the kinetics o f  binding o f H36 IgG and its Fab fragment to 
whole virus particles.
The purpose of this section was to determine the functional affinities of the H36 IgG 
and Fab in order determine whether the loss of neutralization efficiency in the Fab 
relative to the IgG could be explained by reduction in functional affinity. The 
method used to calculate the binding kinetics of the antibodies to whole virus was 
adapted from Schofield and Dimmock, (1996) and uses SPR technology with the 
BIAcore 2000 instrument.
Figure 6.7 shows the real-time binding kinetics of four concentrations of H36 
IgG. The data has been X and Y transformed in order to equalise the injection points 
(t=0) and the response to zero. The data was fitted using the BIAevaluation (v3.0.2) 
software package. Dissociation and association data were fitted individually and the 
means of the local fits was calculated to get an overall functional affinity (KD) for the 
concentrations analysed (Table 6.5). Figure 6.8 shows the real time binding kinetics 
for four concentrations of H36 Fab. The data have been transformed and then 
analysed as for the IgG (Table 6.5). Comparison of the means of the equilibrium 
dissociation constants (Ko), considered to represent the functional affinity in this 
study, reveals that the H36 IgG and Fab are almost identical with values of 5.60x10' 
10 M and 5.55xl0'10 M respectively. These affinities are very high, being similar to 
the values quoted by Schofield and Dimmock, (1996) for FPV monoclonal IgGs. 
This shows that the Fab has not lost any affinity relative to the IgG and hence 
reduction of affinity cannot explain the reduced neutralization efficiency seen in the 
Fab.
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Figure 6.7 The binding of H36 IgG at five concentrations to captured whole influenza virus particles. Analysis was conducted in the 2-1
format, so curves show the relative response difference (Resp. Diff) between background control channel and the channel containing captured 
virus, measured in response units (RU) against time measured in seconds(s). Dark lines represent the area of dissociation used in the local fits.
RU
Time s
H36 IgG 1[jg/ml 
H36 IgG 2pg/ml 
H36 IgG 4pg/ml 
H36 IgG 6[jg/ml 
H36 IgG 8|jg/ml
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Figure 6.8 The binding of H36 Fab at four concentrations to captured whole influenza virus particles. Analysis was conducted in the 2- 
1 format, so curves show the relative response difference (Resp. Diff) between background control channel and the channel containing 
captured virus, measured in response units (RU) against time measured in seconds(s). Dark lines represent the area of dissociation used in the 
local fits.
RU
H36 Fab 2pg/ml 
H36 Fab 4pg/ml 
H36 Fab 6pg/ml 
H36 Fab 8pg/ml
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Table 6.5 Local fits of association and dissociation curves for H36 IgG and H36 
Fab. Table shows association and dissociation rate constants (ka and kd) and 
equilibrium association and dissociation constants (Ka  and K d ) for binding to 
captured whole virus particles. Chi2 value indicates goodness of fit of the Langmuir 
1:1 binding model used (<1 = good fit).
Antibody ka (1/Ms) M  1/s) Ka (1/M) Kd ( M) Chi2
H36 IgG lpg/ml 8.40xl05 4.75X10-4 1.77xl09 5.65xlO"10
H36 IgG 2pg/ml 6.88xl05 3.62X10-4 1.90xl09 5.26xlO'10
H36 IgG 4pg/ml 5.81xl05 2.92x1 O'4 1.99xl09 5.03xl0'10
H36 IgG 6pg/ml 4.71xl05 2.25xl0'4 2.09xl09 4.78xlO‘10
H37 IgG 8pg/ml 3.60xl05 2.65X10-4 1.36xl09 7.35xlO‘10
0.057
Mean H36 IgG* 5.88x10s 3.24xl04 1.82xl09 5.60x10"1U
H36 Fab 2pg/ml 1.09xl06 4.43xl0'4 2.47xl09 4.05xl0"10
H36 Fab 4pg/ml 8.17xl05 3.84x1 O'4 2.13xl09 4.70xl0'10
H36 Fab 6pg/ml 6.13x10s 3.18X10-4 1.21xl09 5.19xlO‘10
H36 Fab 8pg/ml 4.34x10s 3.59X10-4 1.21xl09 8.27xlO'10
0.160
Mean H36 Fab 7.38xl05 3.75xl0’4 1.94xl09 5.55xl0lu
* values are the means of each column and hence equations to determine Ka 
and Kd only apply to raw data in the columns (KA = k jk d and KD = kd/ka)
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6.5 H36 F(ab)2
6.5.1 Analysis o f  the relationship between attachment and infectivity ofA/PR/8 to
MDCK cells as a function o f H36 F(ab)2 concentration.
The analysis of the effect of H36 F(ab) 2 on virus attachment is shown in Figure 6.9. 
Neuraminidase pre-treatment reduced the level of attachment of virus by 85% and 
this decreased with increasing IgG, showing that the majority of the attachment in 
these attachment ELISAs is specific to sialic acid-containing receptors and that Fc 
receptor capture of neutralized virus was not involved.
In common with H36 IgG, the F(ab) 2 also shows disparity between the loss of 
infectivity and the inhibition of attachment (Figure 6.9). This discrepancy between 
inhibition of attachment and infectivity indicates that inhibition of attachment is not 
the sole mechanism acting in the neutralization by this antibody fragment. At higher 
concentrations of F(ab)2, inhibition of attachment is responsible for a larger 
component of the neutralization, at N9o inhibition of attachment was 78%, whereas, 
at N5o, inhibition of attachment was only 2 %. Thus the mechanism of neutralization 
of the H36 IgG and the H36 F(ab) 2 are similar, and are in contrast with the H36 Fab. 
No further analysis of the F(ab) 2 was carried out.
6.6 Summary: Comparison of the characteristics of neutralization 
of H36 IgG and its antibody fragments.
The order of neutralization efficiency was IgG>F(ab)2>Fab. However, this 
difference was not uniform over the entire concentration range, as the N50 of the Fab 
required 104-fold higher concentration than the IgG, whereas the N90 of the Fab was 
only 15-fold greater. The Fab and IgG have almost identical affinities (5.5xlO' 10 M 
and 5.6x1 O' 10 M respectively) and hence affinity cannot account for the loss of 
neutralization efficiency.
The IgG neutralized virus by two simultaneous mechanisms, inhibition of 
attachment of virus to target cells and inhibition of fusion of virus with the target cell 
membrane. In contrast, the Fab neutralized by inhibition of attachment as its sole 
mechanism, suggesting that loss of neutralization efficiency relative to the
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Figure 6.9 Analysis of the relationship between A/PR8 infectivity and 
attachment to MDCK cells as a function of H36 F(ab)2 concentration. Infectivity 
and attachment were assayed by ELISA in parallel in the same batch of monolayers 
in 96 well plates, using the same virus-antibody mixtures. Inhibition of attachment 
of A/PR8 to neuraminidase-treated cells was used as the negative control. Data are 
the mean of three experiments. Curves were generated as in Figure 6.1 (R = >0.99 
for all attachment and infectivity data).
■ % Attachment 
T % Infectivity
* % Attachment to neuraminidase-treated cells
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IgG may be related to differences in the mechanism of neutralization (discussed in 
more detail later). The relationship between attachment and infectivity of virus 
neutralized by the F(ab)2 and IgG was very similar.
6.7 MAb H37-45-5R3
The H37 MAb is an IgG3 and is specific for antigenic site Ca2 on the viral HA. 
Hence, analysis of the mechanism of neutralization of virus with this MAb will 
determine if it is isotype or antigenic site-dependent.
6.7.1 Comparison o f the neutralization o f A/PR/8 by H37 IgG and its Fab 
fragment by plaque reduction.
Figure 6.10 shows the percentage neutralization as a function of H37 concentration 
for IgG and Fab. The neutralization data shows a large difference between the 
curves, indicating that the Fab has a lower neutralization efficiency compared to the 
parent IgG. The Fab fragment requires a 360-fold higher concentration than the IgG 
at N50, and a 178-fold higher concentration at N90 (Table 6.6).
6.7.2 Analysis o f  the relationship between A/PR/8 virus infectivity and 
attachment to both MDCK and BHK cells as a function o f H37 IgG 
concentration.
Attachment of influenza to both cell types decreases with increasing concentration of 
IgG (Figure 6.11 A and B). However, the decrease in the level of attachment does 
not correlate well with decrease in the level of infectivity. For example, at N50 in 
Figure 6.11 (A) there is only a 20% inhibition of attachment and the same point in 
Figure 6.11 (B) there is a 15% reduction in attachment. Comparisons of the 
attachment and infectivity curves by an unpaired T-test show them to be significantly 
different (Figure 6.11(A) P value = 0.027 and (B) P value = 0.047, where p = <0.05 
is significant). At higher concentrations, inhibition of attachment becomes a larger 
proportion of the neutralization, for example at N90 in Figure 6.11 (A) there is a 65% 
inhibition of attachment and the same point in Figure 6.11 (B) there is a 50% 
inhibition of attachment.
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Figure 6.10 Neutralization of A/PR8 by H37 IgG and Fab in MDCK cells. Data 
are the mean of three experiments, measured by plaque reduction. The bar represents 
SEM. Curves were generated by non-linear regression using the Graphpad Prism 
package (R = >0.98).
Table 6.6 Comparison of the neutralizing activities of H37 IgG and its Fab 
fragments. Data from Figure 8.10.
Antibody Concentration (nM) required to Fab : IgG ratio at
give neutralization of neutralization of
50% 90% 50% 90%
IgG 5.0 14.0 -
Fab 1800.0 2500.0 360 . 1 178 : 1
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Figure 6.11 Analysis of the relationship between A/PR8 infectivity and 
attachment as a function of H37 concentration. Data with MDCK cells (A) and 
BHK cells (B) are shown. Infectivity and attachment were assayed by ELISA in 
parallel in the same batch of monolayers in 96 well plates, using the same virus- 
antibody mixtures. Inhibition of attachment of A/PR8 to neuraminidase-treated cells 
was used as the negative control. Data are the mean of five experiments. Curves 
were generated as in Figure 6.10 (R = >0.98 for all attachment and infectivity data).
■ %  Attachment 
A %  Infectivity
*  %  Attachment to neuraminidasc-trcatcd cells
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log (M)
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6.7.3 Analysis o f  the relationship between A/PR/8 virus injectivity and the 
internalisation in MDCK cells as a function ofH37IgG concentration.
Figure 6.12 shows that as infectivity decreases with increasing H37 IgG 
concentration the percentage internalisation (corrected for inhibition of attachment) 
stays at approximately 100%. These results are again qualitatively consistent with 
those seen with H36 IgG (section 6.2.3) and suggest that H37 IgG also does not 
affect receptor-mediated internalisation of influenza virus. Similar results were 
found with BHK cells (data not shown)
6.7.4 Analysis o f  the relationship between A/PR/8 virus infectivity and endosomal 
fusion in both MDCK and BHK cells as a function o f H37 IgG 
concentration.
Negative controls used in this assay were consistent with those used for analysis of 
H36 IgG and data in tables 6.8 and 6.9 demonstrate again that the fluorescent signal 
obtained was specific for virus-driven fusion.
Figures 6.13 and 6.14 show that as infectivity decreases with increasing 
concentration of H36 IgG the percentage fusion also decreases in both MDCK and 
BHK cells respectively. This indicates a causal relationship between inhibition of 
virus-cell fusion and neutralization by H37 IgG. Comparisons of the fusion and 
infectivity curves using an unpaired T-test revealed that in both MDCK and BHK 
cells that they were not significantly different (for Figure 6.13, P = 0.443 and for 
Figure 6.14 P = 0.563).
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Figure 6.12 Analysis of the relationship between A/PR8  infectivity and the 
internalisation in MDCK cells as a function of H37 IgG concentration. Both 
infectivity and internalisation were assayed in parallel in the same batch of 
monolayers in 96 well plates, using the same virus-antibody mixtures. Data are 
corrected for inhibition of attachment to cells measured in the same experimental 
system All data are the mean of three experiments. The curve was generated as in 
Figure 6 .10 (R = >0.99)
-9.0 -8.5 -8.0 -7.5
log (M)
g l  % Internalisation A % Infectivity
Table 6.7 Analysis of the internalisation of non-neutralized (N0) and Nso virus 
under the negative control conditions. Data is presented as percentage inhibition 
of internalisation relative to non-neutralized virus at 37°C (standard conditions). 
Data for neutralized virus is corrected for inhibition of attachment. Data are the 
mean of three experiments.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N„ 94 (+/-2)
Cold (4°C) -  Nso 91 (+/- 9)
Hypertonic treated - No 79 (+/- 5)
Hypertonic treated -  N50 86 (+/- 9)
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Figure 6.13 Analysis of the relationship between A/PR8  infectivity and fusion of 
virus to MDCK cells as a function of H37 concentration. Both sets of data were 
obtained using 3 cm monolayers. Infectivity was determined by plaque reduction 
and fusion was measured by fluorescence dequenching of R18-labelled virus. Data 
are the mean of three experiments and have been corrected for inhibition of virus 
attachment to cells. Curves were generated as in Figure 6.10 (R = >0.99 for all 
fusion and infectivity data).
Table 6 .8  Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data is presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N0 89 (+/- 2)
Bafilomycin treated - N0 8 8  (+/- 4)
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Figure 6.14 Analysis of the relationship between A/PR8  infectivity and fusion of 
virus to BHK cells as a function of H37 concentration. Both sets of data were 
obtained using 3 cm monolayers. Infectivity was determined by plaque reduction 
and fusion was measured by fluorescence dequenching of R.18-labelled virus. Data 
are the mean of three experiments and have been corrected for inhibition of virus 
attachment to cells. Curves were generated as in Figure 8.10 (R = >0.99 for all 
fusion and infectivity data).
Table 6.9 Analysis of the fusion of noil-neutralized virus under the negative 
control conditions. Data is presented as percentage inhibition of fusion relative 
to non-neutralized virus at 37°C. Data are the mean of three experiments.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 87 (+/- 4)
Bafilomycin treated - N0 79 (+1-9)
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6.8 Fab H37
6.8.1 Analysis o f  the relationship between attachment and infectivity o f A/PR/8 
virus to both MDCK and BHK cells as a function Fab H37
Figure 6.15 (A) and (B) indicates that attachment of virus to both types of cell 
decreases with increasing concentrations of Fab. The decrease in attachment, in 
contrast to the situation with the IgG, correlates very closely with loss of infectivity, 
suggesting a causal relationship. Comparison of attachment and infectivity curves for 
MDCK and BHK cells using an unpaired T-test revealed that the curves were not 
significantly different (Figure 6.15 (A) P value = 0.765 and (B) P value = 0.716). 
This suggests that neutralization of virus by Fab H37 occurs by one dominant 
mechanism, inhibition of attachment.
6.9 Real-time kinetic analysis of H37 IgG and its Fab to virus 
particles using surface plasmon resonance.
6.9.1 Comparison o f  the kinetics o f  binding o f H37 IgG and its Fab fragment to 
whole virus particles.
Figures 6.16 and 6.17 show the real-time binding kinetics of four concentrations of 
H37 IgG and Fab respectively. The data have been transformed and then analysed as 
described before with H36 IgG (Table 6.10). The affinity (Kd) of the H37 Fab was 
4 .2 -fold lower than the IgG. It is also interesting to note that the association constant 
(Ka ) was 24-fold lower than the IgG and it is evident from the slope of the 
dissociation phase in Figure 6.17 that the Fab had a faster dissociation (14-fold) and 
this may be relevant in an equilibrium based neutralization assay. However, neither 
value can explain the 360-fold difference in neutralization efficiency at N50 or the 
178-fold difference at N90.
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Figure 6.15 Analysis of the relationship between A/PR8 infectivity and 
attachment as a function of Fab H37 concentration. Data with MDCK cells (A) 
and BHK cells (B) are shown. Infectivity and attachment were assayed by ELISA in 
parallel in the same batch of monolayers in 96 well plates, using the same virus- 
antibody mixtures. Inhibition of attachment of A/PR8 to neuraminidase-treated cells 
was used as the negative control. Data are the mean of five experiments. Curves 
were generated as for Figure 6.10 (R = >0,99 for all attachment and infectivity data).
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Figure 6.16 The binding of H37 IgG at five concentrations to captured whole influenza virus particles. Analysis was conducted in the 2- 
1 format, so curves show the relative response difference (Resp Diff) between background control channel and channel containing captured 
virus, measured in response units (RU) against time measured in seconds(s). Dark lines represent the area of dissociation used in the local fits.
H37 IgG (2.5pg/ml) 
H37 IgG (5pg/ml) 
H37 IgG (lOpg/ml) 
H37 IgG (12.5fjg/ml)
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Figure 6.17 The binding of H37 Fab at four concentrations to captured whole influenza virus particles. Analysis was conducted in the 
2-1 format, so curves show the relative response difference (Rresp Diff) between background control channel and channel containing captured 
virus, measured in response units (RU) against time measured in seconds(s). Dark lines represent the area of dissociation used in the local fits.
Fab H37 (10pg/ml 
Fab H37 (12.5pg/r 
Fab H37(17.5|jg/r 
Fab H37 (20|jg/ml
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Table 6.10 Local fits of association and dissociation curves for H37 IgG and 
Fab. Table shows association and dissociation rate constants (ka and kj) and 
equilibrium association and dissociation constants (Ka and Kd) for binding to 
captured whole virus particles. Chi2 value indicates goodness of fit of the Langmuir 
1:1 binding model used (<1 = good fit).
Antibody ka (1/Ms) (1/s) Ka (1/M) Afl(M) Chi2
H37 IgG 2.5pg/ml 5.26xl05 1.54xl0'4 3.41xl09 2.93xlO’10
H37 IgG 5.0pg/ml 3.99xl05 1.45x1 O'4 2.75xl09 3.64xlO'10
H37 IgG 10.0pg/ml 4.31xl05 1.54x1er4 2.80xl09 3.57xl0‘10
H37 IgG 12.5pg/ml 3.43xl05 1.84x1 O'4 1.86xl09 5.37xlO'10
0.292
H37 IgG Mean 4.25x10s 1.59xl04 2.71xl09 3.88x10 10
H37 Fab 10.0pg/ml 2.78xl05 2.25xl0'3 1.24xl08 8.08xl0‘9
H37 Fab 12.5pg/ml 2.71xl05 2.28xl0'3 1.19xl08 8.43xl0'9
H37 Fab 17.5pg/ml 2.31xl05 2.22x1 O'3 1.04xl08 9.60x1 O’9
H37 Fab 20.0pg/ml 2.18xl05 2.14x10‘3 1.02xl08 9.82x1 O'9
0.223
H37 Fab Mean 2.48x10s 2.22x10‘3 1.12x10s 8.98 x1er5
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6.10 Summary: Comparison of the mechanism of neutralization of 
influenza by H37 IgG and Fab H37.
The Fab possessed a lower neutralization activity compared to the IgG. However, 
this difference was not uniform across the neutralization range with the Fab at N50 
requiring a 360-fold higher concentration compared to the IgG, whilst it only 
required a 170-fold higher concentration at the N90 point. This suggests that the 
efficiency of neutralization of the Fab increased with increasing concentration. The 
affinity of the Fab was 4.3-fold lower relative to the IgG, with higher kj being 
responsible for the difference. However, this difference could not explain the 170- to 
360-fold difference in neutralization activity.
Investigation of the mechanism of neutralization revealed striking similarities 
with the H36 IgG, being able to simultaneously inhibit attachment of virus to target 
cells and fusion of virus with target membranes. The Fab also showed similarities to 
the H36 Fab neutralizing solely by inhibition of attachment of virus to target cells.
6.11 MAb H9-D3-4R2
The H9 MAb differs from the H36 and H37 MAbs in its antigenic site specificity, 
binding to site Cb.
6.11.1 Comparison o f the neutralization by plaque reduction by 119 IgG and Fab.
Figure 6.18 indicates that neutralization efficiency of the Fab fragment is reduced 
compared to the IgG. The H9 Fab had poor neutralizing activity and it was not 
possible due to the large quantities required to achieve 1 0 0 % neutralization of virus. 
Table 6 .11 reveals that there is a difference between the efficiency of neutralization 
at 50% and at 90% with the Fab compared to the IgG. At N50 the Fab requires a 375- 
fold higher concentration than the IgG, in contrast to the 208-fold higher 
concentration required at N9o.
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Figure 6.18 Neutralization of A/PR8 by H9 IgG and Fab. Data are the mean of 
three experiments of neutralization on MDCK cells, measured by plaque reduction 
The bar represents SEM. The curves were generated by non-linear regression using 
the Graphpad Prism software package (R = >0.97)
Table 6.11 Comparison of the neutralizing activities of H9 lgG and its Fab 
fragments. Data from Figure 8.18.
Antibody Concentration (nM) required to Fab : IgG ratio at
give neutralization of neutralization o f
50% 00% 50% 00%
IgG 40.0 120.0 -
Fab 15000.0 25000.0 375 : 1 208 : 1
6.11.2 Analysis o f  the relationship between A/PR8 virus infectivity and attachment 
to both MDCK and BHK cells as a function o f H9 IgG concentration.
Attachment of influenza to both cell types decreased with increasing concentration of 
IgG (Figure 6.19 A and B). The decrease in the level of attachment, as also seen 
with the H36 and H37 IgGs, does not correlate well with the decrease in the level of 
infectivity. For example, at N50 in Figure 6.19 (A), there is only a 20% inhibition of 
attachment and the same point in Figure 6.19 (B) there is a 15% reduction in 
attachment. An unpaired T-test showed the attachment and infectivity curves to be 
significantly different (Figure 6.19(A) P value = 0.034 and (B) P value = 0.002, 
where p = <0.05 is significant). At higher concentrations, inhibition of attachment 
became the dominant mechanism of neutralization.
6.11.3 Analysis o f  the relationship between A/PR/8 virus infectivity and 
internalisation as a function o f H9 IgG concentration.
This assay was carried out simultaneously with the attachment assay and the level of 
internalisation was corrected for inhibition of attachment (as described previously for 
H36 IgG).
Figure 6.20 shows that as infectivity decreased with increasing H9 IgG 
concentration the percentage internalisation is unaffected. These results are again 
consistent with those seen with the H36 and H37 IgGs (section 6.2.3) and suggest 
that H9 IgG also did not affect receptor-mediated internalisation of influenza virus.
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Figure 6.19 Analysis of the relationship between A/PR8 infectivity and 
attachment as a function of H9 IgG concentration. Data with MDCK cells (A) 
and BHK cells (B) are shown. Both infectivity and attachment were assayed by 
ELISA in parallel in the same batch of monolayers in 96 well plates, using the same 
virus-antibody mixtures. Analysis of attachment of A/PR8 to neuraminidase treated 
cells was used as the negative control. Data are the mean of five experiments. 
Curves were generated as in Figure 6.18 (R = >0.98 for all attachment and infectivity 
data).
▲ % Infectivity
*  % Attachment to neuraminidase-treated cells
Figure 6.20 Analysis of the relationship between A/PR8  infectivity and the 
internalisation in MDCK cells as a function of H9 IgG concentration. Both 
infectivity and internalisation were assayed in parallel in the same batch of 
monolayers in 96 well plates, using the same virus-antibody mixtures. Data are 
corrected for inhibition of attachment to cells measured in the same experimental 
system. All data are the mean of three experiments. Curve was generated as in 
Figure 6.18 (R = >0.98)
log (M)
▲ % Infectivity 
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Table 6.12 Analysis of the internalisation of non-neutralized (N0) and N50 virus 
under the negative control conditions. Data is presented as percentage inhibition 
of internalisation relative to non-neutralized virus at 37°C (standard conditions). 
Data for neutralized virus is corrected for inhibition of attachment. Data are the 
mean of three experiments.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 95 (+/- 7)
Cold (4°C) -  N50 90 (+/- 11)
Hypertonic treated - No 81 (+/- 6)
Hypertonic treated -  N50 8 6  (+/- 5)
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6.11.4 Analysis o f  the effect o f  H37 IgG on endosomal fusion o f A/PR/8 virus in 
cells
The negative controls used in this assay were consistent with those used for analysis 
of H36 IgG and data in Tables 6.13 and 6.14 demonstrate again that the fluorescent 
signal obtained was specific for virus-driven fusion.
Figures 6.21 and 6.22 show that as infectivity decreased with increasing 
concentration of H9 IgG the percentage fusion also decreases in both MDCK and 
BHK cells respectively. This indicates a causal relationship between inhibition of 
virus-cell fusion and neutralization by H9 IgG. Comparisons of the fusion and 
infectivity curves using an unpaired T-test revealed that in both MDCK and BHK 
cells that they were not significantly different (for Figure 6.21, P value = 0.164 and 
for Figure 6.22 P value = 0.267).
6.12 Fab H9-D3-4R2
6.12.1 Analysis o f  the relationship between A/PR/8 virus infectivity and 
attachment to both MDCK and BHK cells as a function o f Fab H9 
concentration.
Attachment of virus to both types of cell was unaffected by increasing concentrations 
of Fab (Figure 6.23 A and B). This is in direct contrast to the situation seen with the 
IgG, in which attachment is affected. As a result the H9 Fab must be neutralizing the 
virus by interfering with a stage(s) further along the virus infectious cycle. This 
situation is also in direct contrast to the H36 and H37 Fabs which only inhibited 
attachment in this system and again shows that Fab mechanism of neutralization can 
be very different to that seen with the IgG.
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Figure 6.21 Analysis of the relationship between A/PR8 infectivity and fusion of 
virus to MDCK cells as a function of H9 concentration. Both sets of data were 
obtained using 3 cm monolayers. Infectivity was determined by plaque reduction 
and fusion was measured by fluorescence dequenching of R18-labelled virus. Data 
are the mean of three experiments and have been corrected for inhibition of virus 
attachment to cells. Curves were generated as in Figure 6.18 (R = >0.98 for all 
fusion and infectivity data).
Table 6.13 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data is presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
i n ternalisation
Cold (4°C) -  No 91 (+/- 9)
Bafilomycin treated - No 81 (+/- 12)
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Figure 6.22 Analysis of the relationship between A/PR8 infectivity and fusion of 
virus to MDCK cells as a function of H9 concentration. Both sets of data were 
obtained using 3 cm monolayers. Infectivity was determined by plaque reduction 
and fusion was measured by fluorescence dequenching of R18-labelled virus. Data 
are the mean of three experiments and have been corrected for inhibition of vims 
attachment to cells. Curves were generated as in Figure 6.18 (R = >0.98 for all 
fusion and infectivity data).
Table 6.14 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data is presented as percentage inhibition of fusion relative to 
non-neutralized vims at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 89 (+/- 6)
Bafilomycin treated - N0 79 (+/- 15)
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Figure 6.23 Analysis of the relationship between A/PR8 infectivity and 
attachment as a function of Fab H37 concentration. Data with MDCK cells (A) 
and BHK cells (B) are shown. Infectivity and attachment were assayed by ELISA in 
parallel in the same batch of monolayers in 96 well plates, using the same virus- 
antibody mixtures. Inhibition of attachment of A/PR8 to neuraminidase-treated cells 
was used as the negative control. Data are the mean of five experiments. Curves 
were generated as in Figure 6.18 (R = >0.99 for all infectivity data).
■ % Attachm ent 
▲ % Infectivity
¥  % Attachm ent to neuraminidase-treated cells
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6.12.2 Analysis o f the relationship between A/PR/8 virus infectivity and 
internalisation as a function o f H9 Fab concentration.
This assay was carried out simultaneously with the attachment assay and the level of 
internalisation was corrected for inhibition of attachment (as described previously for 
H36 IgG).
Figure 6.24 shows that as infectivity decreased with increasing H9 Fab 
concentration the percentage internalisation stayed at approximately 100%. These 
results are again consistent with those seen with the other antibodies described 
previously and suggest that H9 Fab also did not affect receptor-mediated 
internalisation of influenza virus.
124
Figure 6.24 Analysis of the relationship between A/PR8 infectivity and the 
internalisation in MDCK cells as a function of H9 Fab concentration. Both 
infectivity and internalisation were assayed in parallel in the same batch of 
monolayers in 96 well plates, using the same virus-antibody mixtures. Data are 
corrected for inhibition of attachment to cells measured in the same experimental 
system. All data are the mean of three experiments. Curve was generated as in 
Figure 6.18 (R = > 0.99)
log (M)
Ü  % Internalisation A % Infectivity
Table 6.15 Analysis of the internalisation of lion-neutralized (N0) and Nso virus 
under the negative control conditions. Data is presented as percentage inhibition 
of internalisation relative to non-neutralized virus at 37°C (standard conditions). 
Data for neutralized virus is corrected for inhibition of attachment. Data are the 
mean of three experiments.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N„ 94 (+/- 8)
Cold (4°C) -  Nso 90 (+/- 7)
Hypertonic treated - No 78 (+/- 8)
Hypertonic treated -  N50 85 (+/- 11)
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6.12.3 Analysis o f  the relationship between A/PR/8 virus injectivity and endosomal 
fusion in both MDCK and BHK cells as a function o f H9 Fab 
concentration.
The negative controls used in this assay were consistent with those used for analysis 
of H36 IgG and data in Tables 6.16 and 6.17 demonstrate again that the fluorescent 
signal obtained was specific for virus-driven fusion.
Figures 6.25 and 6.26 show that as infectivity decreased with increasing 
concentration of H9 Fab the percentage fusion also decreased in both MDCK and 
BHK cells respectively. This indicates a causal relationship between inhibition of 
virus-cell fusion and neutralization by H9 Fab. Comparisons of the fusion and 
infectivity curves using an unpaired T-test revealed that in both MDCK and BHK 
cells that they were not significantly different (for Figure 6.25, P value = 0.302 and 
for Figure 6.26 P value = 0.908). Therefore, it is possible to conclude that the H9 
Fab neutralizes by inhibition of fusion and hence demonstrates that bivalency is not 
vital for fusion inhibition. It is interesting to note that in both cell types that fusion 
inhibition is not complete and at higher concentration of Fab cannot account for the 
entire loss of infectivity. However, without further experimentation it is unknown 
whether these differences are significant or are just a factor of the very poor 
neutralizing ability of the Fab.
6.13 Real-time kinetic analysis of H9 IgG and its Fab to virus 
particles using surface plasmon resonance.
6.13.1 Comparison o f the kinetics o f  binding o f H9 IgG and its Fab fragment to 
whole virus particles.
Figures 6.27 and 6.28 show the real-time binding kinetics of four concentrations of 
H9 IgG and Fab respectively. The data have been transformed and then analysed in 
an equivalent manner to H36 IgG (Table 6.18). Comparison of the means of the 
equilibrium dissociation constant (KD), shows that the H9 IgG and Fab are almost 
identical with values of 5.29x10 M and 5.49x10 M respectively. This suggests that 
the Fab has not lost any affinity relative to the IgG and hence reduction of affinity 
cannot explain the reduced neutralization efficiency of the Fab.
126
Figure 6.25 Analysis of the relationship between A/PR8 infectivity and fusion of 
virus to MDCK cells as a function of H9 Fab concentration. Both sets of data 
were obtained using 3 cm monolayers. Infectivity was determined by plaque 
reduction and fusion was measured by fluorescence dequenching of R18-labelled 
virus. Data are the mean of three experiments and have been corrected for inhibition 
of virus attachment to cells. Curves were generated as in Figure 6.18 (R = >0.97 for 
all fusion and infectivity data).
Table 6.16 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data is presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 91 (+/- 6)
Bafilomycin treated - No 80 (+/- 9)
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Figure 6.26 Analysis of the relationship between A/PR8 infectivity and fusion of 
virus to MDCK cells as a function of H9 Fab concentration. Both sets of data 
were obtained using 3 cm monolayers. Infectivity was determined by plaque 
reduction and fusion was measured by fluorescence dequenching of R18-labelled 
virus. Data are the mean of three experiments and have been corrected for inhibition 
of virus attachment to cells. Curves were generated as in Figure 6.18 (R -  >0.97 for 
all fusion and infectivity data).
Table 6.17 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data is presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 89 (+/- 5)
Bafilomycin treated - N0 86 (+/- 15)
128
6.14 Summary: Comparison of the mechanism of neutralization of 
influenza A virus by H9 IgG and Fab.
The efficiency of neutralization of H9 Fab increased with increasing concentration, 
but its neutralization activity was lower than the IgG. The lower neutralization 
activity of the Fab compared to the IgG could not be explained by differences in 
affinity.
Investigation of the mechanism of neutralization of the H9 IgG revealed 
striking similarities with the H36 and H37 IgGs, being able to simultaneously inhibit 
both attachment of virus to target cells and fusion of virus to target membranes. 
However, the Fab displayed a unique mechanism of neutralization, inhibiting fusion 
of virus to target membranes. This demonstrated that bivalency was not required for 
inhibition of fusion.
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Figure 6.27 The binding of H9 IgG at five concentrations to captured whole influenza virus particles. Analysis was conducted in the 2-1
format, so curves show the relative response difference (Resp Diff) between background control channel and channel containing captured 
virus, measured in response units (RU) against time measured in seconds(s). Dark lines represent the area of dissociation used in the local fits.
RU
H9 IgG 7.5gg/ml 
H9 IgG 10.0pg/ml 
H9 IgG 12.5|jg/ml 
H9 IgG 15.0pg/ml
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Figure 6.28 The binding of H9 Fab at four concentrations to captured whole influenza virus particles. Analysis was conducted in the 2- 
1 format, so curves show the relative response difference (Resp Diff) between background control channel and channel containing captured 
virus, measured in response units (RU) against time measured in seconds(s). Dark lines represent the area of dissociation used in the local fits.
RU
H9 Fab 7.5pg/ml 
H9 Fab 10.0pg/ml 
H9 Fab 12.5pg/ml
Time s
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Table 6.18 Local fits of association and dissociation curves for H9 IgG and Fab.
Table shows association and dissociation rate constants (ka and kj) and equilibrium 
association and dissociation constants (Ka and Kd) for binding to captured whole 
virus particles. Chi2 value indicates goodness of fit of the Langmuir 1:1 binding 
model used (<1 = good fit).
Antibody ka (1/Ms) kd ( 1/s) Ka (1/M) Kd ( M) Chi4
H9 IgG 7.5pg/ml 1.35xl05 4.98xl0'5 2.76xl09 3.62x1 O’10
H9 IgG 10.0pg/ml l.llx lO 5 3.81xl0'5 2.92xl09 3.42xlO'10
H9 IgG 12.5pg/ml 9.66xl04 3.65xl0'5 2.65xl09 3.78xlO'10
H9 IgG 15.0pg/ml 8.95xl04 2.10x1 O'5 4.26x109 2.35xlO'10
0.034
H9 IgG Mean 1.08xl05 3.64xl05 3.15xl09 3.29xl010
H9 Fab 7.5pg/ml 1.45xl05 6.80xl0‘5 2.13xl09 4.69xlO'10
H9 Fab 10.0pg/ml 1.18xl05 2.15xl0'5 5.5xl09 1.82xlO'10
H9 Fab 12.5|ig/ml 1.13xl05 4.47x1 O'5 2.52xl09 3.96x1 O'10
0.036
H9 Fab Mean 1.25x10s ~4.47x10 s 3.38xl09 3.49xl0lü
132
6.15 Discussion :
6.15.1 Comparison o f the characteristics o f  neutralization o f A/PR/8 virus by the 
IgGs and their Fobs.
This study demonstrates that the Fabs are neutralizing, indicating that bivalency is 
not required for neutralization. However, each Fab had a lower neutralization 
efficiency than its respective IgG. A trend seen in the Fabs was that they are all 
more efficient at neutralizing at N90 than N50 relative to their IgGs (Table 6.19). This 
suggested that Fab neutralizing activity increased with increasing concentration.
A possible explanation for the loss of neutralization activity by the Fabs is a 
reduction in affinity compared to the IgGs. However, the IgGs and the Fabs have 
similar affinities; the 4.3-fold lower affinity of the H37 Fab compared to its IgG 
being the largest. Therefore, loss of affinity cannot explain the large reduction (104- 
to 370-fold at N50) in neutralization efficiency. Hence, there appears to be no 
correlation between neutralization and affinity. The similarity in the affinities of the 
IgGs and their Fabs could be explained by the affinities of the IgGs being above the 
>10'9 threshold suggested to be sufficiently high that it dominates the loss of 
bivalency and results in only a small difference in affinity with the Fabs (Parham, 
1983). An alternative explanation of the similar affinities is that the IgGs also bind 
monovalently (Schofield and Dimmock, 1996).
The Fabs can be entered into a classification scheme which has five categories 
depending on neutralization activity and affinity (Schofield et al., 1997b). H36 and 
H9 Fab are members of group I, which represents Fabs that have a similar affinity to 
their IgG, but lower neutralization activity. The H37 Fab is a member of group III, 
which represents Fab whose loss of neutralization activity exceeds the reduced 
affinity by at least 10-fold. All the IgGs and Fabs had very high affinities, with all 
the IgG affinities being higher than those described for anti-Fowl plaque virus (FPV) 
IgGs (Schofield and Dimmock, 1996).
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Table 6.19 Summary of the mechanism of neutralization by H36, H37 and H9 IgGs and their antibody fragments in MDCK cells.
MAb Antigenic
site
Concentration (nM) 
required to give 
N 5 0  N 90
Percentage inhibition of 
attachment at 
N 5 0  N 90
Inhibition of 
internalisation
Inhibition o f 
fusion
H36 IgG Sb 0.5 6.0 10 73 No Yes
H36 Fab Sb 52.0 90.0 42 88 No -
H36 F(ab)2 Sb 4.0 15.0 3 74 ND ND
H37 IgG Ca2 5.0 14.0 20 65 No Yes
H37 Fab Ca2 1800.0 2500.0 42 87 No -
H9 IgG Cb 40.0 120.0 20 55 No Yes
H9 Fab Cb 15000.0 25000.0 1 1 No Yes
ND = Not done
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6.15.2 Comparison o f the neutralization activity o f  H36, H37 and H9 IgGs and 
Fabs.
The ranking order of the antibodies based on neutralization activity is H36 > H37 > 
H9 and this order is mirrored when comparing the neutralizing activity of their Fabs. 
From this arises the interesting question of what are the factors that affect the 
efficiency of neutralization of virus by each of the antibodies?
Each of the antibodies binds to a different antigenic sites on the HA molecule 
and it is possible that intrinsic properties of the specific antigenic site or its 
relationship to the receptor binding site may affect its neutralization activity (Figure 
6.29). Previously Brown et al. (1990) postulated that MAb A2, specific for site C 
(H3 HA numbering system, near to site Cb in the HI HA) was the least efficient at 
neutralization and HI because its antigenic site was furthest from the receptor 
binding site and thus MAbs binding to this site were the least able, relative to the 
other antigenic sites, to sterically hinder the receptor-HA interaction. This concept 
has been recently supported by a study which compared the X-ray crystallographic 
structure of the BHA-Fab complexes of one Fab binding to a site which comprises 
part of the receptor-binding site and another Fab which binds to a site at a distance 
from the receptor binding site (Fleury et al., 1999). This showed that the HC19 Fab 
was an order of magnitude more efficient at neutralization than the HC45 Fab, even 
though they were had similar affinities. The authors suggested that even the 
antibodies that bind at a distance from the receptor-binding site can sterically 
interfere with attachment, with the antibodies binding close to the receptor binding 
site being more efficient at steric hindrance. The data presented in this thesis is also 
supportive, as the HI ranking order of H36 > H37 > H9 (data not shown) mirrors the 
neutralization order, suggesting steric hindrance was lowest in H9 which binds to site 
Cb the furthest from the receptor binding site. The H9 Fab data is also supportive of 
this hypothesis, as it has the lowest neutralization activity relative to its IgG, 
compared with H36 and H37 Fabs. Also the Fab H9 does not inhibit virus 
attachment to either MDCK and BHK cells and does not give HI. These data suggest 
that reducing the molecular length of the H9 IgG 2-fold when making its Fab 
fragment has had the largest impact on the ability to sterically hinder receptor 
interactions, as one would expect if distance from the receptor-binding site
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Figure 6.29 Diagrammatic representation of a monomer of the HI 
haemagglutinin, based on the H3 crystal structure. MAb binding sites and cell- 
receptor binding site are annotated.
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was important.
Another study using an H7 virus showed that MAb 8/4 which binds to site III 
(equivalent of Cb) also has a low neutralization titre and a very poor HI titre (Yoden 
et al., 1985). Thus three studies have shown that antibodies to the site furthest from 
the receptor binding site (Cb in HI, III in H7 and C in H3) are the least efficient at 
neutralizing compared to MAbs to other sites and hence suggests that this could be a 
general property of these antigenic regions. The primary immune response in 
BALB/c mice is predominantly restricted to site Cb (Kavaler et al., 1990), suggesting 
that this may represent an immune evasion strategy during primary influenza
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infection in which antibodies are biased to low efficiency neutralizing epitopes. 
However, many more MAbs need to be analysed to further this hypothesis.
The H37 IgG:Fab neutralization ratio was very low (360:1 at N 5 0 )  compared to 
the H36 (104:1) and almost to the H9 Fab levels (375:1). The H37 IgG binds to site 
Ca2 and it seems unlikely that distance from the receptor binding site can fully 
explain the large loss of neutralization efficiency. In fact, the study by Brown et al., 
(1990) concluded that apart from site C there was no absolute correlation between 
antigenic site recognised by the MAbs and its neutralization and HI activity. 
Therefore, the orientation of binding of the IgGs may also play a role in the ability to 
neutralize and give HI (Schofield et al., 1997b); Poumbourios et al., 1990). It is 
possible that relative to the H36 IgG, the H37 IgG has a binding angle that is not 
efficient at interfering with the receptor-binding site. The reduction of length (or 
molecular mass) when an IgG is made into a Fab add to this non-optimal binding 
angle effect, resulting in a low efficiency of steric hindrance of the HA-cell receptor 
interaction. We therefore postulate that the neutralization efficiency of the IgGs 
(H36>H37>H9) is affected by both the distance of the epitope from the receptor­
binding site and the binding angle of the IgG relative to the receptor site. However, a 
large panel of MAbs to different antigenic sites needs to be studied to support this.
6.15.3 Comparison o f the mechanism o f neutralization o f A/PR/8 virus by the 
IgGs and their antibody fragments.
This study is the first to determine the mechanism of neutralization of influenza virus 
by a Fab. Not only did the Fabs differ in their mechanism of neutralization from the 
IgGs, but that they also differed from each other. Analysis of the relationship 
between attachment to target cells and infectivity of virus neutralized by the IgGs 
indicated that inhibition of attachment was a major mechanism of neutralization, 
particularly when neutralization was > 90%, but could not account for the entire loss 
of infectivity. Internalisation of neutralized, but attached virus was unaffected. 
However, decreases in virus-cell fusion correlated with neutralization suggested a 
causal relationship. The mechanism of neutralization of the three IgGs was 
strikingly similar and indicated that antigenic site or isotype had no affect on the 
mechanism of neutralization. The IgGs seemingly exhibited a complex 
neutralization process, with comparison of N50 and N90 points revealing a shifting
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dominance of mechanisms. At the N90 point inhibition of attachment accounts for 
the majority of loss of virus infectivity, whereas at N50 inhibition of attachment 
accounts for the minority of the loss of infectivity and the majority can be attributed, 
by inference, to inhibition of fusion. Thus there is a spectrum of neutralization 
activity which starts with fusion inhibition and ends with attachment inhibition. In 
between both mechanisms operate simultaneously, with dominance of each 
mechanism depending on the IgG concentration. An interesting consequence of this 
conclusion is that inhibition of fusion must operate at a lower density of IgG 
molecules per virion than inhibition of attachment, indicating it to be the primary 
neutralization mechanism. The above conclusion could also be relevant to a number 
of other neutralization studies, including neutralization of influenza A, HIV-1 and 
transmissible gastroenteritis coronavirus (TGEV) (Outlaw et al., 1990; Ugolini et al., 
1997; Sune et al., 1990). In these studies the level of inhibition of attachment did 
also not account for the amount of neutralization observed, suggesting that other 
mechanisms were acting.
In contrast, Fabs H36 and H37 inhibited attachment as their sole mechanism of 
neutralization, whereas H9 Fab did not inhibit attachment, but decreases in virus-cell 
fusion with infectivity suggested a causal relationship.
C om parison  o f  the IgG and Fab neutralization at N90 -
The mechanism of neutralization at N90 for the H36, H37 and H9 IgGs and H36 and 
H37 Fabs is predominantly inhibition of attachment. It is generally accepted that 
inhibition of attachment is caused by steric hindrance of the HA-cell receptor 
interaction and therefore, it is likely that the most important factor in the difference 
in neutralization at N 9 0  is molecular mass of the antibody.
Fab is approximately half the length of an IgG and hence Schofield et al., 
(1997b) suggested that on a theoretical basis one might expect a reduction of only 2- 
fold in the efficiency of steric hindrance (inhibition of attachment). Steric hindrance, 
however, is a complex phenomenon, which is affected not only the length and the 
molecular mass of the antibody, but also the valency and orientation of antibody 
binding in relation to the receptor-binding site and the flexibility and rotational 
freedom displayed by the antibody (Burton, 1990; NisonofF et al., 1975; Padlan, 
1994). It has also been suggested that steric hindrance may be affected by the
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valency of the virus-IgG interaction (Schofield, 1996). For example, an IgG that 
binds monovalently may have a greater degree of rotational freedom increasing the 
probability of interference with receptor interactions. The valency of the virus-IgG 
interaction in this study is unknown, but the similar affinity values for IgGs and Fabs 
suggest that the IgGs may bind monovalently. Also the molecular volume of the 
antibody is also a useful parameter to consider. In fact combining these properties, 
which could act synergistically, gives us the concept of the volume occupied by the 
antibody, i.e., the space in which the antibody can have a physical effect, which 
would be larger than the molecular volume per se (Outlaw, 1989). A Fab would 
have a much lower effective volume and this could account for the observed loss of 
neutralization activity compared to the IgG. The relatively poor ability to sterically 
hinder the HA-receptor interaction could also explain why Fab has a higher 
neutralization efficiency at the higher concentrations required to give N90 compared 
to the lower concentrations at N50.
At N90 the H9 Fab cannot inhibit attachment of virus to cells but inhibits 
fusion. This could be due to the relationship between the antigenic site, Cb, and the 
receptor-binding site, as discussed previously. The H9 Fab has the lowest 
neutralization activity and this may be due to its inability to inhibit the attachment 
process.
Comparison of the IgG and Fab neutralization at N50:
The mechanism of neutralization at N50 of the H9 Fab was inhibition of fusion, 
whilst both the H36 and H37 Fabs inhibited attachment. The IgGs all neutralize 
predominantly, though not exclusively by inhibition of fusion. If we first examine 
the H36 and H37 Fabs compared to their IgGs. First impressions suggest a simple 
model, with the difference between the IgGs and the Fabs at N50 being inhibition of 
fusion. However, this situation is more complicated as data presented in chapter 7 
shows that these Fabs can inhibit fusion of virus pre-attached to cells. Thus 
bivalency is not absolutely required for fusion inhibition, which is further supported 
by the H9 Fab, where inhibition of fusion seems to be sole mechanism of 
neutralization.
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W hy do w e not see inhibition o f  fusion by H 36 and H 37 Fab at N 50?
It is possible that the processes of inhibition of attachment and fusion are both due to 
steric hindrance, and that this is directly linked to molecular volume. Therefore, the 
inhibition of attachment and fusion could occur at similar efficiencies, such that they 
give the impression of a single mechanism. The H9 Fab did not inhibit attachment of 
virus to cells suggesting that the processes of fusion inhibition and attachment 
inhibition can be segregated and that binding to different regions of the HA may 
allow the antibody to interfere with different parts of the fusion process.
The situation with the IgG is complicated and could depend on whether the 
IgGs bind (I) monovalently or (II) bivalently -
(I) If the IgGs can only bind monovalently then the difference between the 
IgGs and Fabs must be due to the greater molecular volume. Therefore, the 
argument would follow that its greater molecular volume allows the IgGs 
inhibit the fusion process. This occurs even at low IgG:virus ratios, but as 
the ratio increases the higher density of IgG molecules starts to inhibit 
attachment. In contrast, the lower molecular volume of the Fab means that 
they require a high density of molecules per virion to initiate neutralization, 
so at lower Fab : virion ratios they sterically hinder the fusion process only 
as efficiently as they inhibit attachment. The concept that fusion inhibition 
is related to molecular volume is supported by the H9 Fab which inhibits 
fusion but has the lowest neutralization activity. The F(ab)2 data is also 
supportive as at N50 it requires an 8 -fold higher concentration relative to the 
IgG, but its mechanism of neutralization is very similar. Hence, if 
bivalency was of sole importance in fusion inhibition then you would 
expect the F(ab)2 to neutralize with the same efficiency as the IgG. 
Therefore, the 8 -fold loss of neutralization efficiency indicates that 
molecular volume is important at the N50 point.
(II) If the IgGs can bind bivalently too neighbouring HA spikes, then the 
difference with the Fabs could be due to the IgGs possessing two 
mechanisms of fusion inhibition. (A) a monovalent inhibition of fusion 
which may sterically hinder some part of the fusion process and is linked to 
molecular mass (process possibly used by H9 Fab) and (B) a bivalent 
inhibition of fusion, where at lower concentrations of IgG where bivalent
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binding has a higher probability (due to availability of epitopes), the IgGs 
crosslink HA spikes and possibly prevent correct orientation into a fusion 
active pore. Therefore the argument follows that at N50 bivalent inhibition 
of fusion becomes increasingly dominant and hence you see inhibition of 
fusion at lower IgG concentrations. As the IgG:virus ratio increases, 
epitope availability decreases, and hence monovalent binding dominates, 
which has a higher probability of inhibiting attachment.
An important component of future study in this area should be to elucidate the 
valency of the binding of the IgGs. This could be done in two ways (I) by using 
cryo-electron microscopy to directly visualise the binding of the antibodies to the 
virus, and (II) by construction of a monovalent antibody, with one Fab arm specific 
for A/PR/8 virus and the other arm to a non-viral epitope. This hybrid IgG would 
only bind monovalently to the virus but would have the equivalent molecular mass as 
standard IgG. Hence it would allow discrimination between the effects of bivalency 
and molecular mass in the analysis of the mechanism of neutralization. An attempt 
was made by fusion of hybridomas to construct a monovalent antibody with H36 IgG 
and anti-rat CD4 IgG components, but unfortunately time did not allow completion.
In summary, comparison of the mechanisms of neutralization of the IgGs and 
their Fabs revealed the following features in common:
(I) Fabs are less efficient at neutralizing than their IgGs.
(II) Fabs are less efficient at neutralizing at N jo  than N 9 0  relative to their IgGs.
(III) IgGs have a complex mechanism of neutralization and simultaneously 
neutralize by inhibition of attachment and fusion.
(IV) At low concentrations (<N50) IgGs neutralize mainly by inhibition of 
fusion.
(V) At high concentrations (>Ngo) IgGs neutralize by mainly inhibiting 
attachment.
(VI) Fabs have a simpler mechanism of neutralization, compared to their IgGs 
and neutralize by a single mechanism across the range of concentrations 
tested.
From the data presented it is my opinion that both molecular volume and
bivalency play a role in neutralization by these IgGs and these may vary in
importance depending on the concentration analysed. An example of how the
importance of bivalency and molecular volume may vary with the MAb being
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analysed is exemplified by studies by Schofield et al., (1997b) and Yoden et al., 
(1985) who both discovered Fabs which showed almost no neutralization 
activity. These suggested that the mechanism of neutralization of the parental 
IgG was heavily dependent on bivalency.
6,15.4 Neutralization o f  influenza and other animal viruses by Fab fragments.
Currently this study represents the only data available on the mechanism of 
neutralization of influenza by Fabs, with very little known about the mechanism of 
Fab fragments in general.
Three previous studies have looked at the characteristics of Fab neutralization 
of influenza. All agreed with the findings of this thesis that a higher concentration 
Fab than of IgG is required to cause neutralization. An early study examined the 
neutralization by Fab fragment prepared from polyclonal anti-sera raised in rabbits 
(Lafferty, 1963). These Fabs were neutralizing, but infectivity was recoverable after 
dilution of virus-Fab mixtures. This reversibility was attributed to Fab dissociating 
from antigen due to its lower affinity and hence it was suggested bivalent interaction 
with virus was important for IgG neutralization. However, there were no affinity 
data to back-up this assertion.
A second study of Fab neutralization of influenza A virus focussed on four 
MAbs to different antigenic regions (I-IV) on the HA of influenza 
A/seal/Massachusetts/1/80 (H7N7) (Yoden et al., 1985). Two MAbs from groups I 
and II were able to neutralize virus and give HI, however, two MAbs from groups III 
and IV were able to neutralize but had very poor HI activity. Fabs to group I and II 
displayed a 32- to 64-fold drop in neutralization titres respectively compared to 
parent IgG, whilst Fabs to groups III and IV had a greater than 100-fold loss of 
neutralization and no HI titre. However, analysis by ELISA of Fab binding, 
indicated that they bound equally well to the virus as their IgGs. Addition of the 
anti-Fab improved Fab neutralization to the same order of magnitude as parent IgG, 
but did not recover HI titre. All of the MAbs inhibited haemolysis of RBCs, which is 
considered to be analogous to inhibition of fusion, whereas only Fabs to groups I and 
II showed this ability. The authors concluded that bivalent binding was important in 
HI and was crucial for neutralization by MAbs to group Iff and IV. This proposal 
was supported by a follow-up study which showed that MAb 81/6 to group IV bound
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bivalently to HA rosettes and inhibited virus fusion in MDCK cells (Imai <?/ ¿7/., 
1998). However, generally conclusions made in the study were poor, they did not 
show conclusively that anti-Fab antibodies cross-linked Fabs to restore bivalency, 
they paid no attention to the fact that Fabs have reduced molecular mass, and they 
gave no thought to orientation of the antibody and its effect on HI.
More recently a study of neutralization and HI ability of five anti-HA influenza 
A/fowl plague/Rostock/34 (H7N1) (FPV) virus IgG MAbs, their Fabs and F(ab)2s 
(Schofield et al., 1997b) was carried out. This study showed that Fabs required 54- 
to 542-fold higher concentration to achieve 90% neutralization than IgG, and 14- to 
66-fold more for HI. The F(ab)2s required only 1.4- to 4-fold higher concentration to 
achieve 90% neutralization than their IgGs. The functional affinities determined by 
SPR, of IgGs and Fabs only differed by 3- to 4-fold and is similar to the results I 
obtained, which was not considered to be sufficient to explain losses of 
neutralization. The small differences in dissociation constant between the IgG and 
the Fab suggested that the Fab bound monovalently and hence reduction in 
neutralization activity may have resulted from a decrease in molecular mass. 
However, it should be stressed that this study did not determine the valency of the 
virus-IgG interaction and it is possible the reduction of affinity of Fabs isolated from 
very high affinity IgGs will be small, not affected greatly by loss of bivalent 
interaction (Parham, 1983). Therefore, this study did not rule out bivalency as a 
cause of the loss of neutralization activity. Collectively, the studies by Yoden et al, 
(1985) and Schofield et al, (1997) have implicated both molecular mass and valency 
in the efficiency of neutralization of Fab fragments. This thesis has examined this 
question from a mechanistic angle and again has indicated that both molecular mass 
and valency are probably involved in loss of neutralization efficiency.
Very little is known of the mechanism of neutralization of other viruses by 
Fabs, with only a few studies available in the literature. A study of the mechanism of 
neutralization of HIV-1 virus by the human bl2 IgG and Fab fragment indicated that 
the Fab differed from its IgG, similar to that shown with the anti-A/PR/8 virus Fabs 
in this study (Mclnerney et al., 1997). Neither of the antibodies affected attachment 
to a C8166 T-cell line as judged by FACs analysis. The bl2 IgG inhibited virus-cell 
fusion by a variety of assays including cell to cell fusion, R18 fluorescence fusion 
assay and resistance to trypsin removal. In contrast, these assays suggested that the 
Fab did not have any effect on virus-cell fusion and immunofluorescence data
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showed the same pattern of p24 staining of Fab neutralized virus as non-neutralized 
virus. The authors concluded by inference that the Fab inhibiting a post-fusion 
event. Another study showed that the Fab could inhibit attachment of virus to cells. 
However, a direct causal relationship was not established as attachment inhibition 
was much lower than neutralization. For example, at >99% neutralization inhibition 
of attachment was at only 55% (Ugolini et al., 1997). This suggests that the 
remaining level of neutralization must be due to effects on other stages of the HIV-1 
virus infectious cycle, similar to that proposed in this study.
Only two other studies of the mechanism of neutralization of Fab fragments are 
available and these studies concluded that the Fabs have the same mechanisms as 
their parent IgGs. In a study of Western equine encephalitis virus, a Fab to epitope 
E2C inhibited attachment of virus to Vero cells, but was 10-fold less efficient than its 
parent IgG (Roehrig et al., 1988). Interestingly, addition of anti-Fab F(ab)2 to the 
Fab did not increase its ability to inhibit attachment of virus to cells. This is, 
however, a poor study in that only one Fab fragment out of a panel of MAbs was 
analysed, attachment data was not correlated with infectivity and also only one 
neutralizing concentration was used.
A study of human rhinovirus type-14 used MAbs to the four distinct 
neutralization sites at conditions giving 95% neutralization (Colonno et al., 1989). A 
Hela cell membrane-binding assay was used to investigate the effect of non­
aggregating MAbs on attachment, and all MAbs were found to affect attachment to 
varying extents. For example, the concentration of MAbs NimIA-34 and NimIB-29 
required to inhibit attachment by 95% was equal to the concentration required to give 
95% neutralization, while for MAbs NimII-28 and NImIII-33 the ratio of the 
inhibition of attachment to cells : neutralization was 1:6. Analysis of Fab fragments 
showed that they required a 13- to 61-fold higher concentration to achieve 95% 
neutralization than their IgGs. Membrane-binding analysis revealed that they all 
exhibited a dose response inhibition of attachment to membrane preparations. 
However, this again is a poor study, with only one point (95% neutralization) being 
given for neutralization, rather than a full concentration versus neutralization analysis 
and hence comparison of neutralization and inhibition of attachment are not possible 
over a range of concentrations as I have done in this thesis. The deficiencies in the 
past two studies makes comparisons with my study difficult. However, it is 
interesting that their Fabs inhibit attachment, similar to that seen with H36 and H37
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Fabs. Currently, no Fabs have been reported that neutralize by inhibition of fusion 
indicating that H9 Fab has a novel mode of action.
Other studies of Fab neutralization in the literature have not examined the 
mechanism of neutralization. However, four recent studies have examined 
functional affinity in relation to the neutralizing ability of Fabs. The HTV-1 specific 
F105 IgG and Fab had similar affinities of 6.9xlO'8M and 5.7xl0'8 M respectively 
(Cavacini et a l, 1994). The Fab required between 4- and 10-fold higher 
concentration than its IgG to neutralize HIV-1 IIIB, whilst the neutralizing activity of 
the F(ab)2 was similar to the IgG. As in my study the authors found that the 
functional affinity did not predict neutralizing activity. The authors argued that 
valency affected the neutralizing activity of the FI05 IgG, with the influence of 
bivalency not being a function of affinity or steric effects (molecular mass). They 
concluded that differences were due to the bivalent binding inducing conformational 
changes in the oligomeric gpl20.
In contrast, a recent investigation of panel of HIV-1 specific IgGs and Fabs 
determined that the gpl20 oligomer-binding : neutralization ratios fell within a 
relatively narrow range for antibodies to different neutralization epitopes (Parren et 
al., 1998). The authors suggested that the affinity of binding was the major factor in 
neutralization efficiency. They expanded this by suggesting that occupancy of the 
neutralization epitopes by antibodies rather than epitope specificity was the most 
important factor, as the large size of the antibody relative to the gpl20 should allow 
steric hindrance of the CD4-binding region from any of the neutralization epitopes 
(Klasse and Moore, 1996; Parren et al., 1998). This report differs from results 
described by Schofield and Dimmock, (1996) and Schofield et al., (1997) and in this 
thesis, which indicated that intrinsic properties of the epitope are important. It is 
possible that differences between HIV-1 and influenza A viruses are responsible.
A study comparing the neutralizing activities of murine hepatitis virus (MHV) 
by a MAb 7-10A IgG, its F(ab)2 and its Fab showed that the Fabs were less efficient 
at neutralizing than the IgG (Lamarre and Talbot, 1995). The Fab required a 197- 
fold higher concentration than its IgG to give 50% neutralization, whereas the F(ab)2 
only required 3-fold more. Examination of functional affinity revealed that the Fab 
had a dissociation constant (KD) of 2.0xl0‘9M, which was 14-fold higher than the 
IgG. However, the affinities were calculated to an anti-idiotype MAb mimicking the 
epitope recognised by the MAb 7-10A and this has to be less ideal than using whole
145
virus particles. Lamarre and Talbot, (1995) concluded that bivalency was not 
essential for neutralization by MAb 7-10A, but did enhance its neutralization ability 
in vitro.
A comparison of the neutralizing activity of Rabies virus by a recombinant Fab 
(rFab57) of MAb 57 described a FabilgG neutralization ratio of 13:1 (Dietzschold et 
al., 1990). The dissociation constants measured by ELISA against whole Rabies 
virus showed that the Fab was 12-fold higher than the MAb. This indicated that the 
affinity and neutralization were reduced by the same proportion. This is in direct 
contrast to the anti-influenza Fabs in this thesis that either have the same or slightly 
lower affinity than their IgGs, but with much lower neutralization levels (104- to 
375-fold lower at N50).
6.15.5 Critique o f the techniques used in this chapter.
It has been previously established and reinforced in this thesis that neutralization is a 
complex and multi-factorial process. Therefore, numerous methods must be used to 
try to correlate loss of viral infectivity with loss of a particular viral function 
essential in the initial stages of infection. Causal relationships can be established 
with care, but these depend on the compatibility of the assays. Therefore, it is 
important to illustrate the limitations and strengths of the techniques used.
6.15.5.1 Preparation o f Fabs -
The Fabs were prepared by enzymatic digestion and are different isotypes. Hence it 
is possible that the loss of efficiency of the H37 and H9 Fabs compared to H36 Fab 
could be due to a lower stability of the IgG3 isotype under the reducing and 
enzymatic conditions used in their preparation. However, this was probably not so as 
the Fabs had similar affinities to their IgGs. Protease damage of Fabs could be 
avoided by expressing recombinant Fabs.
6.15.5.2 Attachment and infectivity ELISA assays-
The ELISA used to detect virus attached to cells involved permeabilisation of virions 
and detection of internal viral-NP antigen. In this way anti-HA neutralizing MAb
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does not interfere with the detection system. However, it is susceptible to 
interference by contaminating free NP antigen, either from cell debris or broken virus 
particles. In order to reduce these levels to a minimum the virus preparations were 
double purified by both velocity and density centrifugation, and freeze-thawing of 
the virus was kept to a minimum to prevent viral envelope fracture. NP detection of 
paraformaldehyde-fixed virus bound to MDCK cell monolayers was only 5% of the 
methanol treated virus indicating that free NP contributed little to the signal.
Every effort was made in this study to keep the assay of attachment and assay 
of infectivity (both ELISAs) comparable. This included using cell monolayers 
seeded from the same batch of cells, equal volumes of virus from the same 
neutralization mixture were inoculated on to the monolayers and the same detection 
substrate was used with ELISAs being developed simultaneously. Also the level of 
attachment and infectivity was calculated as a percentage of the non-neutralized virus 
control and hence allowed results to be directly compared.
6.15.5.3 Virus internalisation ELISA -
This assay was designed to be directly comparable to the attachment and infectivity 
ELISAs, using the same cell and neutralization mixtures. However, because the 
amount of virus used in the mechanism studies was above the percentage law (the 
range of antibody dilutions which can neutralize a fixed amount of virus to the same 
extent) (Andrewes and Elford, 1933; Brioen and Boeyé, 1985), a fixed amount of 
virus was used in the attachment and internalisation assays. Hence, the assay 
suffered from a low signal compared to the attachment and infectivity ELISAs. This 
was possibly due to the fact that only a fraction of attached virus actually internalises 
and/or also the permeabilsation methods used were very harsh. Therefore, it is 
possible that this ELISA was less sensitive, but differences were again kept to a 
minimum by calculating the percentage of internalisation.
6.15.5.4 Virus-cell fusion assay -
This assay uses R18 labelled virus, which has the disadvantage of causing some loss 
of infectivity (Wunderli-Allenspach et a l, 1993). Therefore preparing the virus 
stock involved a balance between fluorescent label and infectivity. The stock of
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labelled virus used in this study had approximately a 2.5-fold loss of infectivity 
compared to unlabelled stocks. As a result it is possible that the behaviour of the 
remaining infectious population did not accurately reflect the behaviour of the fully 
infectious stocks (unlabelled). Possibly the most accurate fusion assays are those in 
which the target membranes are labelled so that the R18 does not affect infectivity. 
However, this is only possible with model membrane systems, such as erythrocyte 
ghosts and liposomes and was not possible with the cells used in this study.
This assay examined only one time point, whereas a more complete analysis 
would have been to monitor the virus-cell fusion over a range of time points. This 
data would have allowed us to investigate the effect of the antibodies on the kinetics 
of virus-cell fusion.
Finally the R18 fluorescence assay detects virus envelope to cell membrane 
lipid mixing, known as hemi-fusion and does not detect full fusion pore formation 
and the passage of aqueous material in full fusion. Therefore, extrapolating the R18 
fluorescence data to fusion must be done with care. A complete fusion analysis 
should also use techniques that allow detection of full fusion, such as calcein label. 
However, it must be highlighted that the perfect fusion assay is not yet available, and 
in this study we have only used the fluorescence data to indicate a causal relationship 
between loss of infectivity and inhibition of fusion.
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7 Results: Investigation of the post-attachment 
neutralization (PAN) of influenza A/PR/8/34 virus 
by monoclonal IgGs and their Fabs.
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7.1 Introduction
Post-attachment neutralization (PAN) is defined as a reduction in viral infectivity 
achieved by antibody reacting with virus that has already attached to the target cell, 
but has not yet fused with the target membrane or been internalised (Armstrong and 
Dimmock, 1996). If a MAb or Fab can give PAN, it can evidently inhibit an event(s) 
beyond viral attachment (Jackson, 1998). This chapter investigates the ability of the 
anti-A/PR/8 virus IgGs and Fabs to PAN. Results presented in chapter 6 indicated 
that IgGs were able to simultaneously neutralize by both inhibition of attachment and 
inhibition of fusion. Analysis of the relationship between attachment and infectivity 
showed them to be significantly different; however, inhibition of attachment made a 
major contribution to the neutralization process. PAN was investigated here to -
(1) Provide compelling evidence of the ability of the antibodies to neutralize 
by mechanisms other than inhibition of attachment.
(2) Examine the relevance of molecular mass and valency to PAN, by the use 
ofFabs.
The ability of antibodies to give PAN of influenza A virus is confined to a 
single study in which polyclonal rabbit antiserum gave complete PAN of A/PR/8 
virus at 3°C, whereas at 37°C the virus became progressively more resistant to PAN 
(Ishida and Ackermann, 1956). As this paper only examined polyclonal sera and 
hence this area requires revisiting with MAbs.
PAN is self-evidently not concerned with inhibition of attachment; hence 
examination of the mechanism of PAN is of interest. The mechanism of PAN of 
influenza virus has not yet been addressed, although there are a limited number of 
studies of other viral systems. A study of the PAN of rabies virus, suggested that the 
neutralizing MAbs caused a 3-fold increase in the release of cell bound virus 
(Dietzschold et al., 1987). The virus that remained attached was endocytosed, which 
lead the authors to propose that the virus was neutralized by inhibition of an event 
beyond internalisation. Antiserum to West Nile Fever virus (WNFV) was capable of 
PAN (Gollins and Porterfield, 1986). The virus was not eluted from the cell surface 
and loss of infectivity paralleled inhibition of uncoating of viral RNA. This 
indicated that the antibodies caused PAN by inhibition of endosomal virus-cell 
fusion. Endosomal virus-cell fusion of vesicular stomatitis virus (VSV) with Vero
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cells was also inhibited by neutralizing antiserum (Blumenthal et al., 1987). A study 
of poliovirus showed that out of 19 neutralizing MAbs, 6 showed PAN (Vrijsen et 
al., 1993). PAN was shown to involve the inhibition of the cell-mediated shift from 
the 135S native virus to an 80S particle. Evidence from one of the PAN positive 
MAbs suggested it bound bivalently, whilst a PAN negative MAb probably bound 
monovalently. Therefore, the authors suggested that the ability to give PAN was 
dependent on valency.
In this section I have examined the dose-response relationship of PAN and its 
temperature dependence using three IgGs and their Fabs. All of the antibodies were 
capable of PAN with varying degrees of efficiency relative to their standard 
neutralization activity (neutralization of virus before its attachment to cells). The 
mechanism of PAN was investigated and of endosomal virus-cell fusion proportional 
to loss of infectivity indicated a causal relationship. The process of the antibody- 
mediated fusion inhibition was investigated, and results indicated that the low pH- 
dependent conformational change of the viral HA was unaffected and that there was 
a requirement for the antibodies to be present prior to initiation of the cold-fusion 
intermediate (low pH at 4°C). Collectively, these data suggested that all the 
antibodies were inhibiting an early stage of virus-cell fusion.
7.2 Comparison of the standard neutralization (STAN) and PAN at 
4°C and 37°C of the IgGs and their Fabs.
7.2.1 STAN and PAN at 4°C and37°Cby H36 IgG.
Figure 7.1 indicates that the H36 IgG had a PAN activity. The H36 IgG had a 
similar efficiency of PAN at both 4°C and 37°C. However, PAN at both 4°C and 
37°C was less efficient than STAN. At the 50% neutralization point (N50) it was 50- 
fold less efficient, whereas it was only 10.3-fold less efficient at the 90% 
neutralization point (N90). This indicated that the efficiency of PAN activity 
increases with increasing concentration.
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Figure 7.1 Comparison of the standard neutralization (STAN) and post- 
attachment neutralization (PAN) of A/PR/8 virus by H36 IgG in MDCK cells.
Data are the mean of three experiments measured by plaque assay. The bars 
represent the standard error of the means (SEM). Curves were generated by non­
linear regression using the Graphpad Prism package (R = > 0.98 for all curves).
7.2.2 STAN and PAN at 4 °C and 37°C o f A/PR/8 by H36 Fab.
Figure 7.2 shows that H36 Fab also had PAN activity. The Fab also showed similar 
efficiencies of PAN at 4°C and 37°C, indicating its activity to be independent of 
temperature. However, unlike the H36 IgG whose PAN efficiency was significantly 
lower than its STAN, the efficiency of Fab PAN and STAN were very similar. A 
comparison of the STAN and PAN at 37°C at N50 by unpaired T-test showed that 
they were not significantly different (P = 0.617, where significance is < 0.05).
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Figure 7.2 Comparison of the STAN and PAN of A/PR/8 virus by H36 Fab in
MDCK cells. Data are the mean of three experiments measured by plaque assay.
The bars represent the SEM. Curves were generated as in Figure 7.1 (R = >0.99).
STAN at 37°C A PANat37°C ♦ PAN at 4°C
7.2.3 STAN and PAN at 4 °C and 37°C o f A/PR/8 virus by H3 7 Ig(i.
H37 IgG also showed PAN activity (Figure 7.3). Levels of PAN activity were 
similar at 4°C and 37°C, suggesting that PAN was temperature independent. 
However, PAN activity was significantly (P = <0.0001 at N 50) less efficient than 
STAN. The lower efficiency of PAN is not uniform being 7-fold lower than STAN 
at N 50, whilst only 1 .8 -fold lower at N90. H37 and H36 IgGs are thus similar with 
respect to PAN.
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Figure 7.3 Comparison of the STAN and PAN of A/PR/8 virus by H37 IgG in
MDCK cells. Data are the mean of three experiments measured by plaque assay.
The bars represent the SEM. Curves were generated as in Figure 7.1 (R = >0.98).
7 .2.4 STAN and PAN at 4 °C and 37°C o f A/PR/8 virus by H3 7 Fab.
H37 Fab also had PAN activity (Figure 7.4). The PAN activity at 4°C and 37°C was 
similar. However, in contrast to the H36 Fab PAN activity, the H37 Fab PAN was 
slightly more efficient than STAN. This was a consistent and interesting result, but 
the difference between the curves at N50 was found not to be significant by an 
unpaired T-test (P = 0.175). Therefore, it must be concluded that the PAN activity of 
the H37 Fab is similar to its STAN.
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Figure 7.4 Comparison of the STAN and PAN of A/PR/8 virus by H37 Fab in
MDCK cells. Data are the mean o f three experiments measured by plaque assay.
The bars represent the SEM. Curves were generated as in Figure 7.1 (R = >0.99).
7.2.5 STAN and PAN at 4 °C and 37 °C o f A/PR/8 virus by H9 IgG.
Figure 7.5 shows that the H9 IgG also had PAN activity. The PAN activity of the H9 
IgG was very similar to the H36 and H37 IgGs, being of similar efficiency at the two 
temperatures tested and having a lower efficiency at N50 than N90. The PAN was 
also of significantly lower efficiency (P = 0.01) than the STAN.
155
Figure 7.5 Comparison of the STAN and PAN of A/PR/8 virus by H9 IgG in
MDCK cells. Data are the mean o f three experiments measured by plaque assay.
The bars represent the SEM. Curves were generated as in Figure 7.1 (R = >0.98).
7.2.6 STAN and PAN at 4 °C and 37°CofA/PR/H virus by H9 Fab.
Figure 7.6 shows that H9 Fab also had PAN activity. The PAN activity of the H9  
Fab unlike the other antibodies had a greater efficiency at 37°C than at 4°C. It also 
had a greater efficiency of PAN than STAN. Comparison of the STAN and PAN at 
N50 by unpaired T-test indicated that they were significantly different (P = <0.0001). 
This suggested that the H9 Fab neutralized pre-attached virus at a greater efficiency 
than it could neutralize unattached virus.
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Figure 7.6 Comparison of the STAN and PAN of A/PR/8 virus by H9 Fab in
MDCK cells. Data are the mean of three experiments measured by plaque assay.
The bars represent the SEM. Curves were generated as in Figure 7.1 (R = >0.97).
■ STAN at 37°C A PANat37°C ♦ PANat4°C
7.3 Kinetics o f PAN of A/PR/8 virus by H36 IgG and Fab.
7.3.1 Comparison o f  the kinetics o f  PAN o f A/PR/8 virus by H36 IgG and Fab at 
4 °C and 37°C in MDCK cells.
If it is to cause PAN, an antibody has to interact with the attached virus before it is 
internalised into the cell. This relationship was investigated by initially allowing 
virus to attach to MDCK cells at 4°C and then shifting the temperature to 37°C. 
Antibody was added at 5-minute intervals for 60 minutes. The assay was controlled 
by leaving the attached virus at 4°C for the entire 60 minutes, to inhibit 
internalisation of virus.
Figure 7.7 (A) shows the kinetics of PAN by H36 IgG at 4°C and 37°C. 
Kinetics of PAN at 37°C shows that the virus becomes refractory to PAN with 
increasing time, being approximately 50% refractory in 10 minutes and 90%
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refractory at 20 minutes. However, there was only a loss of approximately 10% 
PAN in the first 5 minutes, which is slower than a previous study in chicken 
chorioallantoic cells which showed almost a complete loss of PAN activity in a 5 
minute incubation (Ishida and Ackermann, 1956). This difference could represent 
the cells warming to 37°C after the previous 15 minute incubation of the cells at 4°C 
prior to infection designed to inhibition internalisation. The kinetics at 4°C showed 
that over a 60 minute period there was almost no loss of PAN activity indicating that 
virus was not being internalised. Figure 7.7(B) shows that the kinetics of PAN by 
H36 Fab at 37°C and 4°C were very similar to those obtained with the IgG, 
indicating that both interacted with the virus for the same period of time.
Figure 7.7 Analysis of the kinetics of PAN by H36 IgG and Fab at 4°C and 37°C 
in MDCK cells. (A) PAN with H36 IgG at 55 nM and (B) PAN with H36 Fab at 
100 nM. PAN was measured by plaque assay. Data are the mean of two 
experiments. The bars represent the SEM.
7.4 M echanism o f PAN by IgGs and their Fabs
7.4.1 Analysis o f  the relationship between A/PR/H virus internalisation in MDCK 
cells and PAN as a function o f H36 IgG concentration.
This assay was controlled as described in the previous chapter, section 6.2.3. 
Briefly, this involved (a) incubating the cells at 4°C which inhibits endocytosis and 
(b) pre-treatment of cells with hypertonic media which disperses the clathrin lattice.
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Figure 7.8 Analysis of the relationship between A/PR/8 virus internalisation in 
MDCK cells and PAN as a function of H36 IgG. PAN and infectivity were 
assayed in parallel in the same batch of monolayers in 96 well plates, using the same 
virus and antibody stocks. All data are the mean of three experiments. The curve 
has been generated as in Figure 7.1 (R = 0.97).
Log(M)
$3 Internalisation ▲ PAN
Table 7.1 Analysis of the internalisation of non-neutralized (No) virus under the 
negative control conditions. Data are presented as percentage inhibition of 
internalisation relative to non-neutralized virus at 37°C.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 94 (+/- 8)
Hypertonic treated - No 82 (+/- 7)
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Table 7.1 shows that at 4°C internalisation of non-neutralized virus was inhibited by 
94% compared to internalisation at 37°C. Pre-treatment of cells with hypertonic 
media inhibited non-neutralized virus internalisation by 82%. Collectively these data 
indicate that virus is internalised into the cell by clathrin lattice-mediated endocytosis 
and not by an alternative pathway.
Figure 7.8 shows that PAN increased with increasing H36 IgG concentration as 
expected, but the percentage of virus internalised stayed at approximately 100%. 
This also shows that the H36 IgG does not cause release of the virus from the cell 
surface, as total level of input virus remains relatively constant across the IgG 
concentration range. This indicates that neutralized virus is internalised and that the 
mechanism of PAN does not involve inhibition of internalisation in MDCK cells.
7.4.2 Analysis o f  the relationship between A/PR/8 virus internalisation in MDCK 
cells and PAN as a function o f H36 Fab.
The controls in this assay were as described in section 6.3.1, and again showed good 
inhibition of internalisation indicating that virus was being internalised by receptor- 
mediated endocytosis (Table 7.2). Figure 7.9 shows that as PAN increases with 
increasing concentration of H36 Fab, the percentage internalisation remains at 
approximately 100% relative to the non-neutralized control. These data again 
showed that the H36 Fab did not cause release of virus from the cell surface, with 
input virus remaining relatively constant. This indicates that PAN by the H36 Fab 
did not involve inhibition of internalisation.
The relationship between virus internalisation and PAN was also investigated with 
the H37 and H9 IgGs and their Fabs. The results were again very similar to the H36 
antibody, with PAN not affecting internalisation. These data can be seen in 
Appendix I and a summary of the data is given in Table 7.6.
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Figure 7.9 Analysis of the relationship between A/PR/8 virus internalisation in 
MDCK cells and PAN as a function of H36 Fab. PAN and internalisation were 
assayed in parallel in the same batch of monolayers in 96 well plates, using the same 
virus and antibody stocks. All data are the mean of three experiments. The curve 
has been generated as in Figure 7.1 (R = 0.98).
Lo r(M)
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Table 7.2 Analysis of the internalisation of non-neutralized (N0) virus under the 
negative control conditions. Data are presented as percentage inhibition of 
internalisation relative to non-neutralized virus at 37°C.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N« 90 (+/- 3)
Hypertonic treated - N0 79 (+/- 10)
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7.4.3 Analysis o f the relationship between A/PR/8 virus PAN and the virus-cell 
fusion in MDCK cells as a function o f H36 IgG concentration.
As PAN was not mediated by inhibition of internalisation, it was possible that it 
acted by inhibiting virus-cell fusion. Fusion was measured by a fluorescence assay 
using R18-labelled virus, as described in section 6.2.4. The controls included (a) 
fusion carried out at 4°C and (b) pre-treatment of cells with bafilomycin (section 
6.2.4). Table 7,3 shows that at 4°C virus-cell fusion of non-neutralized virus was 
inhibited by 93% and with bafilomycin treated cells by 85%, demonstrating that the 
majority (>85%) of the fluorescent signal was due to virus-cell fusion.
Figure 7.10 shows that as PAN increased with increasing concentration of the 
H36 IgG, the percentage of fusion-inhibition also increased. Comparison of the 
curves with an unpaired T-test showed them not to be significantly different (P = 
0.27), indicating a causal relationship between PAN and inhibition of virus-cell 
fusion.
7.4.4 Analysis o f  the relationship between A/PR/8 virus PAN and the virus-cell 
fusion in MDCK cells as a function ofH36 Fab concentration.
Negative controls indicated that the majority of the fluorescent signal was specific 
for virus-cell fusion (Table 7.4).
Figure 7.11 shows that as PAN increased with increasing H36 Fab 
concentration, the inhibition of fusion also increased. An unpaired t-test showed that 
the curves were not significantly different (P = 0.08), indicating a causal relationship 
between inhibition of virus-cell fusion and PAN by H36 Fab, and that bivalency is 
not required for inhibition of fusion.
The relationship between PAN and virus-cell fusion was also investigated with the 
H37 IgG and Fab and H9 IgG. The results can be seen in Appendix I and a summary 
of the data is presented in Table 7.6. These antibodies all exhibited distinct 
similarities with the H36 IgG and its Fab with increases of PAN correlating with 
increases in inhibition of virus-cell fusion.
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Figure 7.10 Analysis of the relationship between A/PR/8 virus PAN and virus- 
ccll-fusion as a function of H36 IgG concentration. PAN and fusion were assayed 
in parallel in the same batch of monolayers in 3-cm plates, using the same virus and 
antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 9.1 (R = >0.97 for both curves).
Table 7.3 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 93 (+/- 6 )
Bafilomycin treated - No 85 (+/- 6 )
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Figure 7.11 Analysis of the relationship between A/PR/8 virus PAN and virus- 
cell-fusion as a function of H36 Fab concentration. PAN and fusion were assayed 
in parallel in the same batch of monolayers in 3-cm plates, using the same virus and 
antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 7.1 (R = >0.98 for both curves).
Table 7.4 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 87 (+/- 4)
Bafilomycin treated - No 79 (+/-12)
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7.4.5 Analysis o f  the relationship between A/PR/8 virus PAN and virus-cell 
fusion as a function o f H9 Fab concentration.
Results for the controls shown in Table 7.5 again show that the majority of the 
fluorescent signal obtained was specific for virus-cell fusion.
Figure 7.12 shows that as PAN increases with increasing H9 Fab 
concentration, the percentage inhibition of virus-cell fusion also increases, and 
indicates a causal relationship between inhibition of virus-cell fusion and PAN by H9 
Fab. However, unlike earlier data with H36 and H37 IgGs and Fabs, the inhibition 
of fusion by H9 Fab did not fully correlate with neutralization at higher levels and 
curves were found to be significantly different (P = 0.02, where significance is 
<0.05) by unpaired T-test. For example, even though >99% PAN could be obtained 
with the H9 Fab, complete inhibition of fusion could not be obtained.. This 
difference does not appear to represent variability in the assay as it is seen with no 
other antibody and was consistent over the three assays carried out.
7.4.6 Analysis o f  the effect o f H36 IgG on haemolysis o f  chick red blood cells 
(CRBCs) by attached A/PR/8 virus.
Haemolysis of RBCs by influenza virus is a convenient model to investigate fusion. 
The process involved is not strictly the same as virus-cell fusion, but is thought to be 
analogous (Huang et al, 1981). Therefore, investigation of the effect of antibodies 
on haemolysis of RBCs by attached A/PR/8 virus (analogous to PAN) was used here 
to complement the fluorescence based MDCK cell fusion assay.
Figure 7.13 shows that inhibition of haemolysis increased with increasing H36 
IgG concentration compared to the non-neutralized virus control. These data support 
the findings of the fluorescence-based assay in section 7.3.3, and suggest that the 
mechanism of PAN by H36 IgG is inhibition of virus-driven fusion.
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Figure 7.12 Analysis of the relationship between A/PR/8 virus PAN and virus- 
cell-fusion as a function of H9 Fab concentration. PAN and fusion were assayed 
in parallel in the same batch of monolayers in 3-cm plates, using the same virus and 
antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 7.1 (R = >0.98 for both curves).
Table 7.5 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N„ 91 (+1-1)
Bafdomycin treated - N0 79 (+/-10)
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Figure 7.13 Analysis of the effect of H36 IgG concentration on the haemolysis of
CRBCs by pre-attached A/PR/8 virus. Data are the mean of four experiments.
Bars represent the SEM.
7.4. 7 Analysis o f the effect o f  H36 Fab on haemolysis o f  CRBCs by pre-attached 
A/PR/8 virus.
Figure 7.14 shows that inhibition of haemolysis increased with increasing H36 Fab 
concentration, compared to a non-neutralized virus control. These data are 
supportive of the findings of the fluorescence-based assay (section 7 .3 .4 ) and 
indicates that H36 Fab can inhibit virus-driven fusion.
The effect of H37 IgG and Fab and H9 IgG on the haemolysis of RBCs by pre­
attached A/PR/ 8  virus was also investigated. The results obtained were similar to the 
H36 IgG and Fab, with all the antibodies being able to inhibit haemolysis (Appendix 
I). A summary of the data can be seen in Table 7.6.
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Figure 7.14 Analysis of the effect of H36 Fab concentration on the haemolysis of
CRBCs by pre-attached A/PR/8 virus. Data are the mean o f four experiments.
Bars represent the SEM.
7.4.8 Analysis o f  the effect o f H9 Fab on haemolysis o f  CRBCs by pre-attached 
A/PR/8 virus.
Figure 7.15 shows that inhibition of haemolysis increased with increasing H9 Fab 
concentration, compared to a non-neutralized control. However, in common with the 
fluorescence-based fusion assay (section 7.3.5), complete inhibition of haemolysis 
has not been achieved, with the maximum obtainable being approximately 80% 
inhibition of haemolysis. This result was consistent over the four experiments 
carried out. These data suggest that the H9 Fab can partially inhibit virus-driven 
fusion.
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Figure 7.15 Analysis of the effect of H9 Fab concentration on the haemolysis of
CRBCs by pre-attached A/PR/8 virus. Data are the mean of four experiments.
Bars represent the SEM.
7.4.9 Summary o f  the mechanism o f PAN by the antibodies and their Fobs.
A comparison of the mechanism of PAN of the antibodies reveals that neither of the 
antibodies can inhibit internalisation, whereas they are all able to inhibit virus-cell 
fusion and haemolysis of CRBCs (Table 7.6). This suggests that the antibodies and 
their Fabs share a common mechanism of PAN, being inhibition of virus-driven 
fusion. The results also show that the antibodies differ in their efficiency of PAN 
with the ranking order being H36>H37>H9, which is mirrored by their Fabs.
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Table 7.6 Summary of the mechanism of PAN by the antibodies and their Fabs.
MAb Antigenic 50% PAN (nM) Inhibition of internalisation Inhibition of fusion Inhibition of haemolysis
site IgG Fab IgG Fab IgG Fab IgG Fab
H36 Sb 9 75 No No Yes Yes Yes Yes
H37 Ca2 58 1060 No No Yes Yes Yes Yes
H9 Cb 550 1450 No No Yes Yes* Yes Yes*
* Inhibition of fusion/haemolysis not complete, maximum obtainable approximately 80%.
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7.5 Investigation of inhibition of fusion during PAN by the 
antibodies.
Influenza A virus fusion is triggered by a low pH-dependent conformational 
change(s) of the viral HA (Skehel et al., 1982). Recent evidence has suggested that 
the conformational changes can be segregated into a number of intermediates 
(reviewed in the introduction). At 4°C A/PR/8 virus does not fuse at pH 5, but its 
HA undergoes some conformational changes and release of its fusion peptide 
(Stegmann et al., 1990; Tsurudome et al., 1992; Pak et al., 1994). This stage is 
considered to be a pre-fusion intermediate of A/PR/8. As fusion does not occur at 
4°C with this virus strain, it was assumed that further changes caused by increased 
temperature (37°C) are required to make this virus fully fusion competent. 
Therefore, the pre-fusion intermediate was considered to be a first step in the fusion 
process and would allow investigation of whether the antibodies can PAN once the 
fusion process had initiated.
7.5.1 Analysis o f  the sensitivity o f  MAb binding to conformational changes o f the 
HA induced by low pH.
In order to determine if MAbs would give PAN once the pre-fusion intermediate of 
A/PR/8 virus had been established, it was necessary to show that the binding of the 
antibodies was not sensitive to pH 5. This was carried out by ELISA where virus 
was captured on a plate by an anti-HA IgA. The captured virus was treated at either 
pH 7 or pH 5 and the effect on the binding of MAbs was determined (Figure 7.16). 
Control wells without virus showed that background binding of MAb was low. The 
binding of MAb Y8, which is specific for the low pH conformation of the HA, 
increased 18-fold to the pH 5 treated virus compared to the pH 7 treated virus. This 
demonstrated that captured virus had changed to its low pH conformation. Binding 
of the H36, H37 and H9 IgGs to virus treated with either pH 7 or pH 5 was similar, 
indicating that their epitopes were not pH sensitive and therefore, that they should 
bind to the pre-fusion intermediate.
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Figure 7.16 Analysis of the effect of low pH on MAb binding to captured virus.
Virus (50 HAU) was captured by anti-HA IgA coated to the plate The data are the 
mean of four repeats. Bars represent the SEM X-axis labels -  V-pH7 = virus treated 
at pH 7, V-pH5 = virus treated at pH 5, V-pH5* = virus treated at pH 5 at 4°C, N- 
pl 17 = no virus treated at pH 7 and N-pH5 = no virus, treated at pH 5).
7.5.2 Analysis o f  the effect o f  H36 IgG and Fab on haemolysis o f  CRBCs by the 
pre-fusion intermediate o f A/PR/H virus.
The pre-fusion intermediate was investigated using haemolysis of CRBCs. Briefly, 
virus was attached to CRBCs at 4°C and then treated with pH 7 buffer at 4°C or at 
pH 5 to trigger formation of the pre-fusion intermediate. Previous studies have 
shown that prolonged incubation of A/PR/8 at 4°C and pH 5 did not result in fusion 
and this was confirmed in this system (data not shown) (Tsurudome et al., 1992; Pak 
et al., 1994). Virus-CRBC complexes were then adjusted to pH 7 and incubated with 
the antibodies. The effect of antibodies on haemolysis was analysed by shifting pH 
to 5 at 37°C to trigger haemolysis.
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Figure 7.17 shows that virus-CRBC complexes that were pre-treated at pH5 
gave a greater degree of haemolysis compared with pH 7 treated complexes. The 
lack of haemolysis in the inactivated virus control demonstrates that the level of 
haemolysis seen in the virus controls is virus specific. An interesting observation 
was that haemolysis by the pre-fusion intermediate (pH 5 treated) could be triggered 
by increasing temperature to 37°C at neutral pH, and did not require further pH 5 
treatment. This is in direct contrast to results of others who failed to get the A/PR/8 
virus pre-fusion intermediate to fuse at 37°C, pH 7, until further pH 5 treatment (Pak 
et ah, 1994). The concentration of H36 IgG and Fab used gave >90% inhibition of 
haemolysis by pH 7 treated virus. However, levels of haemolysis after treatment 
with H36 IgG and Fab were very similar to those of the pH 5 treated virus control, 
indicating that the antibodies had to be present prior to initiation of fusion to give 
PAN.
These investigations were also carried out on the H37 and H9 IgGs and their Fabs 
and gave similar results, not being able to inhibit haemolysis of CRBCs by virus pre­
treated at pH5 (see Appendix I for results).
7.5.3 Analysis o f  the effect o f the Fabs on the low pH  induced conformational 
change o f the HA ofpre-attached virus (in PAN-like format).
In order to inhibit haemolysis of CRBCs by virus the MAbs are required prior to 
induction of intermediates (that have undergone some of the conformational changes 
of the HA) in the fusion process. This suggested that antibodies may act by 
inhibiting the conformational changes of the HA and thus prevent haemolysis. To 
investigate this, we used a panel of MAbs specific for epitopes present only in the 
low pH form of the HA (Table 7.7). These antibodies were used in an ELISA that 
was designed to be very similar to the standard PAN assay (section 7.2), except that 
the MDCK monolayers were fixed to prevent internalisation of virus. Virus was 
attached to monolayers at 4°C and then incubated with 200 nM of H36 Fab. This 
concentration was sufficient to cause >99% PAN in an assay carried out 
simultaneously (data not shown).
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Figure 7.17 Analysis of the effect of H36 IgG and Fab on haemolysis by tbe cold­
fusion intermediate of A/PR/8 virus. All data have been subtracted from the 
background haemolysis obtained from CRBC controls without virus. All control 
samples were treated as the virus containing samples. Data are the mean of three 
experiments. Bars represent the SEM. X-axis labels -  V-pH7 = pre-attached virus 
incubated at 4°C and pH 7, V-pH5 = pre-attached virus at 4°C and pH 5, V-1A = 
virus inactivated at 37°C and pH 5 prior to attachment, lgG-pH7 = H36 IgG at 66.7 
nM, incubated with pH 7 treated virus, Fab-pH7 = H36 Fab at 200 nM, incubated 
with pH 7 treated virus, IgG-pH5 = H36 IgG at 66.7 nM, incubated with pH 5 
treated virus, Fab-pH5 = H36 Fab at 200 nM, incubated with pH 5 treated virus.
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0. 00^ — 1
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Table 7.7 Characteristics of the conformation-specific MAbs.
MAb Binding Site Specificity
Y8 IgG Sa Low pH HA
H2 IgG Cb Low pH HA
H3 IgG Ca2 Low pH HA
H18 IgG Cb Low pH HA
H17 IgG Ca2 Native HA
(Yewdell etal., 1983)
Virus-Fab complexes were then incubated at pH 7 or pH 5 and at 37°C or 4°C to induce 
conformational changes in the viral HA, and then incubated with the conformation- 
specific MAbs at 4°C. An anti-Fc IgG detection system allowed quantitation of the 
bound conformation-specific IgGs. As a result only the effect of the neutralizing Fabs 
on the HA conformation could be tested by this assay, as the Fc region of the H36 ,H37 
and H9 MAbs would interfere with detection of conformation-specific MAbs. 
Attachment detection ELISAs were carried out to show that virus attachment remained 
constant under the different pH conditions (data not shown).
Figure 7.18 shows the difference in binding to virus treated with either pH 5 or pH 
7 at either 4°C or 37°C of the conformation-specific IgGs. The H17 IgG which binds 
specifically to native HA, had a 4.3-fold decrease in binding to pH 5 (37°C) treated 
virus compared to virus treated at pH 7(37°C). This demonstrated that conditions used 
in the assay caused the viral HA to adopt its low pH conformation. The fold differences 
in binding between pH 7(37°C) treated virus and pH 5(37° or 4°C) treated virus of the 
four low pH specific IgGs is shown in Table 7.8. Collectively, these results show that 
all the IgGs have increased binding to pH 5(37°C) treated virus, again indicating 
adoption of the low pH conformation of the HA. The analysis of the pH 5(4°C) (pre­
fusion intermediate) treated virus indicated that conformational changes of the HA 
occurred, but at a lesser extent than with the pH 5(37°C) treated virus. The H17 IgG is 
specific for site Ca2, which spans the monomer-monomer interface in the HA trimer, 
and it is specific for the native HA conformation. It is interesting that this IgG binds to
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Figure 7.18 Analysis of the effect of H36 Fab on the low pH-induced conformational change of the HA of A/PR/8 virus (in PAN-like 
format). Virus was attached to fixed cell monolayers at 4°C and then incubated with Fab at 4° or 37°C. Neutralized virus was then incubated 
with pH 5 or 7 at 4° or 37°C, and then probed with conformational-specific MAbs. Graph shows binding of conformation-specific MAbs to 
virus. All data have been subtracted from a cell monolayer control without virus. Data are the mean of three experiments. The bars represent the 
SEM. X-axis labels -  V-pH7 (37°C) = MDCK cell attached virus incubated at pH 7 and 37°C, V-pH5 (37°C) = attached virus incubated at pH 5 
and 37°C, V-pH5(4°C) = as previous but at 4°C, Fab-pH7 (37°C) = H36 Fab at 200nM incubated with attached virus treated at pH 7 and 37°C, 
Fab-pH5 (37°C) = H36 Fab at 200nM incubated with attached virus treated at pH 5 and 37°C, Fab-pH5 (4°C) = as previous but at 4°C.
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Table 7.8 Comparison of the binding of the low pH conformation specific MAbs to 
A/PR/8 virus in different stages of fusion.
MAb Fold difference in binding between pH 7 
virus and pH 5 viruses. 
pH5(4°C) pH5(37°Q
Y8 IgG 14.0 25.0
H2 IgG 3.4 5.4
H3 IgG 2.0 5.4
HI 8 IgG 3.2 6.0
a slightly greater extent to the pre-fusion intermediate virus than the pH 5(3 7°C) treated 
virus. This together with the lower binding to cold-fusion intermediate virus of the H3 
IgG, also specific for site Ca2, suggests that the pre-fusion intermediate retains a higher 
proportion of its HA1 globular head structure than the pH 5(37°C) treated virus.
Incubation with sufficient H36 Fab to cause >99% PAN revealed no significant 
differences in the binding of the conformation-specific MAbs between the virus controls 
representing each treatment condition and the virus incubated with neutralizing Fabs 
(Figure 7.18). This indicated that the Fab could not inhibit the low pH induced 
conformational change of the HA. H36 Fab was also tested at lOOnM, sufficient to give 
90% PAN and at 500nM. The lOOnM concentration of Fab gave similar results to those 
described, however, at 500nM binding to the virus by all of the conformation-specific 
MAbs was restricted (data not shown). This was interpreted as steric hindrance by the 
high concentration of Fab.
These investigations were also carried out with the H37 and H9 Fabs and gave similar 
results to those described above (see Appendix 1.7). This indicates that neither of the 
Fabs can inhibit the low pH induced conformational change of the HA and that the Fabs 
must inhibit fusion/haemolysis by an alternative process. In support of this conclusion 
are the results of proteinase-K experiments. These experiments involved proteinase-K 
treatment of H36 Fab neutralized virus (free virus in solution, not PAN format). The 
proteinase-K cleaves the HA only in its low pH form and no difference in the cleavage
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pattern of the HA of pH 5 treated neutralized virus could be seen compared to the non- 
neutralized control (see Appendix 1.8). This again indicated that Fab could not inhibit 
the conformational change of the HA.
7.6 Discussion :
7.6.1 Comparison o f the STAN and PAN ofA/PR/8 virus by the antibodies.
This study is the first to show P A N  activity of influenza by monoclonal IgGs. In every 
case standard neutralization ( S T A N )  by H36, H37 and H9 IgGs was more efficient than 
their P A N .  However, the efficiency of P A N  was higher at P A N 90 than at P A N 5 0  at 37°C 
(Table 7.9). This suggests that P A N  increased in efficiency as antibody concentration 
increased. In contrast, the S T A N  and P A N  activity of the H36 and H37 Fabs were very 
similar, while P A N  activity of the H9 Fab was significantly higher (18-fold at 37°C) 
than its S T A N  activity.
Table 7.9 The relative difference between PAN and STAN by the IgGs at 50% 
PAN (PANso) and 90% PAN (PAN90).
MAb Fold difference
STAN50: PANso STAN90: PAN90
H36 IgG 50.0 10.3
H37 IgG 7.5 5.4
H9 IgG 8.0 5.0
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Why do the Fabs have a better PAN efficiency relative to their STAN than the 
IgGs?
A possible explanation for the lower efficiency of PAN by the IgGs assumes that the 
different areas on the viral surface have a greater importance in the PAN process than 
other areas. For example, a spherical virus particle attaching to a cell will have only one 
sector in contact with the cell. Hence, the remaining HAs on the virus surface not in 
close association with the cell surface should be as freely available to bind IgG as they 
are in unattached virus. If HA availability was the same in both unattached and attached 
virus then the efficiency of PAN by the IgGs should be similar to their STAN. 
However, the lower efficiency of PAN relative to STAN, suggests that IgGs must have 
restricted access to HAs on regions of the virus crucial for the PAN process. It is 
possible that the area of the virus-cell contact may contain the HAs crucial for the PAN 
process. It follows that access of IgG to this area would be restricted, due to steric 
hindrance by both cellular and viral proteins in close apposition at the virus-cell contact 
zone, resulting in lower efficiency of PAN. In contrast, it is likely that access of the 
smaller Fabs is less restricted to the crucial virus-cell contact zone. As a result, their 
PAN activity, relative to their STAN activity, is of higher efficiency compared to their 
IgGs. However, it should be emphasised that the IgGs have a greater PAN activity in 
molar terms than their Fabs. Thus suggesting that they are more efficient at PAN when 
they do gain access to the crucial sites, possibly due to their greater molecular mass. A 
corollary of this hypothesis is that large areas of HA on the viral surface must be 
redundant or a limited importance in the PAN process. However, further 
experimentation is required to establish this point.
Interestingly, the H9 Fab PAN activity was greater than its STAN (Figure 7.6). 
This is counter-intuitive as it is difficult to understand how an antibody can neutralize 
attached virus with limited availability (due to internalisation) better than virus free in 
solution. One possible explanation is that there is a change in HA conformation upon 
receptor-binding that allows increased access to the H9 antigenic site (Cb). The 
increased efficiency of PAN by H9 Fab is seen only at 37°C, whereas at 4°C its 
efficiency is similar to its STAN. This supports the idea that a temperature-dependent 
conformational change is involved. However, this hypothesis is tentative as the 
difference between the PAN and STAN by the H9 Fab even though statistically 
significant, is actually only 1.8-fold. Therefore, the importance of this difference should
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be interpreted with care, especially in the light of the published 3À resolution structure 
of BHA complexed with its receptor indicating that there were no major conformation 
changes (Weis et a l, 1988). However, it is possible that the behaviour of BHA does not 
truly reflect that of complete HA in the virion envelope and that monovalent receptor- 
HA interactions do not adequately reflect the multivalent receptor-HA interactions 
which occurs between virus and cell (Glide and Knowles, 1991).
Comparison of PAN at 4°C and PAN at 37°C showed that they occurred at similar 
efficiencies relative to STAN (except for H9 Fab). This indicated that variation in 
epitope availability was not a factor affecting the PAN of influenza in this temperature 
range as has been suggested for HIV (Armstrong and Dimmock, 1996), Obviously, the 
PAN activity will depend on the rate of internalisation of virus into the cell. Virus 
attached to cells at 4°C remained susceptible to PAN for a 60 minute period. However, 
at 37°C PAN activity decreased rapidly with time and after 10 minutes approximately 
50% of the virus was refractory to PAN. This suggested that the kinetics of PAN is 
very fast as at 37°C, as the majority of virus is only accessible on cell surface for 
approximately 5 minutes and yet the level of PAN is similar to that at 4°C, where virus 
is accessible for over 60 minutes. A comparison of the kinetics of PAN by the H36 Fab 
at 4°C and 37°C gave very similar results to those obtained with the IgG. This 
suggested that epitope availability was not responsible for increased efficiency of PAN, 
relative to STAN seen in the Fabs, compared to the IgGs, as both IgGs and Fabs had 
similar reaction times before internalisation of virus.
7.6.2 Mechanism o f  PAN by the IgGs and their Fabs.
This study is the first to determine the mechanism of PAN of influenza virus by 
monoclonal IgGs and their Fabs. The data suggest that all three IgGs and their Fabs 
shared a similar mechanism of PAN. Antibodies could not inhibit receptor-mediated 
internalisation of virus into MDCK cells, decreases in virus-cell fusion correlated with 
PAN and indicated a causal relationship. This was supported by all of the IgGs and 
Fabs being able to inhibit haemolysis of CRBCs in a dose dependent fashion.
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In contrast to the H36 and H37 Fabs, inhibition of fusion by Fab H9 did not 
correlate well with higher levels of PAN. For example, at >95% PAN there was only 
approximately 80% inhibition of fusion. In addition the H9 Fab inhibited haemolysis of 
CRBCs by approximately 80%. It is currently unknown why inhibition of fusion by H9 
Fab did not show a complete correlation with PAN, as seen with the other antibodies. It 
is possible that either neutralization of A/PR/8 virus can be brought about by less than a 
100% reduction of fusion activity or that inhibition of a post-fusion event contributes to 
the remaining 20% neutralization. However, the small difference could also be due to 
variability in the experimental system. A similar observation has been made with a 
neutralizing 17 amino acid micro-antibody against HIV-1 (Jackson et a l, 1999). 
Analysis by fluorescence fusion (R18 based) assay and cell-cell fusion assay showed 
that only approximately 50% of the neutralization level could be accounted for by 
inhibition of fusion by the micro-antibody.
Collectively, these data strongly suggest that all the IgGs and their Fabs caused 
P A N  by inhibition the virus-cell fusion. Thus antigenic site, isotype or valency of the 
antibody had no affect on the mechanism of P A N .  The P A N  activity of the IgGs and 
Fabs increases with increasing antibody concentration being more efficient at P A N 9 0  
than P A N 5 0 .  Therefore, it can be assumed that the process of inhibition of fusion also 
increases in efficiency with increasing antibody concentration. At higher antibody 
concentration the epitope availability decreases and hence the proportion of antibodies 
bound monovalently would increase. Hence, it may be that antibody bound 
monovalently is more efficient at P A N  and thus more efficient at inhibition of fusion. 
Together, this lends support to a steric hindrance (monovalent binding) model of fusion- 
inhibition, as discussed in Chapter 6, section 6.14.3.
7.6.3 Investigation o f  inhibition offusion during PAN.
7.6.3.1 Characteristics o f  the pre-fusion intermediate o f A/PR/8 virus.
As reviewed in the introduction (section 3.4.1) the X-ray crystal structure at 3Â 
resolution has been obtained for BHA trimer at pH 7 and at pH 5. The pH 5 structure is 
characterised by dissociation of the top HA1 globular domains and extensive
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rearrangements of HA2 domain, including exposure of the normally hidden 
hydrophobic fusion peptides. The pH 5 structure was originally proposed as the fusion 
active conformation (Wilson et a l, 1981; Bullough et a l, 1994). However, recent 
evidence has strongly suggested that this pH 5 structure corresponds to an inactive 
terminal structure marking the end of the fusion process, whilst the fusion active form is 
mediated by a transient conformational intermediate (pre-fusion intermediate), in most 
viral strains (White and Wilson, 1987; Stegmann et a l, 1990). Based on these 
observations a 3-state model relating the conformational transitions of the HA to the 
fusion process has been proposed (Korte et a l, 1999). This model describes the pH- 
driven transition from a tense (T) state, corresponding to the pH 7 crystal structure, to a 
relaxed (R) state. The R state is followed by a transition to the desensitised (D) state, 
corresponding to the pH 5 ciystal structure. The R state is considered to be the fusion 
active conformational intermediate (pre-fusion intermediate). Ciyo-EM studies have 
correlated a fuzzy spike (HA) morphology with the D state, whilst a defined HA 
morphology has been correlated with the T state. The R state retains most of its T spike 
morphology except they seemed less well defined than the T state (Korte et a l, 1999; 
Shangguan et a l, 1998). The pre-fusion intermediate (correlating with R state, but is 
not fusion active)of A/PR/8 virus is not well defined, but can be obtained at low pH and 
lower temperature (pH 5, 4°C) (Tsurudome et a l, 1992). The A/PR/8 viral HA at pH 5, 
4°C has been shown to release its fusion peptides both by the ability to bind target 
membranes (via a hydrophobic interaction) and by immunoprécipitation by anti-fusion 
peptide antibody (Tsurudome et a l, 1992; Pak et al., 1994). Immunoprécipitation of the 
pre-fusion intermediate HA by Y8-10C2 MAb, specific for an epitope in the HA1 
exposed in the low pH conformation (D state), also indicated that there were some 
conformation alterations in the globular head domain. However, the precipitation was 
only 1.6-fold lower than obtained with virus treated at pH 5, 37°C indicating that these 
conformational changes are restricted in the pre-fusion intermediate.
The pre-fusion intermediate was studied here through haemolysis of CRBCs. In 
agreement with previous studies, it was shown that the pre-fusion intermediate (pH 5, 
4°C) did not cause haemolysis during a prolonged (4 hour) incubation at 4°C (Stegmann 
et a l, 1990; Tsurudome et a l, 1992). In addition the A/PR/8 pre-fusion intermediate 
could not be committed to fuse by increasing the temperature to 37°C, at pH 7 (Pak et 
al, 1994). In contrast, results obtained in this thesis showed that haemolysis by the pre­
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fusion intermediate could be triggered at neutral pH by increasing the temperature to 
37°C. The reason(s) for this difference are unknown, but it is possible that differences 
between the fusion assays are responsible. For example, Pak et al (1994) used 
erythrocyte ghosts labelled with R18 and hence analysed the virus-RBC lipid mixing 
(hemi-fusion), whereas in this thesis I have used haemolysis of CRBCs. However, the 
process of haemolysis has not been well characterised and it is possible that differences 
exist compared to the actual fusion process. It is also possible that differences in the 
virus HA sequence or differences in the species o f erythrocyte (human RBCs were used 
by Pak et al (1994) could be responsible. Future work in this area should use R e ­
labelled CRBCs ghosts to try to correlate both fusion and haemolysis results. However, 
results in this thesis are agreement with a study with the X-31 strain of influenza (H3), 
which showed that virus-erythrocyte complexes pre-treated at pH 5, 4°C could be 
committed to fusion at neutral pH (37°C), suggesting subtle differences in the virus 
could be the important factor (Schoch et al., 1992).
Results in this thesis also showed that haemolysis by the pre-fusion intermediate 
(pH 5, 4°C), which had been shifted to pH 7, 37°C, was more efficient than virus that 
had been treated at pH 7, 4°C. This suggests that during the low pH pre-incubation, the 
virus is undergoing changes that prime the virus for the fusion process. This idea is 
supported by Schoch et al (1992), who showed that efficiency of the fusion by the pre­
fusion interval was dependent on the duration of the low pH pre-incubation.
This thesis is the first study to analyse the conformation of the pre-fusion 
intermediate of A/PR/8 virus attached to MDCK cells with a panel of conformation- 
specific MAbs (Figure 7.18). Binding of four MAbs specific for low pH HA 
conformation to the pre-fusion intermediate (pH 5, 4°C) increased relative to neutral 
HA conformation, but was approximately 2-fold less than binding to virus in the pH 5, 
37°C conformation. Hence, this indicated that the conformation of the viral HA of the 
pre-fusion intermediate had undergone changes in three antigenic sites on the HA 
globular head domain, but that these were not as extensive as in the pH 5, 37°C 
structure.
Binding of the HI 7 MAb, that is specific for native HA, to the pre-fusion 
intermediate (pH 5, 4°C) was only 2-fold lower than the binding to the native HA. In 
contrast, the binding to virus treated at pH 5, 37°C decreased by 6.6-fold. Also the 
binding of H3 MAb, specific for epitopes in the HA1 exposed after treatment at low pH,
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had the lowest increase in binding to the pre-fusion intermediate compared to the other 
MAbs specific for epitopes exposed at low pH,. Together, these data suggest that the 
Ca2 antigenic site spanning the monomer-monomer interface of the HA trimer is 
relatively conserved in the pre-fusion intermediate. Conservation of the monomer- 
monomer interface in the pre-fusion intermediate agrees with cryo-EM pictures of HA 
spikes in which there was no detectable dissociation of the HA1 globular heads in the 
HA trimer (Korte et al., 1999; Shangguan eta/., 1998).
Interestingly, the MAbs specific for site Cb showed the highest binding to both 
the pre-fusion intermediate (pH 5, 4°C) and pH 5, 37°C treated virus. This result is in 
agreement with a previous study of pH 5, 37°C treated-A/PR/8, which showed that with 
one exception (MAb Y8-10C2), that binding of 19 MAbs specific for sites Sa and Sb 
was decreased, whilst the binding of all 9 MAbs specific for site Cb had an increased 
binding compared to pH 7, 37°C-treated virus (Yewdell et al., 1983). Collectively, this 
suggests that in the low pH treated HA conformation access to site Cb is less restricted 
than in the neutral pH HA conformation. If  we extrapolate this idea to possible changes 
in site Cb that occur on binding to the cell receptor, then this may explain the increased 
PAN activity of H9 Fab compared to its STAN activity.
In summary, probing the structure of the pre-fusion intermediate HA indicates that 
the HA1 globular head has undergone conformation changes, but that monomer- 
monomer interface is relatively conserved. Future work in this area should use the 
fusion-peptide specific MAbs available to determine whether the fusion-peptide has 
been released.
7.6.3.2 Analysis o f the process o f fusion-inhibition during PAN.
This study has investigated the affect of the IgGs and Fabs on the low pH-induced 
haemolysis of CRBCs by a pre-fusion intermediate (pH 5, 4°C) of A/PR/8 vims and on 
the low pH-dependent conformational change of the viral HA. Initial investigation 
showed that binding of H36, H37 and H9 MAbs to HA was not sensitive to low pH 
treatment. As a result, any change in the PAN activity of pre-fusion intermediates 
should not be due to an inability of the antibodies to bind to virus. It was found that 
neither of the IgGs nor the Fabs could inhibit the haemolysis o f CRBCs by the A/PR/8
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virus pre-fusion intermediate. This indicated that the antibodies had to bind to virus 
prior to the changes induced in the viral HA when it becomes the pre-fusion 
intermediate. Probing the HA of virus previously incubated with neutralizing Fab with 
a panel of conformation-specific MAbs, indicated that under all of the pH and 
temperature conditions studied its conformation was similar to that of virus not treated 
with neutralizing Fab. This indicated that Fab neutralization could not inhibit the low 
pH-induced conformation changes in the HA.
These results suggest that the HA of neutralized virus is functional (i.e. can adopt 
required fusion conformations) and hence that the IgGs and Fabs are inhibiting a very 
early stage of the fusion process. Therefore, it is possible that the inhibition of fusion 
seen with PAN is due to steric hindrance of some early part of the fusion process. A 
recent study of influenza virosome fusion liposomes containing specific anti-HA Fabs 
as surrogate receptors, suggested that high density of Fabs inhibits fusion (Millar et al,, 
1999). Therefore, a possible explanation of PAN by the IgGs and Fabs is that their 
binding to the crucial HA-cell contact zone (discussed earlier) increases the overall 
protein density at this site. This overcrowding sterically inhibits the fusion process 
perhaps by preventing correct orientation of the HA for delivery of the fusion peptide. 
In support of this hypothesis are the following -
(1) Antibodies did not inhibit haemolysis of CRBCs by pre-fusion intermediates 
(the possible first stage of the fusion process), hence the antibodies are 
required prior to initiation of fusion/haemolysis.
(2) Antibodies did not inhibit conformational changes in the HA, indicating that 
the neutralized virus HA is fusion functional.
(3) PAN by the IgG is more efficient in molar terms than the Fab, possibly due to 
its larger molecular mass. The larger molecular mass would enhance its 
ability to sterically hinder an event in the early fusion process.
(4) PAN is more efficient at higher IgG concentrations. At higher concentrations 
the probability that the IgGs bind monovalently is greatly increased due to the 
limited availability of epitopes. Monovalent binding increases the IgGs steric 
hindrance capacity (see chapter 6).
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7.6.4 PAN o f other animal viruses.
This thesis is the first study to determine the mechanism of PAN of influenza A virus by 
monoclonal IgGs and their Fabs. However, PAN has been investigated in a number of 
other viral systems.
The temperature dependence of PAN of HIV-1 virus by a number of monoclonal 
IgGs has been investigated (Armstrong et al., 1996; Armstrong and Dimmock, 1996), 
MAbs ICR 39.13g and F58 were able to give PAN at 2PC and 35°C. However, MAb 
ICR 41. li could only give PAN below 21°C. As a result, it was suggested that this 
phenomenon was linked to a temperature-dependent conformational change in the CD4- 
gpl20 complex, which possibly masks the ICR 41.li epitope. Other MAbs including 
ICR 39.3b do not give PAN at any temperatures, inferring that its epitope is blocked by 
the CD4 interaction. These findings are in contrast with results in this thesis with PAN 
of A/PR/8 being temperature-independent, apart from a difference between PAN at 
37°C and 4°C with the H9 Fab. Another study showed that a MAb to the CD4 protein, 
M-T413 (non-viral epitope) gave PAN of HIV-1 when it was added as late as 120 
minutes post-infection (Rieber et al., 1992). It was also shown that the M-T413 Fab 
could also give effective PAN, indicating that crosslinking was not involved. These 
findings suggested that the PAN activity of the MAb and Fab M-T413 was due to the 
inhibition of conformational rearrangements in the CD4-gpl20 complex. Therefore, 
collectively, the studies on PAN of HIV-1 suggest that it is dependent on 
conformational changes in the receptor complex, which have been previously 
characterised (Sattentau and Moore, 1991; Sattentau et al., 1993). Conformational 
changes upon receptor binding of influenza have not been found.
The importance of the virus-host cell receptor interaction in PAN activity was also 
indicated in a study of enterovirus 71 (Kjellen, 1985), This study showed that 
components of an anti-enterovirus 71 immune serum could only neutralize virus after 
attachment to rhabdomyosarcoma cells but not after attachment to green monkey kidney 
cells. Formation of de novo epitopes was also seen in a study of neutralization of 
Sindbis virus, where glycoprotein E l and E2 underwent conformational changes as a 
consequence of the virus-cell interaction (Flynn et al., 1990). This suggested that 
conformational changes in virus proteins upon receptor interaction revealed de novo 
epitopes that antibodies in the serum could interact with. This is of interest in relation
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to the H9 Fab PAN results in this thesis, as this suggests that a possible relaxation of 
conformation of the HA upon receptor interaction could allow increased PAN.
Two studies of the PAN of CMV virus found MAbs that gave PAN and others 
that did not (Farrell and Shellam, 1990; Ohizumi et al., 1992). The study with HCMV 
found that MAb C-23 could neutralise virus absorbed to cells and could also block cell­
cell infection. Furthermore, the virus remained sensitive to PAN for 120 minutes after 
shifting temperature from 4°C to 37°C (Ohizumi et al., 1992). The sensitivity of 
attached virus to PAN after incubation periods seems to be a feature of viruses that fuse 
with the plasma membrane by a pH-independent mechanism. For example, a study of 
PAN of respiratory syncytial virus by a convalescent serum showed that virus had 
susceptibility of PAN after >60 minutes incubation at 37°C (Osiowy and Anderson, 
1995). In contrast, a study of the PAN of Newcastle disease virus (NDV), which is 
internalised by receptor-mediated endocytosis, showed that it became refractory to PAN 
after only 90 seconds of shifting temperature from 4°C to 37°C (Russell, 1984). 
However, it was shown in this thesis that A/PR/8 virus only starts to become refractory 
to PAN after 5 minutes of the temperature shift from 4°C to 37°C. This is accepted as 
being quite slow for receptor-mediated endocytosis and suggested that the prolonged 
(approximately 15 minutes) incubation at 4°C prior to infectivity that was responsible 
for this delay.
The importance in PAN of the specificity of the antibody was indicated by a study 
of adenovirus neutralization (Wohlfart, 1988). This showed that PAN was seen only 
with anti-hexon serum and not anti-fiber or anti-penton base serum. The authors 
suggested that the mechanism of PAN could be inhibition of low pH-induced 
conformational change of the viral capsid.
Determination of the mechanism of PAN of the IgGs and their Fabs in this thesis 
indicated that they all neutralise by inhibition of fusion/haemolysis. The mechanism of 
PAN has been investigated in only a limited number of other viral systems.
A study of the PAN of rabies virus by MAbs has described two mechanisms of 
action (Dietzschold et al., 1987). This study found that MAbs added after attachment of 
virus to cells caused up to 30% of the bound virus to be released from the cell surface. 
This mechanism has since also been described in PAN of rhesus monkey rotavirus, 
where MAb to the VP8 antigen caused release of virus from MAI 04 cells (Ruggeri and 
Greenberg, 1991). The virus that remained attached to cells in the rabies virus study
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was endocytosed, and it was hypothesised that MAbs neutralize virus by inhibition of 
the virus-cell fusion. Release of attached A/PR8 virus by antibody was not found in this 
thesis as the amount of neutralized virus internalisation was the same as the non- 
neutralized control. Two further studies have also implicated inhibition of fusion as 
being the mechanism of PAN. A study of PAN of West Nile virus indicated PAN 
correlated with inhibition of uncoating of viral RNA (Gollins and Porterfield, 1986), 
Alternatively a study of vesicular stomatitis virus (VSV) used a fluorescent fusion (R18- 
based) assay to analyse fusion and showed that antibody could inhibition fusion by 
>90% (Blumenthal etal., 1987). Investigation of the PAN of African Swine fever virus, 
indicated the antibodies in convalescent sera could PAN (Gomez-Puertas et al, 1996). 
This study showed that the PAN antibodies were specific for protein p30 and that these 
were implicated in inhibition of internalisation as proteinase-K treatment could detach 
approximately 90% of neutralised virus after incubation at 37°C compared to 
detachment o f only approximately 5% in the non-neutralised virus control.
Six MAbs had PAN activity for poliovirus (Vrijsen et al., 1993). This was caused 
by the antibody preventing the cell-mediated conversion of virus to 135S and 80S 
particles. The valency of binding of the MAbs were implicated in this mechanism, 
where it was suggested that PAN positive MAbs bound bivalently, whereas PAN 
negative MAbs bound only monovalently.
Collectively, the studies in the other viral systems often implicate inhibition of the 
fusion step in enveloped virus or an uncoating step in non-envelope viruses as 
responsible for PAN. This is in supportive of results presented in this thesis which 
indicate that all three IgGs and their Fabs also inhibit fusion of the mechanism of PAN.
188
8 Results: Analysis of the reversibility of the 
haemagglutination-inhibition and neutralization of 
influenza A/PR/8 virus by MAbs.
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8.1 Introduction
A number of MAbs have been described that irreversibly neutralize influenza A virus. 
The mechanism of neutralization of A/PR/8 virus by a monoclonal IgA, H37-66, was 
determined to be inhibition of virus-cell fusion (Armstrong and Dimmock, 1992). 
However, when neutralized virus was treated with acidified PEG, to artificially bypass 
the block to fusion, infectivity was not recovered. Immunofluorescence studies of PEG 
fused virus indicated that distribution of internal viral antigens mimicked that of 
infectious virus. A similar situation was also encountered with a monoclonal IgG, HC2, 
to A/fowl plague/Rostock/34 (FPV/R) virus, where viral RNA was found to reach the 
nucleus, but did not undergo transcription or replication (Possee et al., 1982; Rigg et al., 
1989). As a result, it is apparent that internal components of the neutralized virus 
remain dysfunctional independent of the antibody. This requires that MAbs binding to 
the HA on the exterior of the virus transduce a signal through the envelope to the core 
components which results in a permanent (irreversible) loss of infectivity. However, 
evidence for this signal transduction by antibodies and permanent loss of infectivity has 
not been found.
This area was investigated in a study of the reversibility of haemagglutination- 
inhibition (HI) and neutralization of virus by a panel of anti-FPV/R IgGs and the 
monoclonal IgA, H37-66 (Schofield, 1996). In this study ammonium hydroxide 
(AmOH) at pH 11.5 was used as a mild denaturant to remove MAbs from the virus 
post-neutralization, as crucially this treatment did not affect virus infectivity. It was 
found that with half of the MAbs tested (HC3W, HC10 and IgA) the HI and 
neutralization could be reversed. The reversibility correlated well with antibody 
affinities as HC3W and HC10 had lower affinities than the MAbs that could not be 
reversed (the affinity of IgA is unknown). The attachment of virus to cell receptors was 
analysed to determine if the cell receptor acts synergistically with the MAb to trigger 
irreversible neutralization. This study proved inconclusive, as only approximately 10% 
of the total HA and infectivity could be recovered. A very interesting possible 
explanation of this low recovery was that the binding of the IgA to virus attached to a 
cell receptor caused a global conformational change in the viral HA, which resulted in 
an increase in affinity of IgA, and that it became refractory to removal by AmOH. 
However, further investigation of the low recovery phenomenon was not carried out and
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the point at which neutralization becomes irreversible was not found. Hence, 
continuation of this area is warranted and of interest.
In this section the reversibility of the HI and neutralization, both of virus in solution and 
virus attached to cells, by the anti-A/PR/8 virus IgGs, H36, H37 and H9 was examined. 
Neutralization of virus in solution at 4°C and 37°C by the H36, H37 and H9 IgGs was 
reversible. Investigation of reversibility of neutralization by the three IgGs of virus 
attached to cells gave results similar to those seen previously with the IgA, in that 
recovery of HA and infectivity as a result of treatment with bacterial neuraminidase was 
very low. Examination of the low recovery of virus induced by the IgA indicated that it 
was due to the bacterial neuraminidase not removing the virus-MAb complexes from 
the cell surface, possibly due to steric hindrance by the fringe of neutralizing antibody. 
The low recovery phenomenon only occurred at temperatures >20°C, suggesting that 
conformational changes of the viral HA upon receptor binding may play a role. 
Analysis of the reversibility of the HI of attached virus treated at pH 5 and 4°C, showed 
a good HA recovery, indicating virus was removed from the cell surface.
8.2 Analysis of the reversibility of haemagglutination-inhibition (HI) 
and neutralization of virus in solution by MAbs.
8.2.1 Investigation o f the reversibility o f  H I and neutralization o f virus in solution 
by the monoclonal IgA (H3 7-66) at4°C and37°C
This assay compared the reversibility of HI and neutralization of A/PR/8 virus by 10 
and 20 pg/ml of IgA MAb at 4 and 37°C. 10 pg/ml of IgA MAb represented the 
minimum concentration sufficient to cause complete HI and >99% neutralization. 
Hence removal of antibody by ArnOH could be assayed by the recovery of HA and 
infectivity. HI and neutralization of the A/PR/8 virus by IgA MAb was reversed by 
incubation with AmOH and passage through a Sephacryl S-1000 column to separate 
MAb from virus (Figure 8.1). Reversal of HI was not found if virus was not passed
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Figure 8.1 Analysis of the reversibility of HI and neutralization of virus free in 
solution: IgA MAb (H37-66). (A) This shows the percentage recovery of HA
compared to a non-neutralized virus control. Data are the sum of the ten fractions 
collected from the S-1000 column. (B) This shows the percentage recovery of 
infectivity compared to a non-neutralized virus control. Data are the sum of the 
infectivity of the three peak HA fractions. Data are the mean of three experiments. The 
lines represent the standard error of the mean (SEM). 10+A = virus neutralized with 
10|ag/ml of IgA, followed by treatment with AmOH; 10+P = virus neutralized with 
10(j.g/ml of IgA, followed by treatment with PBS; 20+A and 20+P = same as above, but 
with 20|ag/ml IgA. 4°C and 37°C below labels refer to temperature at which the virus 
was neutralized.
4°C  37°C  4°C  37°C  4 °C  3 7 °C  4°C  37°C
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through an S-1000 column, indicating that the IgA rebound to virus upon neutralization 
of pH. This suggested that AmOH did not permanently denature the paratope or epitope 
but rather increased the dissociation rate. The total HA was given by the sum of the HA 
titres of the ten fractions eluted from the S-1000 column (an example of the recovery of 
HA from the S1000 column is shown in Appendix I, Figure 1.9). The total infectivity 
was given by the sum of the infectivity of the three peak HA fractions. The total 
recovery of HA and infectivity was calculated as a percentage of the recovery of a non- 
neutralized virus control.
No reversibility of HI or neutralization could be detected when IgA neutralized 
virus was incubated in PBS rather than AmOH, showing that IgA did not dissociate 
upon dilution. The reversibility of HI and neutralization was not temperature- 
dependent, giving a similar percentage recovery at 4°C and 37°C. However, the 
percentage recovery of HA was affected by the concentration of IgA (Figure 8.1 (A)). 
The recovery when virus was neutralized by 20 pg/ml IgA was approximately 15% 
lower than the recovery of HA obtained with virus neutralized by 10 pg/ml of IgA. 
This suggested that AmOH did not remove all of the antibody at higher concentrations 
of IgA. The percentage recovery of infectivity was also IgA concentration-dependent 
(Figure 8.1(B)). Virus neutralized by 20 jig/ml of IgA gave approximately 35% lower 
percentage recovery of infectivity than virus neutralized by 10 pg/ml of IgA. This again 
indicated that a proportion of IgA remained on the virus after treatment with the AmOH 
and that the remaining IgA gave a higher degree of neutralization than HI.
8.2.2 Investigation o f  the reversibility o f  H I and neutralization o f  virus in solution 
by the monoclonal H36 IgG at 4 °C and 37°C
Figure 8.2 (A and B) indicates that the HI and neutralization of A/PR/8 virus by 10 
pg/ml H36 IgG could be reversed by treatment with AmOH. 10 (ig/ml of H36 IgG was 
the minimum concentration sufficient to cause complete HI and >99% neutralization. 
The H36 IgG did not reverse when diluted in PBS, rather than AmOH.
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Figure 8.2 Analysis of the reversibility of HI and neutralization of virus free in 
solution: H36 IgG. (A) This shows the percentage recovery of HA compared to a non- 
neutralized virus control. Data are the sum of the ten fractions collected from the S- 
1000 column. (B ) This shows the percentage recovery of infectivity compared to a non- 
neutralized virus control. Data are the sum of the infectivity of the three peak HA 
fractions. Data are the mean of three experiments. The lines represent the standard 
error of the mean (SEM). 10+A = virus neutralized with 10 (ig/ml of H36 IgG, 
followed by treatment with AmOH; 10+P = virus neutralized with 10 pg/ml of H36 
IgG, followed by treatment with PBS; 20+A and 20+P = same as above, but with 20 
Hg/ml H36 IgG. 4°C and 37°C below labels refer to the temperature at which the virus 
was neutralized.
i
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(B)
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Like the IgA MAb, reversibility of HI and neutralization could be obtained with the 
H36 IgG at both 4°C and 37°C, indicating that it also was not temperature-dependent. 
However, the reversibility of both HI and neutralization was concentration-dependent, 
with virus neutralized by 20 pg/ml of H36 IgG giving lower recoveries of both HA and 
infectivity than virus neutralized by 10 pg/ml of H36 IgG.
8.2.3 Investigation o f  the reversibility o f  H I and neutralization o f  virus in solution 
by the monoclonalH37IgG at 4°C and37°C.
Figure 8.3 (A and B) shows that HI and neutralization of A/PR/8 virus by 40 pg/ml of 
H37 IgG could be partially reversed by treatment with AmOH. 40 (ig/ml of H37 IgG 
was the minimum sufficient to cause complete HI and >99% neutralization. The 
percentage recovery of HA for 40 pg/ml was approximately 60%, whereas the 
percentage recovery of infectivity was approximately 50%. The recovery, as with 
previous antibodies, was not temperature-dependent. However, the percentage recovery 
of both HA and infectivity was approximately 2-fold less with virus neutralization by 50 
(ig/ml than virus neutralization by 40 |ig/ml. This indicated that recovery was 
dependent on the concentration of the antibody.
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Figure 8.3 Analysis of the reversibility of HI and neutralization of virus free in 
solution: H37 IgG. (A) This shows the percentage recovery of HA compared to a non- 
neutralized virus control. Data are the sum of the ten fractions collected from the S- 
1000 column. (B) This shows the percentage recovery of infectivity compared to a non- 
neutralized virus control. Data are the sum of the infectivity of the three peak HA 
fractions. Data are the mean of three experiments. The lines represent the standard 
error of the mean (SEM). 40+A = virus neutralized with 40 (ag/ml of H37 IgG, 
followed by treatment with AmOH; 40+P = virus neutralized with 40 ng/ml of H37 
IgG, followed by treatment with PBS; 50+A and 50+P = same as above, but with 50 
|ag/ml H37 IgG. 4°C and 37°C below labels refer to the temperature at which the virus 
was neutralized.
^  iooJ
4°C 37°C 4°C 37°C 4°C 37°C 4°C 37°C
4°C 37°C 4°C 37°C 4°C 37°C 4°C 37°C
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8.2.4 Investigation o f the reversibility o f  H I and neutralization o f virus in solution 
by the monoclonalH9 IgG at4°Cand37°C.
Figure 8.4 (A and B) shows that HI and neutralization of A/PR/8 virus by 50|ig/ml of 
H9 IgG is reversible after treatment with AmOH. Reversibility with the H9 IgG is 
similar to the antibodies described previously, being temperature-independent, but IgG 
concentration-dependent.
8.3 Determination of whether antibody bound to virus is completely 
removed by treatment with AmOH.
8.3.1 Investigation o f whether some antibody remains bound to virus after AmOH 
treatment by reactivity with anti-Fab antiserum.
Previous data indicated that lower recoveries of HI and neutralization were obtained 
from virus that had been neutralized with high concentrations of MAb. This suggested 
that AmOH was not removing all of the antibody. Incubation of virus neutralized by 
either the H36, H37 or H9 IgGs with anti-Fab antiserum causes an increase in the HI 
titre of each of the antibodies (data not shown). Therefore, to test whether the virus that 
had been treated with AmOH to remove MAb still had MAb bound, it was incubated 
with anti-Fab antiserum. Decreases of haemagglutination ability of the AmOH-treated 
virus after addition of the anti-Fab antiserum would indicate presence of MAb bound to 
virus after AmOH treatment.
Table 8.1 shows that recovery of HA by virus whose neutralization by the MAbs 
had been reversed by treatment with AmOH was similar to that described previously. 
However, addition of anti-Fab antiserum to this AmOH treated virus resulted in a lower 
recovery of HA. The decrease of HA due to the addition of anti-Fab antiserum was 
dependent on the concentration of the neutralizing MAb prior to AmOH treatment. For 
example, addition of anti-Fab antiserum to virus previously neutralized by lOpg/ml of 
H36 IgG resulted in a 1.8-fold loss of HA, whilst there was a 3.2-fold loss of HA for 
virus previously neutralized with 20pg/ml H36 IgG. This suggested that at higher 
concentrations of MAb the AmOH was less efficient at removal of antibody. The fold
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Figure 8.4 Analysis of the reversibility of HI and neutralization of virus free in 
solution: H9 IgG. (A) This shows the percentage recovery of HA compared to a non- 
neutralized virus control. Data are the sum of the ten fractions collected from the S- 
1000 column. (B) This shows the percentage recovery of infectivity compared to a non- 
neutralized virus control. Data are the sum of the infectivity of the three peak HA 
fractions. Data are the mean of three experiments. The lines represent the standard 
error of the mean (SEM). 50+A = virus neutralized with 50 pg/ml of H9 IgG, followed
by treatment with AmOH; 50+P = virus neutralized with 50 pg/ml of H9 IgG, followed
by treatment with PBS; 75+A and 75+P = 
4°C and 37°C below refer to temperature at
50+A 50+A 50+P 
4°C 37°C 4°C
same as above, but with 75 tig/ml H9 IgG. 
which the virus was neutralized.
■  % recovery of HA
50+P 75+A 75+A 75+P 75+P 
37°C 4°C 37°C 4°C 37°C
(B)
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Table 8.1 The affect of the addition of anti-Fab antiserum to virus neutralized by 
the MAbs at 37°C following treatment by AmOH. Virus neutralized by either of the 
MAbs was treated with AmOH, recovered from the SI000 column and incubated with a 
1 in 500 dilution of the anti-Fab antiserum. The recovery of HA was calculated as a 
percentage of a non-neutralized control.
MAb % recovery o f HA 
no anti-Fab + anti-Fab
Fold decrease in HA 
after addition of anti- 
Fab
IgA 10pg/ml 91 65 1.4
20pg/ml 76 31 2.5
H36 10pg/ml 98 54 1.8
20(ig/ml 83 26 3.2
H37 40pg/ml 63 18 3.5
50pg/ml 31 4 7.8
H9 50pg/ml 78 25 3.1
75|ig/ml 44 7 6.3
decrease in HA after addition of anti-Fab was highest with virus neutralized by the H37 
MAb. This MAb gave the poorest reversibility of HI, suggesting that the recovery of 
HA was poor as the AmOH treatment did not efficiently remove the H37 MAb.
8.4 Analysis of the reversibility of HI and neutralization of virus 
attached to chicken red blood cells (CRBCs).
8.4.1 Investigation o f  the reversibility at 4°C and 37°C o f  H I and neutralization o f  
viruspre-attached to CRBCs: IgA (H37-66).
As HI and neutralization of virus in solution by four IgGs could be reversed in a 
temperature-dependent fashion, it was investigated whether the antibodies act 
synergistically with the target cell receptor to cause an irreversible neutralization. Virus 
was attached to CRBCs at 4°C and then neutralized by addition of MAb. Following
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neutralization, the virus-MAb complexes were removed from the CRBCs by treatment 
with a bacterial neuraminidase. This enzyme cleaves the sialic acid, which constitutes 
the virus receptor, hence allowing removal of virus from the cell surface. The resulting 
virus-MAb complexes were then treated with AmOH and virus and MAbs were 
separated through a Sephacryl S-1000 column.
The percentage recovery of HA and infectivity was <10% with virus neutralized 
by IgA at 37°C, consistent with results described by Schofield (1998) (Figure 8.5 (A) 
and (B)). Also virus diluted with PBS rather than AmOH, showed no recovery of HA 
or infectivity. However, the reversibility of HI and neutralization of virus pre-attached 
to CRBCs was temperature-dependent. In contrast, >90% recovery of HA and 
infectivity was achieved at 4°C, similar to the recoveries seen with virus in solution. 
The reversibility of HI and neutralization was also dependent on antibody concentration, 
with percentage recoveries of HA and infectivity being lower with virus neutralized by 
20 pg/ml IgA, than virus neutralized by 10 pg/ml IgA.
8.4.2 Investigation o f the reversibility at 4°C and 37 °C o f  H I and neutralization o f  
virus pre-attached to CRBCs: IgGs.
Consistent with earlier findings the monoclonal IgA (H37-66) showed a low recovery of 
HA and infectivity after neutralization of pre-attached virus at 37°C. Therefore, 
investigation of whether monoclonal IgGs would also give a similar low recovery was 
carried out.
Less than 10% of HA and infectivity was recovered from virus pre-attached to 
CRBCs and neutralized at 37°C by 10 and 20 (ig/ml of H36 IgG (Figure 8.6 A and B). 
However, as seen with the IgA MAb, the percentage recovery of HA and infectivity at 
4°C was >85%, indicating that the reversibility was temperature-dependent. The 
percentage recoveiy of HA and infectivity was again lower at higher concentrations of 
H36 IgG indicating that reversibility was antibody concentration-dependent.
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Figure 8.5 Analysis of the reversibility of HI and neutralization of virus pre- 
attached to CRBCs: IgA MAb (H37-66). (A) This shows the percentage recovery of 
HA compared to a non-neutralized virus control. Data are the sum of the ten fractions 
collected from the S-1000 column. (B) This shows the percentage recovery of 
infectivity compared to a non-neutralized virus control. Data are the sum of the 
infectivity of the three peak HA fractions. Data are the mean of three experiments. The 
lines represent the standard error of the mean (SEM). 10+A = pre-attached virus 
neutralized with 10 pg/ml of IgA, treated with 1 U/ml bacterial neuraminidase and then 
incubated with AmOH; 10+P = pre-attached virus neutralized with 10 (ag/ml of IgA, 
treated with 1 U/ml bacterial neuraminidase and then incubated with PBS; 20+A and 
20+P = same as above, but with 20 pg/ml IgA. 4°C and 37°C below labels refer to the 
temperature that the virus was neutralized.
4°C 37°C 4°C 37°C 4°C 37°C 4°C 37°C
4°C 37°C 4°C 37°C 4°C 37°C 4°C 37°C
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Figure 8.6 Analysis of the reversibility of HI and neutralization of virus pre­
attached to CRBCs: H36 IgG. (A) This shows the percentage recovery of HA 
compared to a non-neutralized virus control. Data are the sum of the ten fractions 
collected from the S-1000 column. (B) This shows the percentage recovery of 
infectivity compared to a non-neutralized virus control. Data are the sum of the 
infectivity of the three peak HA fractions. Data are the mean of three experiments. The 
lines represent the standard error of the mean (SEM). 10+A = pre-attached virus 
neutralized with 10 |ig/ml of H36 IgG, treated with 1 U/ml bacterial neuraminidase and 
then incubated with AmOH; 10+P = pre-attached virus neutralized with 10 pg/ml of 
H36 IgG, treated with 1 U/ml bacterial neuraminidase and then incubated with PBS; 
20+A and 20+P = same as above, but with 20 og/ml H36 IgG. 4°C and 37°C below 
labels refer to the temperature that the virus was neutralized.
4°C 37°C 4°C 37°C 4°C 37°C 4°C 37°C
(B)
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The reversibility of HI and neutralization of virus pre-attached to CRBCs by the H37 
and H9 IgGs was also investigated (see Appendix 1.10). The reversibility of HI and 
neutralization by both H37 and H9 IgGs was also temperature and antibody 
concentration-dependent, giving low recovery at 37°C, but relatively high at 4°C.
8.5 Analysis of the poor reversibility at 37°C of HI and neutralization 
of virus attached to cells: IgA MAb.
8.5.1 Investigation o f the effect o f temperature on the reversibility o f  H I and 
neutralization o f virus attached to CRBCs: IgA MAb.
Analysis of the effect of temperature on the recovery of HA and infectivity was 
investigated by neutralizing virus attached to CRBCs with 10 pg/ml of IgA MAb in 
different temperature waterbaths. The recovery of HA and infectivity remained >80% 
up to 15°C, but then decreased with temperature > 20°C (Figure 8.7 A and B).
8.5.2 Analysis o f the kinetics o f the recovery o f HA and infectivity o f virus that was 
attached to CRBCs and then neutralized by 10 pg/ml IgA MAb.
Virus attached to CRBCs at 4°C was neutralized with 10 pg/ml of IgA MAb for 60 
minutes at 4°C. The virus-CRBC complexes were pelleted to remove excess IgA, 
resuspended in warm PBS and incubated at 37°C. lU/ml bacterial neuraminidase was 
added to different samples sequentially every 2 minutes to remove virus from CRBCs. 
The virus was then separated from the IgA by treatment with AmOH and passage 
through a Sephacryl S-1000 column.
The recovery of HA and infectivity of virus neutralized by IgA and kept at 4°C for 
30 minutes remained at approximately 90% (Figure 8.8 A and B). However, the 
recovery of HA of virus neutralized by IgA at 4°C and then shifted to 37°C decreased 
very rapidly with time, with decreases of approximately 90% seen after only 4 minutes 
(Figure 8.8 A). This rapid decrease in recovery with time at 37°C was also mirrored by 
the recovery of infectivity (Figure 9.8 B).
203
Figure 8.7 Investigation of the effect of temperature on the reversibility of HI and 
neutralization of virus attached to CRBCs: 10 ng/ml of IgA MAb. Virus was 
attached to CRBCs and then neutralized by IgA at different temperatures. The virus- 
MAb complexes were removed by treatment with bacterial neuraminidase and then 
incubated with AmOH. (A) This shows the percentage recovery of HA compared to a 
non-neutralized virus control. Data are the sum of the ten fractions collected from the 
S-1000 column. (B) This shows the percentage recovery of infectivity compared to a 
non-neutralized virus control. Data are the sum of the infectivity of the three peak HA 
fractions. Data are the mean of two experiments. The lines represent the standard error 
of the mean (SEM). Temp(°C) = temperature in which virus was neutralized by the 
IgA.
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Figure 8.8 Kinetics of the reversibility of HI and neutralization of virus attached to 
CRBCs: 10 pg/ml IgA. Attached virus that had been neutralized by IgA at 4°C was 
warmed to 37°C or kept at 4°C and then treated with bacterial neuraminidase at 2 
minute intervals to remove the virus-MAb complexes. This was followed by treatment 
with AmOH. (A) This shows the percentage recovery of HA compared to a non- 
neutralized virus control. Data are the sum of the ten fractions collected from the S- 
1000 column. (B) This shows the percentage recovery of infectivity compared to a non- 
neutralized virus control. Data are the sum of the infectivity of the three peak HA 
fractions. Data are the mean of two experiments. The lines represent the standard error 
of the mean (SEM). Time in minutes indicates the time at which neuraminidase was 
added to remove virus from the CRBCs, after shifting the temperature from 4°C to
37°C.
(A)
(B)
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8.5.3.1 Investigation o f the reversibility o f HI and neutralization o f virus attached to
fixed MDCK cell: 10^ig/ml o f IgA MAb.
The aim here was to determine if the low recovery of HA and infectivity seen 
previously with virus attached to CRBCs by 10 (ig/ml IgA could be repeated in other 
cell types. 5xl06 MDCK cells were used and fixed with either 2% paraformaldehyde or 
1% formaldehyde for 15 minutes to prevent receptor-mediated endocytosis of the 
attached virus-IgA complexes at 37°C. Virus was not internalised into fixed MDCK 
cells after a 60 minute incubation at 37°C, as verified by attachment detection ELISA 
(data not shown).
Recovery of HA and infectivity of virus attached to fixed MDCK cells and 
neutralized by IgA at 4°C was >75% (Figure 8.9 A and B). However, recovery of HA 
and infectivity of virus attached to MDCK cells and neutralized by IgA at 37°C was 
<15%. This indicated that the low recovery phenomenon at 37°C was not restricted to 
CRBCs.
8.5.3 Analysis o f  the reversibility o f  H I and neutralization o f  virus attached to cells,
other than CRBCs: IgA MAb
8.5.3.2 Investigation o f the reversibility o f H I and neutralization o f virus attached to
fixed  H9 T-cells 10 / ig/ml o f IgA MAb.
4xl06 T-cells were fixed as described previously to prevent endocytosis of attached 
virus-IgA complexes. Attachment of virus to T-cells over a 60 minute period at 37°C 
was determined by neuraminidase assay (data not shown). Reversibility of HI and 
neutralization of virus attached to fixed T-cells by IgA at 37°C was also low (Figure 
8.10 A and B). The low recovery phenomenon at 37°C was consistent in three different 
cell types, indicating that it was not cell type specific.
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Figure 8.9 The reversibility of HI and neutralization of virus attached to fixed 
MDCK cells: 10 pg/ml of IgA. Virus was attached to 5xl06 MDCK cells fixed with 
either 2% paraformaldehyde or 1% formaldehyde for 15 minutes. Attached virus was 
neutralized with IgA, treated with bacterial neuraminidase and then the incubated with 
AmOH. (A) This shows the percentage recovery of HA compared to a non-neutralized 
virus control. Data are the sum of the ten fractions collected from the S-1000 column. 
(B) This shows the percentage recovery of infectivity compared to a non-neutralized 
virus control. Data are the sum of the infectivity of the three peak HA fractions. Data 
are the mean of three experiments. The lines represent the standard error of the mean 
(SEM). 10+A = pre-attached virus neutralized with 10 pg/ml of IgA, followed by 
treatment with AmOH at 4°C; 10+P = pre-attached virus neutralized with 10 pg/ml of 
IgA, followed by treatment with PBS. 4°C and 37°C below labels refer to the 
temperature at which the virus was neutralized.
(A) 100H
804
e 60' s
40H
2(H
10+A 10+A 10+P 10+P
4°C 37°C 4°C 37°C
recoveiy of HA
10+A 10+A 10+P 10+P
4°C 37°C 4°C 37°C
2%  paraform aldehyde - H I ■ 1% fo rm aldehyde.... |
207
Figure 8.10 The reversibility of HI and neutralization of virus attached to fixed H9 
T-cells: 10 pg/ml of IgA. Virus was attached to 5x106 MDCK cells fixed with either 
2% paraformaldehyde or 1% formaldehyde for 15 minutes. Attached virus was 
neutralized with IgA, treated with bacterial neuraminidase and then the incubated with 
AmOH. (A) This shows the percentage recovery of HA compared to a non-neutralized 
virus control. Data are the sum of the ten fractions collected from the S-1000 column. 
(B) This shows the percentage recovery of infectivity compared to a non-neutralized 
virus control. Data are the sum of the infectivity of the three peak HA fractions. Data 
are the mean of three experiments. The lines represent the standard error of the mean 
(SEM). 10+A = pre-attached virus neutralized with 10 pg/ml of IgA, followed by 
treatment with AmOH at 4°C; 10+P = pre-attached virus neutralized with 10 pg/ml of 
IgA, followed by treatment with PBS. 4°C and 37°C below labels refer to the 
temperature at which the virus was neutralized.
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As the poor reversibility of HI and neutralization of virus by IgA at 37°C was not cell 
type specific, I determined if the same phenomenon could be induced by the binding of 
virus to a soluble receptor. The sialoglycoprotein, fetuin, was used at 4 mg/ml which 
was sufficient to give approximately 85% HI of virus, indicating that most of the 
receptor binding sites on the virus were approaching saturation (data not shown). Virus 
bound to fetuin was treated as if attached to a cell and treated with bacterial 
neuraminidase followed by AmOH.
Figure 8.11 (A and B) shows that the recovery of HA and infectivity of virus 
bound to fetuin and neutralized by 10 or 20 pg/ml of IgA at 4°C or 37°C was >85%. 
This demonstrates that virus binding to a soluble receptor, fetuin behaves differently 
from when it binds to receptors on the surface of a cell.
8.5.3.3 Investigation o f  the reversibility o f  HI and neutralization o f  virus bound to a
soluble receptor, fetuin: JO pg/m l o f  IgA MAb.
8.5.4 Quantitation o f the removal o f virus from  the CRBC by bacterial 
neuraminidase after neutralization by MAbs.
8.5.4.1 Analysis o f the effect o f temperature on the recovery o f virus from the CRBC 
after neutralization by MAbs.
Two possible explanations for the poor reversibility of HI and neutralization of virus 
attached to cells by IgA at 37°C were -
(1) the bacterial neuraminidase was not removing the virus-IgA complexes from 
the cell surface,
(2) the virus-IgA complexes were being removed by bacterial neuraminidase, but 
the IgA had become refractory to removal by AmOH.
To differentiate between these explanations the concentration of virus in the supernatant 
after neuraminidase treatment was determined using a biotinylated virus stock and a 
virus-biotin detection ELISA. A/PR/8 virus had biotin attached by sulfo-NHS links as
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Figure 8.11 Reversibility of HI and neutralization of virus bound to a soluble 
receptor, fetuin: the IgA MAb. Virus was incubated with 4mg/ml of fetuin for 60 
minutes at 37°C before addition of IgA MAb. Neutralized virus was then treated with 
bacterial neuraminidase and then the incubated with AmOH. (A) This shows the 
percentage recovery of HA compared to a non-neutralized virus control. Data are the 
sum of the ten fractions collected from the S-1000 column. (B) This shows the 
percentage recovery of infectivity compared to a non-neutralized virus control. Data are 
the sum of the infectivity of the three peak HA fractions. Data are the mean of three 
experiments. The lines represent the standard error of the mean (SEM). 10+A = virus 
neutralized with 10 pg/ml of IgA, followed by treatment with AmOH; 10+P = virus 
neutralized with 10 pg/ml of IgA, followed by treatment with PBS; 20+A and 20+P = 
same as above, but with 20 pg/ml IgA. 4°C and 37°C below labels refer to the 
temperature at which the virus was neutralized.
4°C 37°C 4°C 37°C 4°C 37°C 4°C 37°C
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this could be used in aqueous conditions, hence reducing problems with loss of 
infectivity that occur if solvents are used. Using the biotinylated virus stock a 
quantitative biotin detection ELISA was optimised. Briefly, virus removed by 
neuraminidase treatment of CRBCs was captured on an ELISA plate by an anti-HA IgG 
MAb (HI6, site Sa) and then assayed for its biotin content using a streptavidin- 
conjugate. The optical density (OD) obtained for neuraminidase released virus was then 
compared to a biotinylated virus standard curve of HAU versus OD to determine the 
quantity of virus present (Figure 8.12). The percentage recovery of biotinylated virus 
from the CRBC surface was then calculated by comparing the quantity of neutralized 
virus to a non-neutralized control.
Recovery of virus at 4°C from CRBCs that had been neutralized by either the IgA, 
H36, H37 or H9 MAbs was >90% (Figure 8.13). Recovery of virus from the cell 
surface was higher than the recovery of HA described previously for most of the MAbs. 
For example, virus neutralized by H37 IgG at 4°C gave a recovery of HA of 
approximately 60%, but approximately 91% of virus was recovered from CRBCs. This 
suggested that there was efficient removal of H37 neutralized virus from the cell 
surface, but the AmOH did not efficiently remove the antibody. Recovery of virus from 
CRBCs after neutralization by either of the four MAbs at 37°C was similar (10%) to the 
recovery of HA. This indicated that the virus was removed from the surface of the 
CRBC after neutralization at 4°C, but not after neutralization at 37°C.
8.5.4.2 Analysis o f the effect o f MAb concentration on the recovery o f neutralized
virus from  the CRBC.
Recovery of virus from CRBCs after neutralization by IgA was concentration- 
dependent (Figure 8.14). The higher the concentration of IgA, the lower the recovery of 
virus from the CRBC. For example, recovery of virus neutralized by 4 ng/ml of IgA 
from the CRBCs was >80%, but recovery of virus neutralized by 20 jig/ml of IgA was 
< 10%.
Recovery of virus from CRBCs after neutralization by the IgGs was also antibody 
concentration-dependent (data not shown).
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Figure 8.12 Standard curve of the optical density (OD) at 405nm against IIAU of 
biotinylated virus. The HA titre of the biotinylated virus stock was first determined 
and then fixed concentrations in 100 pi volumes were used on the ELISA plate.
Figure 8.13 The effect of temperature on the recovery of neutralized virus bound 
to CRBCs. The MAbs were used in the following concentrations -  IgA at 10 pg/ml, 
H36 at 10 pg/ml, H37 at 40 pg/ml and H9 at 50 gg/ml. Virus attached to CRBCs was 
neutralized at either 4°C or 37°C and then treated with 1 U/ml bacterial neuraminidase. 
The released virus samples, after treatment of CRBCs, were diluted in serial 2-fold steps 
across the ELISA plate to order to achieve an OD that was in the range of the standard 
curve. The recovery was determined as a percentage of a non-neutralized virus control
4 °C ------------  ----------  37°C
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Figure 8.14 The effect of concentration of neutralizing MAb on the recovery of 
virus from the surface of CRBCs. Virus attached to CRBCs was neutralized at 37°C, 
followed by bacterial neuraminidase at an activity of 1 U/ml. The released virus 
samples were diluted in serial 2-fold steps across the ELISA plate to order to achieve an 
OD that was in the range of the standard curve. The recovery was determined as a 
percentage of a non-neutralized virus control.
100n
fig/ml of IgA
H.5.5 Investigation o f whether IgA MAb could sterically inhibit the viral 
neuraminidase activity.
A possible explanation for the reduced ability of bacterial neuraminidase to remove 
virus from the CRBC surface at higher MAb concentrations, was that the antibody 
fringe could sterically hinder access of the enzyme to the virus cell receptor contact 
sites. To assess this possibility an assay of viral neuraminidase activity was carried out 
with the CRBC-virus-IgA complexes to determine if the fringe of antibody could 
restrict the access of fetuin (neuraminidase substrate) to the viral neuraminidase 
glycoprotein. 10 mg of fetuin was added to the CRBC-virus-IgA complexes for 120 
minutes, the cells were then pelleted and the supernatant was used in a standard
213
neuraminidase assay to determine the extent of cleavage of the terminal N-acetyl 
neuraminic acid residues from the sugar chains on the fetuin substrate.
Table 8.2 shows that the activity of the viral neuraminidase was reduced at higher 
IgA concentration. As the IgA is specific for the HA protein, it is unlikely that this had 
a direct inhibition of viral neuraminidase activity, Hence, this suggests that the higher 
concentrations of IgA can sterically hinder access of the fetuin substrate to the enzyme 
active sites on the neuraminidase glycoprotein. This provides an example of antibody 
steric hindrance to the virus surface and supports the hypothesis that the fringe of IgA 
molecules bound to virus inhibit removal of the virus from the cell surface by steric 
hindrance of the bacterial neuraminidase enzyme.
Table 8.2 Inhibition of viral neuraminidase activity by IgA MAb. Data are the mean 
of two experiments. 4000 HAU A/PR/8 virus was neutralized IgA at 37°C, followed by 
lOmg/ml of fetuin.
IgA
(fig/ml)
OD (549nm) % inhibition o f  
neuraminidase 
activity
0 1.76 (+/-0.37) -
5 1.49 (+/-0.28) 15.3
10 0.83 (+/- 0.32) 52.9
20 0.51 (+/-0.43) 71.1
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8.6 Analysis of the reversibility of HI and neutralization of virus 
attached to the CRBC treated at pH 5, 4°C: IgA MAb.
As the neutralization of virus attached to CRBCs by MAbs at 4°C could be reversed, the 
point of a permanent (irreversible) loss of infectivity had not been found. Therefore, 
investigation of virus neutralized and incubated at low pH was carried out to determine 
if mimicking events in the endosome would trigger a permanent loss of infectivity. 
Treatment of virus with low pH at 4°C does not cause inactivation, hence standard 
assays for viral infectivity could be used (data not shown). Virus was attached to 
CRBCs and then neutralized by IgA at 4°C. The pH was then lowered to pH 5, at 4°C 
for 30 minutes and then virus was removed from the cell surface with bacterial 
neuraminidase enzyme.
HI of virus that was attached to CRBCs, neutralized with IgA and treated at pH 5, 
4°C could be reversed (Figure 8.15). However, unfortunately only 10% of infectivity of 
non-neutralized virus treated at pH 5 ,4°C and with AmOH could be recovered (data not 
shown). This loss o f infectivity was due to exposure to AmOH, as infectivity o f virus 
prior to AmOH treatment was normal. This suggested that conformational changes of 
the virus HA that occur at pH 5, 4°C (see chapter 7) destabilise the HA so that it was 
less tolerant to the high pH (11.5) of AmOH. The same amount (10%) of infectivity 
was also recovered from neutralized virus, suggesting that the conditions used, virus 
attached to cells, neutralized, treated with pH5, 4°C, were not sufficient to cause a 
permanent loss o f infectivity. However, this remains a tentative conclusion as the 
majority of the infectivity was lost and the remaining 10% may not be representative.
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Figure 8.15 The reversibility of HI of virus attached to CRBCs treated at pH 5, 
4°C: IgA MAb. Virus attached to CRBCs were neutralized and treated with citrate 
buffer, pH 5 for 30 minutes at 4°C. Virus-IgA complexes were then removed from the 
cell by lU/ml bacterial neuraminidase. The graph shows the percentage recovery of HA 
compared to a non-neutralized virus control. Data are the sum of the ten fractions 
collected from the S-1000 column. Data are the mean of three experiments. The 
standard error of the mean (SEM) is shown. 10+A = pre-attached virus neutralized with 
10 pg/ml of IgA, incubated at pH 5, 4°C, followed by treatment with AmOH at 4°C; 
10+P = pre-attached virus neutralized with 10 |ug/ml of IgA, incubated at pH 5, 4°C, 
followed by treatment with PBS; 20+A and 20+P = same as above, but with 20 pg/ml 
IgA.
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8.7 Discussion :
8.7.1 Reversibility o f H I and neutralization o f virus in solution by MAbs.
HI and neutralization of virus in solution by IgA MAb (H37-66) was reversible, in 
agreement with the results obtained previously by Schofield (1996). Reversibility of HI 
and neutralization was also seen with three high affinity monoclonal IgGs, H36, H37 
and H9. The reversibility was not temperature-dependent, giving similar recoveries of 
HA and infectivity at both 4°C and 37°C. In agreement with the study by Schofield 
(1996) of reversibility of neutralization of A/FPV/R virus, results in this thesis indicate 
that neutralization of A/PR/8 virus in solution was also not sufficient to trigger a 
permanent (irreversible) loss of infectivity.
The reversibility of HI and neutralization of virus in solution by all the MAbs was 
dependent on the concentration of the antibody used, with higher concentrations giving 
lower recoveries of both HA and infectivity. Schofield (1996) indicated that 
dissociation of virus-MAb complexes by AmOH correlated and was dependent on 
affinity. However, in this thesis the dissociation (reversibility) of the antibodies does 
not correspond with affinity determined by SPR (see chapter 6). The dissociation of 
MAbs by AmOH was ranked IgA, H36>H9>H37, whereas affinity ranking order was 
H36>H37>H9 (IgA not known). The finding that recovery of HA was antibody 
concentration-dependent indicates that reversibility was not solely dependent on 
affinity. The concentration of the MAbs used was standardised as the minimum 
concentration that would give complete HI, as suggested by Schofield (1996). As a 
result, the concentration of MAb used depended on their ability to HI. The HI ranking 
order o f the MAbs was IgA>H36>H37>H9. Therefore, the H9 and H37 MAbs were 
used at the highest concentrations in the reversibility experiments. However, as the 
dissociation by AmOH ranking order does not completely mirror the HI ranking order, 
other factors are involved, and it seems that the reversibility of HI and neutralization is 
dependent on both the concentration of the IVlAb and its affinity. For example, although 
the AmOH reversibility with 40 pg/ml of H37 MAb was 60% and with 50 pg/ml of H9 
MAb was 75%, the affinity of the H37 MAb was higher than H9 MAb. It is interesting 
that Schofield (1996) used two IgGMAbs to A/FPV/R virus, HC2 and HC58 that had 
the lowest HI activity and thus had to be used at the highest concentration. These were 
not dissociated by AmOH, but he did not address the matter of antibody concentration.
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However, it should be noted that the H36, H37 and H9 MAbs used in this thesis have 
similar high affinities, so concentration may be of greater importance than if the MAbs 
had greater differences between their affinities.
The antibody concentration-dependence of the reversibility of all the MAbs 
indicated that AmOH did not permanently denature the paratope or epitope, but rather 
increased the dissociation rate. This suggested that AmOH treatment did not remove all 
of the bound antibody. This was verified experimentally by the addition of anti-Fab 
antiserum which reduced the recovery of HA. This effect was greatest with virus that 
had been neutralized with higher concentrations of MAb prior to AmOH treatment. 
Interestingly, with higher MAb concentrations recovery of infectivity was generally 
lower than recovery of HA, indicating that virus was neutralized by lower 
concentrations of MAb than required for HI.
8.7.2 Reversibility o f H I and neutralization o f virus attached to CRBCs by MA bs
AmOH treatment almost completely reversed HI and neutralization of virus attached to 
CRBCs when the experiment was done at 4°C. However, at 37°C reversibility of HI 
and neutralization with three monoclonal IgGs, H36 (site Sb), H37 (site Ca2) and H9 
(site Cb) and a monoclonal IgA (site Sb), at 37°C was <10% indicating that reversibility 
was not immunoglobin-type or antigenic site specific. Thus reversibility of HI and 
neutralization of virus attached to CRBCs was temperature-dependent.
8.7.2.1 Analysis o f the low reversibility o f HI and neutralization o f attached virus: at
37°C
As the low reversibility of HI and neutralization of attached virus at 37°C occurred with 
all the MAbs, investigation of this phenomenon with the IgA MAb was considered to be 
representative. The temperature-dependence of the low recovery of HA and infectivity 
(low recovery phenomenon) was analysed and found to occur between 15-20°C, with 
further losses of recovery seen over 30°C. Interestingly, this is the same temperature 
threshold as the incorporation of fusion peptide into a membrane and of the 
fusion/haemolysis activity of intact A/PR/8 viruses (Brunner et al., 1991). However,
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this is unlikely to be the same phenomena as (i) no haemolysis of the CRBCs was seen, 
and (ii) the low recovery phenomenon was antibody-dependent, as the majority ofnon- 
neutralized virus could be recovered from the cell at all the temperatures tested.
The low recovery phenomenon was also found to be similar when fixed MDCK 
cells or H9 T-cells were used. Fixed cells were employed to prevent receptor-mediated 
endocytosis of the virus-MAb complexes. This was verified in two ways; (1) using the 
attachment detection ELISA to monitor attached virus on the cell surface over a 60 
minute period at 37°C, which indicated that virus was not internalised and (2) that 
approximately 70% of input non-neutralization virus was recovered after bacterial 
neuraminidase treatment. Therefore, this indicated that uptake of virus into the cell was 
not responsible for the low recovery seen with the virus-MAb complexes at 37°C. The 
low recovery of virus from fixed cells also suggested that changes in virus rather than 
cell proteins were involved. It should be noted that the formaldehyde fixative acts by 
crosslinking, forming methylene bridges at a distance of 2A and hence for proteins to be 
fixed they must be or parts of them must be within this distance (Dimmock et al., 1989). 
However, the methylene bridges are formed with many different groups within proteins, 
therefore increasing the likelihood that proteins would be fixed.
Experiments replacing cells with a soluble receptor analogue, fetuin, found that 
the low recovery phenomenon could not be induced after neutralization of virus by IgA 
at 37°C. This indicated that the low recovery of HA and infectivity was not sialic acid 
receptor specific, but required the presence of the whole cell. However, it could also be 
due to a lower stability of interaction with the fetuin compared to a cell.
Use of biotinylated virus showed that the virus-MAb complexes attached to 
CRBCs had become resistant to removal by bacterial neuraminidase. This 
neuraminidase-resistance was temperature-dependent and took place at 37°C but not at 
4°C. This was consistent with the results for the recovery of HA and infectivity at 4°C. 
The similarities o f the temperature profiles for the low recovery phenomenon and for 
conformational changes which result in the release of the fusion peptide and 
fusion/haemolysis of the virus at low pH suggests that the low recovery phenomenon 
may also be due to conformational changes of the viral HA. The bacterial 
neuraminidase resistance was also antibody concentration-dependent, with a lower 
recovery when higher concentrations of MAbs were used. This suggested that the 
higher concentration of MAbs may sterically hinder the access o f the bacterial
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neuraminidase to the virus-cell contact sites. Desialyation of fetuin, a neuraminidase 
substrate by the virus neuraminidase glycoproteins was also inhibited by the fringe of 
HA-specific MAbs, lending support to the idea that steric hindrance of the bacterial 
neuraminidase might be taking place.
In summary the low recovery phenomenon was>
(1) induced by all the MAbs after neutralization of attached virus at 37°C, indicating it 
not to be immunoglobin-type or antigenic site specific.
(2) concentration-dependent, giving lower recoveries at higher concentrations.
(3) not cell-type specific, being consistent with CRBCs, fixed MDCK cells and fixed 
H9 T-cells. This suggested that the low recovery of virus was not dependent on 
changes in cellular proteins.
(4) not seen when the virus was bound to the soluble receptor, fetuin.
(5) temperature-dependent, indicating that conformational changes may be involved.
(6) due to inhibition of the removal of virus-MAb complexes from the cell surface by 
bacterial neuraminidase.
Why does neutralization of attached virus by MAbs at 37°C result in a low 
recovery of virus from the cell surface?
A hypothesis to explain the low recovery of HA and infectivity of attached virus 
neutralization by MAbs at 37°C is described below and attempts to integrate all of the 
data described previously -
When attached to cells at 37°C the viral HA undergoes conformational or orientational 
changes, with respect to the cell receptors, with the result that the virus is drawn closer 
to the cell surface. Binding of MAb to the virus in high concentrations forms a fringe 
around the virus preventing access to HA-receptor contact site. The conformational 
change of the HA, which draws the virus closer to the surface, begins to occur at £ 
20°C. At 4°C, similar quantities of MAb bind but do not inhibit virus release by 
bacterial neuraminidase as the virus is attached at a distance from cell surface. It is 
possible that soluble receptors also induce this change, but without a cell membrane the 
low recovery phenomenon due to steric hindrance would not be observed. However, it 
is also possible that the change in the HA-receptor complex may be caused by the MAb 
binding, but this is unlikely as MAbs to 3 different antigenic sites on the HA caused the
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same effect. The main problem with this hypothesis is that no evidence has yet been 
described to confirm the existence of a conformational change of the HA upon receptor 
binding at 37°C and neutral pH. In fact a number of studies have been published that 
were antagonistic to this hypothesis. Firstly, the X-ray crystal structure of BHA 
complexed with its sialic acid receptor indicated no major conformational changes, but 
it is possible that BHA is not truly representative of the behaviour of the complete HA. 
In addition the structural analysis was carried out at 4°C, hence a high temperature- 
dependent change would not be seen (Weis et a l, 1988). Also a study of the protesase­
le stability of HA and HA attached to N-acetyl-neuraminyl lactose receptor analogue 
indicated that there were very little differences (Stegmann et a l, 1995). Again this 
study analysed changes of the HA upon receptor binding at 4°C and hence would not 
observe high temperature-dependent changes. However, there are a number of studies 
in support of a conformational or orientational change upon receptor binding. For 
example, a study of A/PR/8 virus liposome binding at low pH and 0°C indicated that 
only a subpopulation of the HA underwent a conformational change and exposed their 
fusion peptide (Tsurudome et a l, 1992). The authors speculated that the change in this 
subpopulation of HAs was triggered by interactions with ganglioside receptors on the 
liposomes. Recently, a study analysing virosome fusion to liposomes containing 
surrogate anti-HA Fab receptors, indicated that fusion is carried out by receptor bound 
HAs (Millar et a l, 1999). These authors suggested that receptors cause the orientational 
changes that prime (or target) the HA for delivery of fusion peptide. This model is 
speculative and without further experimentation alternative explanations are possible. 
For example, it is possible that the virus-MAb complexes could be internalised into the 
CRBCs by pinocytosis. A study demonstrating the pinocytosis of influenza virus by 
CRBCs using E M indicated that only about 9% of attached virus was internalised and 
pinocytotic vesicles are only detected after 5 minutes (Bossart et al., 1973). This would 
seem to be an unlikely explanation, as recoveries of virus are expressed as a percentage 
of the recovery of a non-neutralization virus control. As a result, the virus-MAb 
complexes would have to be pinocytosed preferentially and at a much faster rate than 
the virus control, as kinetics of low recovery of virus indicated that 75% could not be 
recovered after only 2 minutes. Perhaps a more plausible explanation could be that at 
37°C ‘blebbing’ of the CRBC membrane occurs which surrounds the virus particles. 
This effect, together with the fringe ofMAb, stericaily hinders access of the bacterial
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neuraminidase. Future work should involve investigation by electron microscopy to 
rule out the uptake of virus-MAb complexes into the cell and secondly to use receptor 
containing liposomes to try to repeat the low recovery phenomenon.
8.7.3 Reversibility o f H I and neutralization o f virus attached to CRBCs after
incubation at low pH  and 4 °C: IgA MAb
As HI and neutralization of attached virus at 4°C could be reversed, and as at 37°C, lack 
of recovery is likely to be due to steric hindrance, the point at which antibody induces 
an irreversible loss of infectivity had not yet been defined. The final investigation 
analysed the reversibility of HI and neutralization of attached virus after incubation at 
low pH, 4°C, which was intended to mimic early events that normally occur in the 
endosome of the infected cell. This represents the last stage of the influenza infectious 
cycle at which the antibody bound to the HA could trigger a signal that resulted in a 
permanent loss of infectivity. Unfortunately this experiment had to be carried out at
4°C to -
(1) prevent steric hindrance of the bacterial neuraminidase enzyme,
(2) prevent virus fusing with the CRBCs at low pH, which would prevent 
recovery virus,
(3) prevent loss of virus infectivity (pre-incubation of virus without the cell at 
low pH and at temperatures above 4°C results in loss of infectivity) (Korte et 
al., 1999).
The recovery of HA under these conditions was >85%. This indicated that the 
conformational changes in the viral HA that occur at pH5, 4°C (described in chapter 7) 
do not result in steric hindrance and low recovery. This suggests that the changes in the 
viral HA that take place at 37°C are of a different nature to those that occur at low pH 
and at low temperatures. A previous study has indicated that the X:31 strain of 
influenza A virus (H3N2) treated with low pH, at 4°C, could not be removed from a cell 
surface by neuraminidase, probably due to incorporation of the fusion peptide into the 
lipid bilayer (Chemomordik et al., 1998). The >85% recovery of low pH, 4°C treated 
virus with neuraminidase indicates that the majority of the A/PR/8 strain does not insert
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its fusion peptide into the lipid bilayer under these conditions, in agreement with 
previous studies (Brunner et al., 1991; Tsurudome et al., 1992; Pak et al., 1994). 
However, Pak et al., (1994) have demonstrated that at pH 5, 4°C the fusion peptide of 
A/PR/8 has been released. This suggests that the low pH induces changes in the stem 
region causing release of the fusion peptide, whilst higher temperatures (>15°C) cause 
different conformational or orientational changes that facilitate the fusion peptide 
interaction with the target membrane.
Unfortunately, analysis of the recovery of infectivity of virus incubated at low pH 
and 4°C was inconclusive. Only approximately 10% of the infectivity o f non- 
neutralized and neutralized virus was recovered as the low pH treated virus had become 
unstable in the AmOH treatment. However, comparison of the 10% recovered showed 
no differences between non-neutralized and neutralized virus. Therefore, this allows a 
tentative conclusion to be made that the permanent loss of infectivity had not been 
found. It is possible that the low amount of infectivity recovered may not have been 
representative of the 90% unaccounted for and secondly the signal for permanent loss of 
infectivity may require a high temperature (37°C). However, in my opinion these data 
argue against the existence of antibody mediated signal transduction and therefore data 
indicating that neutralization of influenza virus by the IgA MAb (H37-66) involves 
interference of a post-fusion event should be re-evaluated.
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9 Summary of results / discussion
9.1 Overview
Previous examination of the relevance of antibody molecular mass and valency to 
neutralization of influenza virus was inconclusive (Yoden et al., 1985; Schofield, 1996; 
Schofield et a l, 1997b). Schofield (1996) suggested that both valency and molecular 
mass are involved in efficient neutralization. These authors also found that antibody 
affinity was not the sole determinant of the efficiency of neutralization, and suggested 
that other factors, such as intrinsic properties of the epitope and differences in the 
mechanism of neutralization may be important (Schofield et al., 1997a). In this thesis 
the effect of antibody molecular mass and valency on the mechanism of neutralization 
was investigated.
It is commonly assumed that most antibodies neutralized by only one mechanism, 
being a steric inhibition of virus attachment to target cells (Jackson, 1998). PAN 
provides the strongest evidence in support of mechanisms of neutralization other than 
inhibition of viral attachment. Therefore, the ability to give PAN and the mechanism of 
PAN by HA-specific IgGs and their Fabs was investigated.
Earlier studies of the mechanisms of neutralization of influenza by MAbs have 
shown that some neutralize by inhibiting a post-fusion event (Possee et al., 1982; Rigg 
et al., 1989; Armstrong and Dimmock, 1992). Implicit for this mechanism is the ability 
of the antibody to transduce a signal from the envelope proteins to the core of the virus 
and result in an irreversible loss of infectivity. Schofield (1996) investigated the 
reversibility of HI and neutralization by MAbs, using mild denaturant AmOH to 
dissociate the MAbs from virus after neutralization. This initial study did not elucidate 
the point at which neutralization becomes irreversible and hence further investigation 
was carried out in this thesis.
9.2 The efficiency of neutralization
Fab neutralization efficiency was lower than its corresponding IgGs. At lower 
concentrations of Fab required to give 50% neutralization (N50) the neutralization 
efficiency was 104- to 370-fold lower than the IgGs, whilst at higher concentrations 
required to give 90% neutralization (N9o) the neutralization efficiency was 15- to 208-
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fold lower than the IgGs. Affinity was not a major factor in the lower neutralization 
efficiency of the Fabs. Measurements by SPR indicated that affinities of Fabs were 
very similar to their IgGs. The H37 Fab had the largest difference in affinity compared 
to its IgG, being 4.3-fold lower, but this was not able to explain either the 360-fold 
lower neutralization efficiency at N50 or the 170-fold lower efficiency at N90 compared 
to the IgG. These results support those obtained for a panel of HA-specific IgGs and 
Fabs to A/FPV/R virus (Schofield and Dimmock, 1996). Differences in the functional 
affinities of the Fabs and IgGs were too small to be solely responsible for the loss of 
neutralization seen when the IgGs are converted to Fabs. The authors suggested that the 
similar affinities of the Fabs and IgGs indicated that the IgGs were binding to virus 
monovalently, and hence the difference in neutralization efficiency could be due to the 
lower molecular mass of the Fab. However, the valency of the virus-IgG interaction 
was not established in this thesis or by Schofield and Dimmock, (1996) and hence it is 
possible that bivalent binding may have contributed to neutralization efficiency.
Schofield et a\ (1997a) suggested that the neutralization efficiency is affected by 
unknown properties of the epitope. The neutralization efficiency of the IgGs and Fabs 
in this thesis were ranked H36>H37>H9. These antibodies are specific for different 
antigenic sites, suggesting that the antigenic site may be important in the neutralization 
efficiency. It is possible that the relationship between the antigenic site and the 
receptor-binding site on the HA may be a property of the epitope that affects 
neutralization efficiency. For example, the H9 MAb which binds to site Cb, the furthest 
from the receptor-binding site, had a 20-fold lower efficiency of neutralization than the 
H36 IgG, which binds to site Sb on the tip of the HA, close to the receptor-binding site. 
This was further supported by results with the H9 Fab which showed that it did not 
inhibit virus attachment to target cells. In contrast, the H36 and H37 Fabs inhibited 
virus attachment to target cells, indicating that Fabs could sterically hinder the HA-cell 
receptor interaction. This suggested that the H9 Fab did not inhibit virus attachment to 
cells due to the distance of its its antigenic site from the receptor-binding site. 
Therefore, results in this thesis support the view of Schofield et al (1997a), that 
neutralization is affected by epitope specificity. However, a recent study of the 
neutralization of HIV-1 by a panel of MAbs to different epitope groups suggested that 
neutralization was epitope-independent (Parren et al., 1998). It was found that the 50% 
antibody binding values to oligomeric gpl20 and the 50% neutralization litres for MAbs 
specific for different epitope groups correlated. The authors concluded, by inference,
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that the occupancy of binding, i.e. the number of neutralization sites occupied, 
determines neutralization efficiency and not epitope specificity. It is possible that these 
contradictory views are due to the different viruses used, with epitope specificity being 
of greater importance in influenza neutralization than in HIV-1 neutralization. It is my 
opinion that the efficiency of neutralization by MAbs is multi-factorial, being dependent 
on the affinity, epitope specificity and also affected by molecular mass and valency 
when converted to Fab fragments.
9.3 The mechanism of neutralization of influenza A virus
The mechanism of neutralization of influenza virus by Fabs was different from their 
corresponding IgGs. The mechanism of neutralization of influenza virus by the IgGs 
was dependent on antibody concentration. At higher concentrations inhibition of 
attachment accounted for the majority of the loss of infectivity, whereas at lower 
concentrations inhibition of fusion was the dominant mechanism. In between these 
extremes both mechanisms operate simultaneously. In contrast, the mechanism of 
neutralization of the influenza virus by the Fabs was independent of antibody 
concentration. A good correlation between the inhibition of virus attachment to cells 
and the loss of infectivity was found with a range of concentrations of H36 and H37 
Fabs. However the H36 and H37 Fabs could also give PAN by inhibition of virus-cell 
fusion, indicating that they could neutralize by mechanisms other than inhibition of 
attachment under different conditions. The H9 Fab, did not inhibit virus attachment to 
cells, but inhibited virus-cell fusion. Interestingly, inhibition of virus attachment to 
cells by high concentrations of the H36 F(ab)2 accounted for the majority of the loss of 
infectivity, whilst at lower concentrations inhibition of attachment accounted for a 
minority of the loss of infectivity, in a similar manner to the IgGs. This suggested that 
bivalency was important for the ability of the IgGs to neutralize by two mechanisms 
simultaneously. However, it should be noted that molecular mass of the antibody must 
also play a role in the neutralization process, as F(ab)2 had an 8-fold and 2.5-fold loss of 
neutralization efficiency compared to its IgG at N50 and N90 respectively.
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9.4 PAN of influenza A virus
PAN by H36, H37 and H9 IgGs was of lower efficiency than the standard neutralization 
of unattached virus (STAN). However, PAN by the H36 and H37 Fabs was of similar 
efficiency to the STAN. This suggested that the IgGs may have limited access to the 
important sites on the virus for the PAN process, whereas the smaller size of the Fabs 
allowed for a less restricted access. The H9 Fab gave PAN that was of significantly 
higher efficiency than its STAN, suggesting that changes in the HA may have occurred 
to allow a greater access to the antigenic site Cb.
All of the IgGs and their Fabs shared a common mechanism of PAN, being 
inhibition of virus-cell fusion. This demonstrated the IgGs and Fabs can neutralize 
virus by mechanisms other than inhibition of virus attachment to cells, and supports the 
concept of simultaneous neutralization mechanisms as described previously for the 
mechanism of STAN. Collectively, these data suggest that inhibition of virus-cell 
fusion by the IgGs represents their primary neutralization mechanism, with inhibition of 
attachment probably a secondary event occurring at higher concentration of applied 
IgG.
Investigation of the inhibition of fusion by the antibodies, suggested that they 
inhibited an early stage in the fusion process. The efficiency of PAN is greater at high 
antibody concentration, hence antibodies may inhibit virus-cell fusion by molecular 
overcrowding (steric hindrance) at the fusion site (Millar et al., 1999). Therefore, this 
suggests that molecular mass of the antibody is the important factor in its neutralization 
process, with valency being of lesser importance.
9.5 Reversibility of HI and neutralization of influenza A virus
Investigation of the reversibility of HI and neutralization of influenza A virus was 
carried out to find conditions that would trigger a permanent loss of infectivity. 
Neutralization of virus in solution by three HA-specific IgGs and an IgA MAb could be 
reversed. Neutralization by the MAbs at 4°C of virus attached to CRBCs, could also be 
reversed. However, at 37°C the virus could not be recovered from the CRBC surface 
due to steric hindrance of the bacterial neuraminidase used to release the virus. The
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reversibility of neutralization of virus treated at low pH was analysed in order to mimic 
events encountered by the virus in the endosomal stage of its infectious cycle. When 
virus was neutralized and then induced to the pre-fusion intermediate, by treatment at 
pH 5 and 4°C, the virus could be recovered from the CRBC surface, but infectivity was 
about 10%. The loss of infectivity was due to the AmOH (pH 11.5) treatment, 
suggesting that changes occur in the HA when induced in the pre-fusion intermediate, 
that destabilize the HA making it more sensitive to high pH. This result strongly 
supports results in this thesis indicating that the virus HA of the pre-fusion intermediate 
had undergone conformational changes in its globular head domain as detected by a 
panel of conformation-specific MAbs. Approximately 10% of infectivity was recovered 
from both neutralized and non-neutralized low pH treated virus indicating that 
neutralization could be reversed. Hence, as this stage was designed to mimic the last 
point at which the antibody is associated with the core of the virus, it suggested that the 
antibodies do not cause a permanent loss of infectivity.
There are two schools-of-thought of how antibody binding relates to the 
mechanism of neutralization of viruses that have several neutralization sites, each 
containing numerous epitopes. The first proposes that viruses with multiple 
neutralization sites have critical and non-critical epitopes. Binding of one or a few 
antibodies to the critical sites could achieve neutralization, perhaps by triggering a 
signal that causes a permanent loss of infectivity, or by preventing a signal critical for 
infectivity (Dimmock, 1993; McLain and Dimmock, 1994; Dimmock, 1995). The 
second hypothesis known as the occupancy model, proposes that neutralization results 
when the number of unoccupied neutralization sites (epitopes) falls below a threshold 
required for infectivity (Klasse and Moore, 1996; Parren et al., 1998). The inability to 
detect a permanent loss of infectivity in the analysis of reversibility argues against the 
single or critical-hit model of neutralization, and supports the occupancy model. The 
occupancy model assumes that antibodies neutralize by steric hindrance of early events 
of the virus infectious process. It has been proposed in this thesis that the MAbs inhibit 
both the virus attachment to cells and virus-cell fusion by steric hindrance, which also 
fits the occupancy model. However, the occupancy model implies that epitope 
specificity is of limited importance, whereas in this thesis the converse has been argued, 
especially with antibodies binding to antigenic site Cb. It should also be noted that 
neutralized virus was treated with low pH at 4°C which does not accurately represent
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physiological conditions. It is possible that the trigger for the signal that causes a 
permanent loss of infectivity may require a temperature of 37°C.
9.6 Does the influenza virus HA undergo conformational or
orientational changes after binding to the cell receptor?
The generally accepted view, based on the X-ray crystal structure of the BHA-sialic 
acid complex, is that a conformational change does not occur on binding of the HA to 
its cell receptor (Weis et a l, 1988). However, a number of observations in this thesis 
suggest that the influenza A/PR/8/34 HA does undergo change(s) on binding to the cell 
receptor. For example, the H9 Fab had a higher efficiency of PAN than STAN at 37°C. 
This suggested that after binding to the cell receptor the antigenic site, Cb, was more 
accessible to the Fab. A previous study of a panel of MAbs to A/PR/8 virus 
demonstrated that MAbs specific for site Cb had higher binding levels after the virus 
was treated at low pH (Yewdell et a l, 1983). Though this study does not implicate the 
receptor in any changes, it does suggest that conformational changes in the HA can 
increase the accessibility of site Cb.
The recovery of virus from the surface of CRBCs after neutralization by MAbs at 
37°C was <10%. Investigation of the low recovery indicated that the MAbs were 
sterically hindering access of the bacterial neuraminidase, hence inhibiting release. 
However, the MAbs could only inhibit release of the virus by the bacterial 
neuraminidase after the virus had been neutralized at temperatures >20°C. Therefore, it 
was proposed that changes in the HA after binding to the cell receptor at 37°C draws the 
virus closer to the cell surface, hence allowing the fringe of MAb to inhibit access of the 
bacterial neuraminidase. Therefore, this data also supports the idea of changes in the 
HA on cell receptor binding. Recently, a tilting of the HA (50 to 70° angle) has been 
observed after low pH treatment (Tatulian et a l, 1995); Tatulian and Tamm, 1996). It 
is possible that the receptor binding may also induce tilting of the viral HA, hence 
drawing the virus closer to the cell surface. This may function to increase the number 
of HA-receptor interactions and hence stabilise the attachment of virus to cells. This 
idea is supported by a recent study showing a higher affinity binding of influenza virus
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at 37°C, compared to 4°C, suggesting a higher number of receptors are involved in the 
virus attachment at 37°C (Nunes-Correia et ah, 1999).
A further possible function of changes in the virus HA on cell receptor-binding is 
in the fusion process. It is possible that conformational or orientational changes ‘prime’ 
the virus HA for fusion. The hypothesis that the receptor-bound HAs are involved in 
the fusion process remains a controversial area, with a number of studies suggested that 
receptor-bound HAs are not involved (Ellens et al., 1990; Alford et al., 1994). 
However, studies have provided evidence that receptor-binding facilitates the fusion 
process by increasing efficiency and decreasing the lag phase (Stegmann et al., 1995), 
Also a recent study of virosomes containing two antigenically distinct HAs fusing to 
liposomes containing anti-HA Fabs as surrogate receptors, indicated that the HA bound 
to the Fabs was responsible for the fusion activity (Millar et al., 1999). Investigation of 
fusion of influenza A/PR/8/34 (H1N1) virus bound to liposomes at low pH and 0°C, 
indicated that only a subpopulation of HA underwent a conformational change that 
exposed the fusion peptide (Tsurudome et al., 1992). The authors speculated that 
binding to ganglioside receptors triggered the change in this subpopulation. There was 
a 30-fold greater insertion of fusion peptides into the target liposomes membrane after 
the temperature was raised to 37°C. Therefore, it is possible that the HA-cell receptor 
interaction alters the extent or rate of conformational changes and primes the HA for 
insertion of its fusion peptide into the target membranes. Investigation in this thesis of 
the pre-fusion intermediate of A/PR/8 virus, that was induced by treatment at pH 5 and 
4°C, indicated that the globular head domain undergoes a conformational relaxation, 
and also changes in the HA2 stem region allowed release of the fusion peptides (Pak et 
al., 1994). However, even though fusion peptides are released the pre-fusion 
intermediate does not display any fusion activity indicating that the fusion peptides are 
not inserted into the target membrane, or that the extent of fusion peptide insertion was 
not sufficient to cause fusion. Fusion only occurs when the temperature is increased to 
37°C. It is tempting to speculate that perhaps tilting of the HA occurs at 37°C that 
allows insertion of the exposed fusion peptides to the target membrane.
It is interesting that the pre-fusion intermediate forms a fusion-committed state 
and causes haemolysis of CRBCs with high efficiency when incubated at neutral pH 
and 37°C. A study with the X:31 strain of influenza virus has also described a fusion- 
committed state, which fuses to erythrocytes when incubated at neutral pH and 37°C.
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The kinetics and extent of the neutral pH fusion was dependent on the time period of the 
low pH incubation at 4°C, when attached to the erythrocytes (Schoch et al., 1992). 
These studies suggest that incubation at low pH and 4°C in association with cell 
receptors prime the HAs for fusion, so that they only require the further conformational 
changes associated with increased temperature.
It is evident from the literature and data in this thesis that there is a weight of 
circumstantial evidence indicating that changes in the HA on receptor-binding could 
occur and may be important in efficient fusion. However, direct structural evidence is 
lacking and hence this hypothesis requires further investigation.
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I. Appendix
1.1 Calculation of the percentage internalisation of neutralized 
virus, incorporating the correction for the inhibition of 
attachment:
Analysis of the internalisation into MDCK cells of virus neutralized by 0.67 nM 
H36 IgG -
Mean level of internalisation of non-neutralized virus = 1.27 (OD 405nm)
Mean level of internalisation of virus neutralized by 0.67 nM H36 IgG = 0.88 (OD 
405nm)
Percentage internalisation of neutralized virus -
(0.88/1.27)x 100 = 69.3%
Percentage inhibition of attachment, calculated by attachment ELISA = 24%
Therefore, percentage internalisation of neutralized virus, corrected for inhibition of 
attachment -
69.3+24 = 93.3%
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1.2 Calculation of the percentage fusion of neutralized virus, 
incorporating the correction for inhibition of attachment:
Analysis of the fusion in MDCK cells of virus neutralized by 0.33 nM H36 IgG -
Mean level of fluorescence due to fusion of non-neutralized virus = 463
Mean total fluorescence after Triton-X100 of non-neutralized virus = 764
Mean level of fluorescence due to fusion of virus neutralized by 0.33 nM H36 IgG
= 192
Mean total fluorescence after Triton-X100 treatment of neutralized virus = 689
Percentage attachment of virus neutralized by 0.33 nM H36 IgG -
(689/764)X100 = 90.2%
Hence, only 90% of the neutralized virus attaches to cells, so must be compared to 
equivalent amount of non-neutralized virus.
Level of fluorescence due to fusion of 90% of non-neutralized virus control -
463x0.9 = 416.7
Therefore, the percentage fusion of virus neutralized by 0.33 nM H36 IgG -
(192/416.7)X100 = 46%
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I. Figure 1.1 Analysis of the relationship between A/PR/8 virus 
internalisation in MDCK cells and PAN as a function of H37 IgG. PAN and
infectivity were assayed in parallel in the same batch of monolayers in 96 well 
plates, using the same virus and antibody stocks. All data are the mean of three 
experiments. The curve has been generated by non-linear regression using the 
Graphpad Prism package (R = 0.99).
1.3 Analysis of the relationship between A/PR/8 virus PAN and
internalisation as a function of antibody concentration.
Log (M)
Internalisation A PAN
Table 1.1 Analysis of the internalisation of non-neutralized (N0) virus under the 
negative control conditions. Data are presented as percentage inhibition of 
internalisation relative to non-neutralized virus at 37°C.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N„ 90 (+/- 3)
Hypertonic treated - No 87 (+/- 11)
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Figure 1.2 Analysis of the relationship between A/PR/8 virus internalisation in 
MDCK cells and PAN as a function of H37 Fab. PAN and infectivity were 
assayed in parallel in the same batch of monolayers in 96 well plates, using the same 
virus and antibody stocks. All data are the mean of three experiments. The curve 
has been generated as in Figure 1.1 (R = 0.98).
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Table 1.2 Analysis of the internalisation of non-neutralized (No) virus under the 
negative control conditions. Data are presented as percentage inhibition of 
internalisation relative to non-neutralized virus at 37°C.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 84 (+/- 3)
Hypertonic treated - No 79 (+/- 6)
237
Figure 1.3 Analysis of the relationship between A/PR/8 virus internalisation in 
MDCK cells and PAN as a function of H9 IgG. PAN and infectivity were assayed 
in parallel in the same batch of monolayers in 96 well plates, using the same virus 
and antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 1.1 (R = 0.98).
Log (M)
gg Internalisation A PAN
Table 1.3 Analysis of the internalisation of non-neutralized (No) virus under the 
negative control conditions. Data are presented as percentage inhibition of 
internalisation relative to non-neutralized virus at 37°C.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  N„ 95 (+/- 8)
Hypertonic treated - No 84 (+/- 11)
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Figure 1.4 Analysis of the relationship between A/PR/8 virus internalisation in 
MDCK cells and PAN as a function of H9 Fab. PAN and infectivity were assayed 
in parallel in the same batch of monolayers in 96 well plates, using the same viais 
and antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 1.1 (R = 0.97).
Log (M)
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Table 1.4 Analysis of the internalisation of non-neutralized (No) virus under the 
negative control conditions. Data are presented as percentage inhibition of 
internalisation relative to non-neutralized virus at 37°C.
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 91 (+/- 8)
Hypertonic treated - No 80 (+/- 9)
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Figure 1.5 Analysis of the relationship between A/PR/8 virus PAN and virus- 
cell-fusion as a function of H37 IgG concentration. PAN and fusion were assayed 
in parallel in the same batch of monolayers in 3cm plates, using the same virus and 
antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 1.1 (R = >0.98 for both curves).
1.4 Analysis of the relationship between A/PR/8 virus PAN and
virus-cell fusion as a function of antibody concentration.
Table 1.5 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 93 (+/- 4)
Bafilomycin treated - No 85 (+/- 10)
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Figure 1.6 Analysis of the relationship between A/PR/8 virus PAN and virus- 
cell-fusion as a function of H37 Fab concentration. PAN and fusion were assayed 
in parallel in the same batch of monolayers in 3cm plates, using the same virus and 
antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 1.1 (R = >0.98 for both curves).
Table 1.6 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 87 (+/- 7)
Bafilomycin treated - N0 78 (+/- 9)
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Figure 1.7 Analysis of the relationship between A/PR/8 virus PAN and virus- 
cell-fusion as a function of H9 IgG concentration. PAN and fusion were assayed 
in parallel in the same batch of monolayers in 3cm plates, using the same virus and 
antibody stocks. All data are the mean of three experiments. The curve has been 
generated as in Figure 1.1 (R = >0.97 for both curves).
Table 1.7 Analysis of the fusion of non-neutralized virus under the negative 
control conditions. Data are presented as percentage inhibition of fusion relative to 
non-neutralized virus at 37°C. Data are the mean of three experiments
Control conditions % inhibition o f
internalisation
Cold (4°C) -  No 85 (+/- 7)
Bafilomycin treated - No 85 (+/- 11)
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1.5 Analysis of the effect of the antibodies on the haemolysis of
CRBCs by pre-attached A/PR/8 virus.
Figure 1.8 Analysis of the effect of H37 IgG concentration on the haemolysis of 
CRBCs by pre-attached A/PR/8 virus. Data are the mean of four experiments. 
Bars represent the SEM.
243
Figure 1.9 Analysis of the effect of H37 Fab concentration on the haemolysis of 
CRBCs by pre-attached A/PR/8 virus. Data are the mean of four experiments. 
Bars represent the SEM.
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Figure 1.10 Analysis of the effect of H9 IgG concentration on the haemolysis of 
CRBCs by pre-attached A/PR/8 virus. Data are the mean of four experiments. 
Bars represent the SEM.
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1.6 Investigation of the effect of the antibodies on haemolysis of
CRBCs by the cold-fusion intermediate of A/PR/8 virus.
Figure 1.11 Analysis of the effect of H37 IgG and Fab on haemolysis of CRBCs 
by the cold-fusion intermediate of A/PR/8 virus. All data have been subtracted 
from the background haemolysis obtained from CRBC controls without virus. All 
control samples were treated as the virus containing samples. Data are the means of 
experiments. Bars represent the SEM. X-axis labels -  V-pH7 = pre-attached virus 
incubated at 4°C and pH7, V-pH5 — pre-attached virus at 4°C and pH5, V-IA = vims 
inactivated at 37°C and pH5 prior to attachment, lgG-pH7 = H37 IgG at 120nM, 
incubated with pH7 treated vims, Fab-pH7 = H37 Fab at 3pM, incubated with pH7 
treated vims, IgG-pH5 = H37 IgG at lOOnM, incubated with pH5 treated virus, Fab- 
pH5 = H37 Fab at 3pM, incubated with pH5 treated vims.
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Figure 1.12 Analysis of the effect of H9 IgG and Fab on haemolysis of CRBCs by 
the cold-fusion intermediate of A/PR/8 virus. All data have been subtracted from 
the background haemolysis obtained from CRBC controls without virus. All control 
samples were treated as the virus containing samples. Data are the means of 
experiments. Bars represent the SEM. X-axis labels -  V-pH7 = pre-attached virus 
incubated at 4°C and pH7, V-pH5 = pre-attached virus at 4°C and pH5, V-IA = virus 
inactivated at 37°C and pH5 prior to attachment, IgG-pH7 = H9 IgG at 1334nM, 
incubated with pH7 treated virus, Fab-pH7 = H9 Fab at 20pM, incubated with pH7 
treated virus, IgG-pH5 = H9 IgG at 1334nM, incubated with pH5 treated virus, Fab- 
pH5 = H9 Fab at 20pM, incubated with pH5 treated virus.
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1.7 T he affect of PAN by the Tabs on the low pH induced conform ational change of the HA.
Figure 1.13 Analysis of the affect of H37 Fab on the low pH-induced conformational change of the HA of A/PR/8 virus (in PAN-like 
format). Virus was attached to fixed monolayers at 4°C and then incubated with Fab at 4 or 37°C. Neutralized virus was then incubated with pH
5 or 7 at 4 or 37°C, and then probed with conformation-specific MAbs. Graph shows binding of conformation-specific MAbs to virus. All data 
have been subtracted from a cell monolayer control without virus. Data are the mean of three experiments. The bars represent the SEM. X-axis 
labels -  V-pH7(37°C) = attached virus incubated at pH7 and 37°C, V-pH5(37°C) = attached virus incubated at pH5 and 37°C, V-pH5(4°C) = as 
previous but at 4°C, Fab-pH7(37°C) = H37 Fab at 3pM incubated with attached virus treated at pH7 and 37°C, Fab-pH5(37°C) = H37 Fab at
3pM incubated with attached virus treated at pH5 and 37°C, Fab-pH5(4°C) = as previous but at 4°C. H17 IgG
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H3 IgG 
H2 IgG 
]Y8 IgG
1 . 7 5 - ]
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Figure 1.14 Analysis of the affect of 119 Fab on the low pH-induced conformational change of the HA of A/PR/8 virus (in PAN-like 
format). Virus was attached to fixed monolayers at 4°C and then incubated with Fab at 4 or 37°C. Neutralized virus was then incubated with pH 
5 or 7 at 4 or 37°C, and then probed with conformation-specific MAbs. Graph shows binding of conformation-specific MAbs to virus. All data 
have been subtracted from a cell monolayer control without virus. Data are the mean of three experiments. The bars represent the SEM. X-axis 
labels -  V-pH7(37°C) = attached virus incubated at pH7 and 37°C, V-pH5(37°C) = attached virus incubated at pH5 and 37°C, V-pH5(4°C) = as 
previous but at 4°C, Fab-pH7(37°C) = H9 Fab at 20pM incubated with attached virus treated at pH7 and 37°C, Fab-pH5(37°C) = H9 Fab at 
20pM incubated with attached virus treated at pH5 and 37°C, Fab-pH5(4°C) = as previous but at 4°C.
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1.8 Investigation of the effect of H36 Fab on the low pH induced 
conform ational change o f the viral HA by proteinase-K  
digestion.
Figure 1.15 Susceptibility to proteinase-K digestion following low pH treatment 
of neutralized or non-neutralized virus. Virus was incubated with H36 Fab or 
PBS, followed by exposure to pH 5 or pH 7.5 for 30 minutes, returned to pH 7.5 and 
then digested with 1 pg/ml of proteinase-K for 30 minutes at 37°C.
Lane 1 = non-neutralized virus, incubated at pH 5
2 = non-neutralized virus, incubated at pH 7.5
3 = H36 Fab incubated at pH 7.5
4 = neutralized virus, incubated at pH 5
5 = H36 Fab incubated at pH 5
6 = neutralized virus, incubated at pH 7.5.
NP, nucleoprotein; Ml, matrix protein; HA1 and 2, haemagglutinin protein
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1.9 Reversibility o f HI by ammonium hydroxide.
Figure 1.16 Reversibility of HI by ammonium hydroxide: IgA. Enough IgA was 
used to completely inhibit the HA titre. This mixture was incubated with 0.1M 
AmOH (pH 11.5) for 30 minutes at 4°C and then virus was separated from antibody 
by size exclusion on a Sephacryl SI000 column. 100 pi fractions were collected, 
returned to neutral pH and assayed for HA activity. Graphs show example of the 
recovery of HA in each fraction.
1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0
F ra c tio n
1.10 Reversibility o f HI and neutralization of virus pre-attached to 
CRBCs
Figure 1.17 Analysis of the reversibility of HI and neutralization of virus pre­
attached to CRBCs: H37 IgG. (A) This shows the percentage recovery of HA 
compared to a non-neutralized virus control. Data are the sum of the ten fractions 
collected from the S-1000 column. (B) This shows the percentage recovery of 
infectivity compared to a non-neutralized virus control. Data are the sum of the 
infectivity of the three peak HA fractions. Data are the mean of three experiments. 
The lines represent the standard error of the mean (SEM). 40+A = pre-attached virus 
neutralized with 40 pg/ml of H37 IgG, treated with 1 U/ml bacterial neuraminidase 
and then incubated with AmOH; 40+P = pre-attached virus neutralized with 40 
p.g/ml of H37 IgG, treated with 1 U/ml bacterial neuraminidase and then incubated 
with PBS; 50+A and 50+P = same as above, but with 50 pg/ml H37 IgG. 4°C and 
37°C below labels refer to the temperature that the virus was neutralized.
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Figure 1.18 Analysis of the reversibility of HI and neutralization of virus prc- 
attached to CRBCs: H9 IgG. (A) This shows the percentage recovery of HA 
compared to a non-neutralized virus control. Data are the sum of the ten fractions 
collected from the S-1000 column. (B) This shows the percentage recovery of 
infectivity compared to a non-neutralized virus control. Data are the sum of the 
infectivity of the three peak HA fractions. Data are the mean of three experiments. 
The lines represent the standard error of the mean (SEM). 50+A = pre-attached virus 
neutralized with 50 p-g/ml of H9 IgG, treated with 1 U/ml bacterial neuraminidase 
and then incubated with AmOH; 50+P = pre-attached virus neutralized with 50 
(ig/ml of H9 IgG, treated with 1 U/ml bacterial neuraminidase and then incubated 
with PBS; 75+A and 75+P = same as above, but with 75 pg/ml H9 IgG. 4°C and 
37°C below labels refer to the temperature that the virus was neutralized
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